ID CAH2_HUMAN Reviewed; 260 AA. AC P00918; B2R7G8; Q6FI12; Q96ET9; DT 21-JUL-1986, integrated into UniProtKB/Swiss-Prot. DT 23-JAN-2007, sequence version 2. DT 02-SEP-2026, entry version 279. DE RecName: Full=Carbonic anhydrase 2; DE EC=4.2.1.1 {ECO:0000269|PubMed:12171926, ECO:0000269|PubMed:15300855, ECO:0000269|PubMed:1909891, ECO:0000269|PubMed:1910042, ECO:0000269|PubMed:4994926, ECO:0000269|PubMed:7761440, ECO:0000269|PubMed:7901850, ECO:0000269|PubMed:9398308}; DE AltName: Full=Carbonate dehydratase II; DE AltName: Full=Carbonic anhydrase C; DE Short=CAC; DE AltName: Full=Carbonic anhydrase II; DE Short=CA-II; DE AltName: Full=Cyanamide hydratase CA2 {ECO:0000305}; DE EC=4.2.1.69 {ECO:0000269|PubMed:10550681}; GN Name=CA2; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=3108857; DOI=10.1093/nar/15.11.4687; RA Montgomery J.C., Venta P.J., Tashian R.E., Hewett-Emmett D.; RT "Nucleotide sequence of human liver carbonic anhydrase II cDNA."; RL Nucleic Acids Res. 15:4687-4687(1987). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RX PubMed=3121496; DOI=10.1016/0888-7543(87)90008-5; RA Murakami H., Marelich G.P., Grubb J.H., Kyle J.W., Sly W.S.; RT "Cloning, expression, and sequence homologies of cDNA for human carbonic RT anhydrase II."; RL Genomics 1:159-166(1987). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RA Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S., Neubert P., RA Kstrang K., Schatten R., Shen B., Henze S., Mar W., Korn B., Zuo D., Hu Y., RA LaBaer J.; RT "Cloning of human full open reading frames in Gateway(TM) system entry RT vector (pDONR201)."; RL Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Urinary bladder; RX PubMed=14702039; DOI=10.1038/ng1285; RA Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., RA Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., RA Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S., RA Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., RA Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., RA Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., RA Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., RA Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., RA Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., RA Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., RA Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., RA Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., RA Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., RA Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., RA Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., RA Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., RA Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., RA Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., RA Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., RA Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., RA Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., RA Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., RA Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., RA Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., RA Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., RA Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., RA Isogai T., Sugano S.; RT "Complete sequencing and characterization of 21,243 full-length human RT cDNAs."; RL Nat. Genet. 36:40-45(2004). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Ovary; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [7] RP PROTEIN SEQUENCE OF 2-260, CLEAVAGE OF INITIATOR METHIONINE, AND RP ACETYLATION AT SER-2. RX PubMed=4207120; DOI=10.1016/s0021-9258(19)42734-8; RA Lin K.-T.D., Deutsch H.F.; RT "Human carbonic anhydrases. XII. The complete primary structure of the C RT isozyme."; RL J. Biol. Chem. 249:2329-2337(1974). RN [8] RP PROTEIN SEQUENCE OF 2-260. RX PubMed=823150; DOI=10.1016/s0021-9258(17)33081-8; RA Henderson L.E., Henriksson D., Nyman P.O.; RT "Primary structure of human carbonic anhydrase C."; RL J. Biol. Chem. 251:5457-5463(1976). RN [9] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-77. RX PubMed=3000449; DOI=10.1016/0167-4781(85)90006-5; RA Venta P.J., Montgomery J.C., Hewett-Emmett D., Tashian R.E.; RT "Comparison of the 5' regions of human and mouse carbonic anhydrase II RT genes and identification of possible regulatory elements."; RL Biochim. Biophys. Acta 826:195-201(1985). RN [10] RP FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES. RX PubMed=4994926; DOI=10.1016/s0021-9258(18)62326-9; RA Khalifah R.G.; RT "The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow RT kinetic studies on the native human isoenzymes B and C."; RL J. Biol. Chem. 246:2561-2573(1971). RN [11] RP INTERACTION WITH SLC4A4. RX PubMed=14567693; DOI=10.1021/bi0353124; RA Alvarez B.V., Loiselle F.B., Supuran C.T., Schwartz G.J., Casey J.R.; RT "Direct extracellular interaction between carbonic anhydrase IV and the RT human NBC1 sodium/bicarbonate co-transporter."; RL Biochemistry 42:12321-12329(2003). RN [12] RP INTERACTION WITH SLC4A7. RX PubMed=14736710; DOI=10.1152/ajpcell.00382.2003; RA Loiselle F.B., Morgan P.E., Alvarez B.V., Casey J.R.; RT "Regulation of the human NBC3 Na+/HCO3- cotransporter by carbonic anhydrase RT II and PKA."; RL Am. J. Physiol. 286:C1423-C1433(2004). RN [13] RP INTERACTION WITH SLC4A4. RX PubMed=15218065; DOI=10.1113/jphysiol.2004.065110; RA Pushkin A., Abuladze N., Gross E., Newman D., Tatishchev S., Lee I., RA Fedotoff O., Bondar G., Azimov R., Ngyuen M., Kurtz I.; RT "Molecular mechanism of kNBC1-carbonic anhydrase II interaction in proximal RT tubule cells."; RL J. Physiol. (Lond.) 559:55-65(2004). RN [14] RP FUNCTION, INTERACTION WITH SLC26A6, AND SUBCELLULAR LOCATION. RX PubMed=15990874; DOI=10.1038/sj.emboj.7600736; RA Alvarez B.V., Vilas G.L., Casey J.R.; RT "Metabolon disruption: a mechanism that regulates bicarbonate transport."; RL EMBO J. 24:2499-2511(2005). RN [15] RP ACTIVITY REGULATION, FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=17314045; DOI=10.1016/j.bmcl.2007.01.113; RA Temperini C., Innocenti A., Guerri A., Scozzafava A., Rusconi S., RA Supuran C.T.; RT "Phosph(on)ate as a zinc-binding group in metalloenzyme inhibitors: X-ray RT crystal structure of the antiviral drug foscarnet complexed to human RT carbonic anhydrase I."; RL Bioorg. Med. Chem. Lett. 17:2210-2215(2007). RN [16] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RX PubMed=21269460; DOI=10.1186/1752-0509-5-17; RA Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., RA Bennett K.L., Superti-Furga G., Colinge J.; RT "Initial characterization of the human central proteome."; RL BMC Syst. Biol. 5:17-17(2011). RN [17] RP PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-165 AND SER-172, AND RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Liver; RX PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014; RA Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L., RA Ye M., Zou H.; RT "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver RT phosphoproteome."; RL J. Proteomics 96:253-262(2014). RN [18] RP X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS). RX PubMed=4621826; DOI=10.1038/newbio235131a0; RA Liljas A., Kannan K.K., Bergsten P.-C., Waara I., Fridborg K., RA Strandberg B., Carlbom U., Jaerup L., Loevgren S., Petef M.; RT "Crystal structure of human carbonic anhydrase C."; RL Nature New Biol. 235:131-137(1972). RN [19] RP X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) IN COMPLEX WITH ZINC ION. RX PubMed=3151019; DOI=10.1002/prot.340040406; RA Eriksson A.E., Jones T.A., Liljas A.; RT "Refined structure of human carbonic anhydrase II at 2.0-A resolution."; RL Proteins 4:274-282(1988). RN [20] RP X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) IN COMPLEX WITH ZINC ION AND RP INHIBITORS. RX PubMed=3151020; DOI=10.1002/prot.340040407; RA Eriksson A.E., Kylsten P.M., Jones T.A., Liljas A.; RT "Crystallographic studies of inhibitor binding sites in human carbonic RT anhydrase II: a pentacoordinated binding of the SCN-ion to the zinc at high RT pH."; RL Proteins 4:283-293(1988). RN [21] RP X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF MUTANT SER-199 IN COMPLEX WITH RP ZINC ION, FUNCTION, CATALYTIC ACTIVITY, MUTAGENESIS OF THR-199, AND RP BIOPHYSICOCHEMICAL PROPERTIES. RX PubMed=1909891; DOI=10.1021/bi00102a005; RA Krebs J.F., Fierke C.A., Alexander R.S., Christianson D.W.; RT "Conformational mobility of His-64 in the Thr-200TO: human carbonic RT anhydrase II."; RL Biochemistry 30:9153-9160(1991). RN [22] RP X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF MUTANTS PHE-142; TYR-142 AND RP HIS-142 IN COMPLEX WITH INHIBITORS, AND MUTAGENESIS OF VAL-142. RX PubMed=1932029; DOI=10.1021/bi00110a008; RA Alexander R.S., Nair S.K., Christianson D.W.; RT "Engineering the hydrophobic pocket of carbonic anhydrase II."; RL Biochemistry 30:11064-11072(1991). RN [23] RP X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF MUTANT ALA-121, FUNCTION, RP CATALYTIC ACTIVITY, MUTAGENESIS OF VAL-121, AND ACTIVITY REGULATION. RX PubMed=1910042; DOI=10.1016/s0021-9258(19)47376-6; RA Nair S.K., Calderone T.L., Christianson D.W., Fierke C.A.; RT "Altering the mouth of a hydrophobic pocket. Structure and kinetics of RT human carbonic anhydrase II mutants at residue Val-121."; RL J. Biol. Chem. 266:17320-17325(1991). RN [24] RP X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) IN COMPLEX WITH ZINC ION AND RP INHIBITORS, ACTIVITY REGULATION, FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=1336460; DOI=10.1111/j.1432-1033.1992.tb17490.x; RA Mangani S., Haakansson K.; RT "Crystallographic studies of the binding of protonated and unprotonated RT inhibitors to carbonic anhydrase using hydrogen sulphide and nitrate RT anions."; RL Eur. J. Biochem. 210:867-871(1992). RN [25] RP X-RAY CRYSTALLOGRAPHY (1.54 ANGSTROMS) IN COMPLEX WITH ZINC ION AND RP INHIBITORS. RX PubMed=1433293; DOI=10.1016/0022-2836(92)90531-n; RA Haakansson K., Carlsson M., Svensson L.A., Liljas A.; RT "Structure of native and apo carbonic anhydrase II and structure of some of RT its anion-ligand complexes."; RL J. Mol. Biol. 227:1192-1204(1992). RN [26] RP X-RAY CRYSTALLOGRAPHY (1.88 ANGSTROMS) IN COMPLEX WITH COBALT ION AND RP BICARBONATE. RX PubMed=1474587; DOI=10.1016/0022-2836(92)90327-g; RA Haakansson K., Wehnert A.; RT "Structure of cobalt carbonic anhydrase complexed with bicarbonate."; RL J. Mol. Biol. 228:1212-1218(1992). RN [27] RP X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF MUTANT CYS-94 IN COMPLEX WITH RP ZINC ION, AND MUTAGENESIS OF HIS-94. RX PubMed=8431430; DOI=10.1021/bi00057a015; RA Alexander R.S., Kiefer L.L., Fierke C.A., Christianson D.W.; RT "Engineering the zinc binding site of human carbonic anhydrase II: RT structure of the His-94-->Cys apoenzyme in a new crystalline form."; RL Biochemistry 32:1510-1518(1993). RN [28] RP X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF MUTANT ALA-197; GLU-197; HIS-197 RP AND ARG-197, FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF LEU-197. RX PubMed=8485129; DOI=10.1021/bi00068a005; RA Nair S.K., Christianson D.W.; RT "Structural consequences of hydrophilic amino acid substitutions in the RT hydrophobic pocket of human carbonic anhydrase II."; RL Biochemistry 32:4506-4514(1993). RN [29] RP X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) OF MUTANT CYS-198 IN COMPLEX WITH RP ZINC ION, FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF THR-198. RX PubMed=8399159; DOI=10.1021/bi00089a005; RA Ippolito J.A., Christianson D.W.; RT "Structure of an engineered His3Cys zinc binding site in human carbonic RT anhydrase II."; RL Biochemistry 32:9901-9905(1993). RN [30] RP X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF MUTANT ALA-201 IN COMPLEX WITH RP ZINC ION, FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF PRO-201. RX PubMed=8218160; DOI=10.1021/bi00092a003; RA Tweedy N.B., Nair S.K., Paterno S.A., Fierke C.A., Christianson D.W.; RT "Structure and energetics of a non-proline cis-peptidyl linkage in a RT proline-202-->alanine carbonic anhydrase II variant."; RL Biochemistry 32:10944-10949(1993). RN [31] RP X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) IN COMPLEX WITH ZINC ION AND RP INHIBITORS. RX PubMed=8482389; DOI=10.1016/0014-5793(93)81565-h; RA Joensson B.M., Haakansson K., Liljas A.; RT "The structure of human carbonic anhydrase II in complex with bromide and RT azide."; RL FEBS Lett. 322:186-190(1993). RN [32] RP X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) OF MUTANT VAL-198 IN COMPLEX WITH RP ZINC ION AND INHIBITORS, FUNCTION, CATALYTIC ACTIVITY, MUTAGENESIS OF RP THR-198, AND BIOPHYSICOCHEMICAL PROPERTIES. RX PubMed=8262987; DOI=10.1016/s0021-9258(19)74269-0; RA Krebs J.F., Ippolito J.A., Christianson D.W., Fierke C.A.; RT "Structural and functional importance of a conserved hydrogen bond network RT in human carbonic anhydrase II."; RL J. Biol. Chem. 268:27458-27466(1993). RN [33] RP X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) IN COMPLEX WITH INHIBITOR AND ZINC RP ION. RX PubMed=8331673; DOI=10.1006/jmbi.1993.1365; RA Mangani S., Liljas A.; RT "Crystal structure of the complex between human carbonic anhydrase II and RT the aromatic inhibitor 1,2,4-triazole."; RL J. Mol. Biol. 232:9-14(1993). RN [34] RP X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF MUTANT HIS-199 IN COMPLEX WITH RP BICARBONATE AND ZINC ION, FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF RP THR-199. RX PubMed=8451242; DOI=10.1002/prot.340150110; RA Xue Y., Vidgren J., Svensson L.A., Liljas A., Jonsson B.H., Lindskog S.; RT "Crystallographic analysis of Thr-200-->His human carbonic anhydrase II and RT its complex with the substrate, HCO3-."; RL Proteins 15:80-87(1993). RN [35] RP X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) OF MUTANTS IN COMPLEX WITH RP BICARBONATE AND ZINC ION, FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF RP GLU-106 AND THR-198. RX PubMed=7901850; DOI=10.1002/prot.340170112; RA Xue Y., Liljas A., Jonsson B.H., Lindskog S.; RT "Structural analysis of the zinc hydroxide-Thr-199-Glu-106 hydrogen-bond RT network in human carbonic anhydrase II."; RL Proteins 17:93-106(1993). RN [36] RP X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) IN COMPLEX WITH COBALT; COPPER; RP NICKEL AND MANGANESE IONS. RX PubMed=15299481; DOI=10.1107/s0907444993008790; RA Haakansson K., Wehnert A., Liljas A.; RT "X-ray analysis of metal-substituted human carbonic anhydrase II RT derivatives."; RL Acta Crystallogr. D 50:93-100(1994). RN [37] RP X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) MUTANT GLN-106 IN COMPLEX WITH THE RP INHIBITOR ACETATE, AND MUTAGENESIS OF GLU-106. RX PubMed=15299482; DOI=10.1107/s0907444993009667; RA Haakansson K., Briand C., Zaitsev V., Xue Y., Liljas A.; RT "Wild-type and E106Q mutant carbonic anhydrase complexed with acetate."; RL Acta Crystallogr. D 50:101-104(1994). RN [38] RP X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF 2-259 OF MUTANTS ALA-94; CYS-94; RP CYS-96; CYS-119 AND ASP-119 IN COMPLEX WITH ZINC ION. RX PubMed=7803386; DOI=10.1021/bi00255a004; RA Ippolito J.A., Christianson D.W.; RT "Structural consequences of redesigning a protein-zinc binding site."; RL Biochemistry 33:15241-15249(1994). RN [39] RP X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) IN COMPLEX WITH THE INHIBITOR RP TRIFLUOROMETHANE SULFONAMIDE. RX PubMed=8070585; DOI=10.1016/0014-5793(94)00798-5; RA Haakansson K., Liljas A.; RT "The structure of a complex between carbonic anhydrase II and a new RT inhibitor, trifluoromethane sulphonamide."; RL FEBS Lett. 350:319-322(1994). RN [40] RP X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) IN COMPLEX WITH INHIBITORS. RX PubMed=8142888; DOI=10.1002/pro.5560030115; RA Smith G.M., Alexander R.S., Christianson D.W., McKeever B.M., RA Ponticello G.S., Springer J.P., Randall W.C., Baldwin J.J., Habecker C.N.; RT "Positions of His-64 and a bound water in human carbonic anhydrase II upon RT binding three structurally related inhibitors."; RL Protein Sci. 3:118-125(1994). RN [41] RP X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF MUTANTS ARG-197; ASP-197 AND RP PHE-197 IN COMPLEX WITH THE INHIBITOR ACETAZOLAMIDE. RX PubMed=7696263; DOI=10.1021/bi00012a016; RA Nair S.K., Krebs J.F., Christianson D.W., Fierke C.A.; RT "Structural basis of inhibitor affinity to variants of human carbonic RT anhydrase II."; RL Biochemistry 34:3981-3989(1995). RN [42] RP X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) IN COMPLEX WITH INHIBITORS. RX PubMed=7608893; DOI=10.1021/jm00013a004; RA Boriack P.A., Christianson D.W., Kingery-Wood J., Whitesides G.M.; RT "Secondary interactions significantly removed from the sulfonamide binding RT pocket of carbonic anhydrase II influence inhibitor binding constants."; RL J. Med. Chem. 38:2286-2291(1995). RN [43] RP X-RAY CRYSTALLOGRAPHY (2.20 ANGSTROMS) OF MUTANTS ASP-198; GLU-198 AND RP HIS-198 IN COMPLEX WITH ZINC ION, FUNCTION, CATALYTIC ACTIVITY, MUTAGENESIS RP OF THR-198, AND BIOPHYSICOCHEMICAL PROPERTIES. RX PubMed=7761440; DOI=10.1073/pnas.92.11.5017; RA Ippolito J.A., Baird T.T. Jr., McGee S.A., Christianson D.W., Fierke C.A.; RT "Structure-assisted redesign of a protein-zinc-binding site with femtomolar RT affinity."; RL Proc. Natl. Acad. Sci. U.S.A. 92:5017-5021(1995). RN [44] RP X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF THE MUTANT GLN-117 IN COMPLEX RP WITH ZINC ION AND THE INHIBITOR ACETAZOLAMIDE, FUNCTION, CATALYTIC RP ACTIVITY, AND MUTAGENESIS OF GLU-117. RX PubMed=8639494; DOI=10.1021/bi9526692; RA Huang C.C., Lesburg C.A., Kiefer L.L., Fierke C.A., Christianson D.W.; RT "Reversal of the hydrogen bond to zinc ligand histidine-119 dramatically RT diminishes catalysis and enhances metal equilibration kinetics in carbonic RT anhydrase II."; RL Biochemistry 35:3439-3446(1996). RN [45] RP X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) OF MUTANTS GLY-65; HIS-65; LEU-65; RP PHE-65; SER-65 AND THR-65 IN COMPLEX WITH ZINC ION. RX PubMed=8987974; DOI=10.1021/bi9617872; RA Scolnick L.R., Christianson D.W.; RT "X-ray crystallographic studies of alanine-65 variants of carbonic RT anhydrase II reveal the structural basis of compromised proton transfer in RT catalysis."; RL Biochemistry 35:16429-16434(1996). RN [46] RP X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) IN COMPLEX WITH THE INHIBITOR RP DANSYLAMIDE. RX PubMed=8557623; DOI=10.1074/jbc.271.2.1003; RA Nair S.K., Elbaum D., Christianson D.W.; RT "Unexpected binding mode of the sulfonamide fluorophore 5-dimethylamino-1- RT naphthalene sulfonamide to human carbonic anhydrase II. Implications for RT the development of a zinc biosensor."; RL J. Biol. Chem. 271:1003-1007(1996). RN [47] RP X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) IN COMPLEX WITH THE ACTIVATOR RP HISTAMINE, FUNCTION, CATALYTIC ACTIVITY, AND ACTIVITY REGULATION. RX PubMed=9265618; DOI=10.1021/bi970760v; RA Briganti F., Mangani S., Orioli P., Scozzafava A., Vernaglione G., RA Supuran C.T.; RT "Carbonic anhydrase activators: X-ray crystallographic and spectroscopic RT investigations for the interaction of isozymes I and II with histamine."; RL Biochemistry 36:10384-10392(1997). RN [48] RP X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF MUTANTS ASN-94; ASN-119 AND RP GLN-119 IN COMPLEX WITH ZINC ION, FUNCTION, CATALYTIC ACTIVITY, MUTAGENESIS RP OF HIS-94 AND HIS-119, AND BIOPHYSICOCHEMICAL PROPERTIES. RX PubMed=9398308; DOI=10.1021/bi971296x; RA Lesburg C.A., Huang C., Christianson D.W., Fierke C.A.; RT "Histidine --> carboxamide ligand substitutions in the zinc binding site of RT carbonic anhydrase II alter metal coordination geometry but retain RT catalytic activity."; RL Biochemistry 36:15780-15791(1997). RN [49] RP X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) IN COMPLEX WITH THE INHIBITOR RP BRINZOLAMIDE. RX PubMed=9541386; DOI=10.1002/pro.5560070303; RA Stams T., Chen Y., Boriack-Sjodin P.A., Hurt J.D., Liao J., May J.A., RA Dean T., Laipis P., Silverman D.N., Christianson D.W.; RT "Structures of murine carbonic anhydrase IV and human carbonic anhydrase II RT complexed with brinzolamide: molecular basis of isozyme-drug RT discrimination."; RL Protein Sci. 7:556-563(1998). RN [50] RP X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) IN COMPLEX WITH SULFONAMIDE RP INHIBITORS AND ZINC ION. RX PubMed=9865942; DOI=10.1002/pro.5560071201; RA Boriack-Sjodin P.A., Zeitlin S., Chen H.H., Crenshaw L., Gross S., RA Dantanarayana A., Delgado P., May J.A., Dean T., Christianson D.W.; RT "Structural analysis of inhibitor binding to human carbonic anhydrase II."; RL Protein Sci. 7:2483-2489(1998). RN [51] RP X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) IN COMPLEX WITH CYANAMIDE AND RP SUBSTRATE, FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES. RX PubMed=10550681; DOI=10.1007/s007750050375; RA Briganti F., Mangani S., Scozzafava A., Vernaglione G., Supuran C.T.; RT "Carbonic anhydrase catalyzes cyanamide hydration to urea: is it mimicking RT the physiological reaction?"; RL J. Biol. Inorg. Chem. 4:528-536(1999). RN [52] RP X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) IN COMPLEX WITH CYANAMIDE, FUNCTION, RP AND CATALYTIC ACTIVITY. RX PubMed=11015219; DOI=10.1021/bi000937c; RA Guerri A., Briganti F., Scozzafava A., Supuran C.T., Mangani S.; RT "Mechanism of cyanamide hydration catalyzed by carbonic anhydrase II RT suggested by cryogenic X-ray diffraction."; RL Biochemistry 39:12391-12397(2000). RN [53] RP X-RAY CRYSTALLOGRAPHY (1.50 ANGSTROMS) OF MUTANTS ILE-93/MET-95/VAL-97 AND RP SER-93/LEU-95/MET-97 IN COMPLEX WITH COBALT; COPPER AND ZINC IONS. RX PubMed=11076507; DOI=10.1021/bi001649j; RA Cox J.D., Hunt J.A., Compher K.M., Fierke C.A., Christianson D.W.; RT "Structural influence of hydrophobic core residues on metal binding and RT specificity in carbonic anhydrase II."; RL Biochemistry 39:13687-13694(2000). RN [54] RP X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) OF THE MUTANT ALA-64 IN COMPLEX WITH RP 4-METHYLIMIDAZOLE, FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF HIS-64. RX PubMed=11327835; DOI=10.1021/bi002295z; RA Duda D., Tu C., Qian M., Laipis P., Agbandje-McKenna M., Silverman D.N., RA McKenna R.; RT "Structural and kinetic analysis of the chemical rescue of the proton RT transfer function of carbonic anhydrase II."; RL Biochemistry 40:1741-1748(2001). RN [55] RP X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF MUTANT VAL-130 IN COMPLEX WITH RP FLUOROAROMATIC INHIBITORS. RX PubMed=11572683; DOI=10.1021/ja011034p; RA Kim C.Y., Chandra P.P., Jain A., Christianson D.W.; RT "Fluoroaromatic-fluoroaromatic interactions between inhibitors bound in the RT crystal lattice of human carbonic anhydrase II."; RL J. Am. Chem. Soc. 123:9620-9627(2001). RN [56] RP X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) IN COMPLEX WITH THE INHIBITOR SUGAR RP SULFAMATE RWJ-37497, ACTIVITY REGULATION, FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=11802772; DOI=10.1042/0264-6021:3610437; RA Recacha R., Costanzo M.J., Maryanoff B.E., Chattopadhyay D.; RT "Crystal structure of human carbonic anhydrase II complexed with an anti- RT convulsant sugar sulphamate."; RL Biochem. J. 361:437-441(2002). RN [57] RP X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF THE MUTANT PRO-198/SER-205 IN RP COMPLEX WITH BICARBONATE AND INHIBITORS, FUNCTION, CATALYTIC ACTIVITY, AND RP MUTAGENESIS OF THR-198. RX PubMed=12056894; DOI=10.1021/bi020053o; RA Huang S., Sjoeblom B., Sauer-Eriksson A.E., Jonsson B.H.; RT "Organization of an efficient carbonic anhydrase: implications for the RT mechanism based on structure-function studies of a T199P/C206S mutant."; RL Biochemistry 41:7628-7635(2002). RN [58] RP X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF THE MUTANT HIS-7, FUNCTION, RP CATALYTIC ACTIVITY, AND MUTAGENESIS OF TYR-7. RX PubMed=12171926; DOI=10.1074/jbc.m205791200; RA Tu C., Qian M., An H., Wadhwa N.R., Duda D., Yoshioka C., Pathak Y., RA McKenna R., Laipis P.J., Silverman D.N.; RT "Kinetic analysis of multiple proton shuttles in the active site of human RT carbonic anhydrase."; RL J. Biol. Chem. 277:38870-38876(2002). RN [59] RP X-RAY CRYSTALLOGRAPHY (1.93 ANGSTROMS) IN COMPLEX WITH INHIBITORS, RP FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=11831900; DOI=10.1021/jm010163d; RA Kim C.Y., Whittington D.A., Chang J.S., Liao J., May J.A., RA Christianson D.W.; RT "Structural aspects of isozyme selectivity in the binding of inhibitors to RT carbonic anhydrases II and IV."; RL J. Med. Chem. 45:888-893(2002). RN [60] RP X-RAY CRYSTALLOGRAPHY (2.25 ANGSTROMS) IN COMPLEX WITH INHIBITORS. RX PubMed=12166932; DOI=10.1021/jm011112j; RA Grueneberg S., Stubbs M.T., Klebe G.; RT "Successful virtual screening for novel inhibitors of human carbonic RT anhydrase: strategy and experimental confirmation."; RL J. Med. Chem. 45:3588-3602(2002). RN [61] RP X-RAY CRYSTALLOGRAPHY (1.94 ANGSTROMS) IN COMPLEX WITH INHIBITORS. RX PubMed=11818565; DOI=10.1073/pnas.032673399; RA Grzybowski B.A., Ishchenko A.V., Kim C.Y., Topalov G., Chapman R., RA Christianson D.W., Whitesides G.M., Shakhnovich E.I.; RT "Combinatorial computational method gives new picomolar ligands for a known RT enzyme."; RL Proc. Natl. Acad. Sci. U.S.A. 99:1270-1273(2002). RN [62] RP X-RAY CRYSTALLOGRAPHY (1.05 ANGSTROMS) OF THE MUTANT ALA-64 IN COMPLEX WITH RP THE INHIBITOR 4-METHYLIMIDAZOLE AND ZINC ION. RX PubMed=12499545; DOI=10.1107/s0907444902019455; RA Duda D., Govindasamy L., Agbandje-McKenna M., Tu C., Silverman D.N., RA McKenna R.; RT "The refined atomic structure of carbonic anhydrase II at 1.05 A RT resolution: implications of chemical rescue of proton transfer."; RL Acta Crystallogr. D 59:93-104(2003). RN [63] RP X-RAY CRYSTALLOGRAPHY (1.50 ANGSTROMS) IN COMPLEX WITH INHIBITORS, ACTIVITY RP REGULATION, FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=14736236; DOI=10.1021/jm030912m; RA Weber A., Casini A., Heine A., Kuhn D., Supuran C.T., Scozzafava A., RA Klebe G.; RT "Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective RT celecoxib: new pharmacological opportunities due to related binding site RT recognition."; RL J. Med. Chem. 47:550-557(2004). RN [64] RP X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) IN COMPLEX WITH THE ANTI-CANCER RP AGENT 667-COUMATE, FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=15453828; DOI=10.1042/bj20041037; RA Lloyd M.D., Pederick R.L., Natesh R., Woo L.W., Purohit A., Reed M.J., RA Acharya K.R., Potter B.V.; RT "Crystal structure of human carbonic anhydrase II at 1.95 A resolution in RT complex with 667-coumate, a novel anti-cancer agent."; RL Biochem. J. 385:715-720(2005). RN [65] RP X-RAY CRYSTALLOGRAPHY (1.63 ANGSTROMS), MUTAGENESIS OF ASN-62; HIS-64 AND RP ASN-67, FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES. RX PubMed=15667203; DOI=10.1021/bi0480279; RA Fisher Z., Hernandez Prada J.A., Tu C., Duda D., Yoshioka C., An H., RA Govindasamy L., Silverman D.N., McKenna R.; RT "Structural and kinetic characterization of active-site histidine as a RT proton shuttle in catalysis by human carbonic anhydrase II."; RL Biochemistry 44:1097-1105(2005). RN [66] RP X-RAY CRYSTALLOGRAPHY (1.76 ANGSTROMS) IN COMPLEX WITH DUAL RP AROMATASE-STEROID SULFATASE INHIBITORS, FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=15865431; DOI=10.1021/bi047692e; RA Lloyd M.D., Thiyagarajan N., Ho Y.T., Woo L.W., Sutcliffe O.B., Purohit A., RA Reed M.J., Acharya K.R., Potter B.V.; RT "First crystal structures of human carbonic anhydrase II in complex with RT dual aromatase-steroid sulfatase inhibitors."; RL Biochemistry 44:6858-6866(2005). RN [67] RP X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) IN COMPLEX WITH ACTIVATOR RP L-HISTIDINE, FUNCTION, CATALYTIC ACTIVITY, AND ACTIVITY REGULATION. RX PubMed=16214338; DOI=10.1016/j.bmcl.2005.08.069; RA Temperini C., Scozzafava A., Puccetti L., Supuran C.T.; RT "Carbonic anhydrase activators: X-ray crystal structure of the adduct of RT human isozyme II with L-histidine as a platform for the design of stronger RT activators."; RL Bioorg. Med. Chem. Lett. 15:5136-5141(2005). RN [68] RP X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) IN COMPLEX WITH INHIBITOR. RX PubMed=16134940; DOI=10.1021/jm050333c; RA Menchise V., De Simone G., Alterio V., Di Fiore A., Pedone C., RA Scozzafava A., Supuran C.T.; RT "Carbonic anhydrase inhibitors: stacking with Phe131 determines active site RT binding region of inhibitors as exemplified by the X-ray crystal structure RT of a membrane-impermeant antitumor sulfonamide complexed with isozyme II."; RL J. Med. Chem. 48:5721-5727(2005). RN [69] RP X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS), FUNCTION, CATALYTIC ACTIVITY, AND RP MUTAGENESIS OF HIS-64 AND THR-199. RX PubMed=16106378; DOI=10.1002/prot.20615; RA Bhatt D., Tu C., Fisher S.Z., Hernandez Prada J.A., McKenna R., RA Silverman D.N.; RT "Proton transfer in a Thr200His mutant of human carbonic anhydrase II."; RL Proteins 61:239-245(2005). RN [70] RP X-RAY CRYSTALLOGRAPHY (1.50 ANGSTROMS). RX PubMed=16511248; DOI=10.1107/s1744309105038248; RA Budayova-Spano M., Fisher S.Z., Dauvergne M.T., Agbandje-McKenna M., RA Silverman D.N., Myles D.A., McKenna R.; RT "Production and X-ray crystallographic analysis of fully deuterated human RT carbonic anhydrase II."; RL Acta Crystallogr. F 62:6-9(2006). RN [71] RP X-RAY CRYSTALLOGRAPHY (1.15 ANGSTROMS) IN COMPLEX WITH INHIBITORS. RX PubMed=16820676; DOI=10.1107/s1744309106020446; RA Fisher S.Z., Govindasamy L., Boyle N., Agbandje-McKenna M., Silverman D.N., RA Blackburn G.M., McKenna R.; RT "X-ray crystallographic studies reveal that the incorporation of spacer RT groups in carbonic anhydrase inhibitors causes alternate binding modes."; RL Acta Crystallogr. F 62:618-622(2006). RN [72] RP X-RAY CRYSTALLOGRAPHY (1.46 ANGSTROMS) IN COMPLEX WITH INHIBITORS RP VALDECOXIB AND CELECOXIB, ACTIVITY REGULATION, FUNCTION, AND CATALYTIC RP ACTIVITY. RX PubMed=16290146; DOI=10.1016/j.bmcl.2005.09.040; RA Di Fiore A., Pedone C., D'Ambrosio K., Scozzafava A., De Simone G., RA Supuran C.T.; RT "Carbonic anhydrase inhibitors: Valdecoxib binds to a different active site RT region of the human isoform II as compared to the structurally related RT cyclooxygenase II 'selective' inhibitor celecoxib."; RL Bioorg. Med. Chem. Lett. 16:437-442(2006). RN [73] RP X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) IN COMPLEX WITH N-HYDROXYUREA, RP ACTIVITY REGULATION, FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=16759856; DOI=10.1016/j.bmcl.2006.05.068; RA Temperini C., Innocenti A., Scozzafava A., Supuran C.T.; RT "N-hydroxyurea -- a versatile zinc binding function in the design of RT metalloenzyme inhibitors."; RL Bioorg. Med. Chem. Lett. 16:4316-4320(2006). RN [74] RP X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) IN COMPLEX WITH INHIBITORS. RX PubMed=17000110; DOI=10.1016/j.bmcl.2006.09.022; RA Menchise V., De Simone G., Di Fiore A., Scozzafava A., Supuran C.T.; RT "Carbonic anhydrase inhibitors: X-ray crystallographic studies for the RT binding of 5-amino-1,3,4-thiadiazole-2-sulfonamide and 5-(4-amino-3-chloro- RT 5-fluorophenylsulfonamido)-1,3,4-thiadiazole-2-sulfonamide to human isoform RT II."; RL Bioorg. Med. Chem. Lett. 16:6204-6208(2006). RN [75] RP X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) IN COMPLEX WITH L- AND D-HISTIDINE, RP ACTIVITY REGULATION, FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=16807956; DOI=10.1002/chem.200600159; RA Temperini C., Scozzafava A., Vullo D., Supuran C.T.; RT "Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII, RT and XIV with l- and d-histidine and crystallographic analysis of their RT adducts with isoform II: engineering proton-transfer processes within the RT active site of an enzyme."; RL Chemistry 12:7057-7066(2006). RN [76] RP X-RAY CRYSTALLOGRAPHY (0.99 ANGSTROMS) IN COMPLEX WITH TWO-PRONG RP INHIBITORS. RX PubMed=16506782; DOI=10.1021/ja057257n; RA Jude K.M., Banerjee A.L., Haldar M.K., Manokaran S., Roy B., Mallik S., RA Srivastava D.K., Christianson D.W.; RT "Ultrahigh resolution crystal structures of human carbonic anhydrases I and RT II complexed with 'two-prong' inhibitors reveal the molecular basis of high RT affinity."; RL J. Am. Chem. Soc. 128:3011-3018(2006). RN [77] RP X-RAY CRYSTALLOGRAPHY (1.71 ANGSTROMS) IN COMPLEX WITH INHIBITOR. RX PubMed=16787097; DOI=10.1021/ja061574s; RA Alterio V., Vitale R.M., Monti S.M., Pedone C., Scozzafava A., Cecchi A., RA De Simone G., Supuran C.T.; RT "Carbonic anhydrase inhibitors: X-ray and molecular modeling study for the RT interaction of a fluorescent antitumor sulfonamide with isozyme II and RT IX."; RL J. Am. Chem. Soc. 128:8329-8335(2006). RN [78] RP X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) IN COMPLEX WITH L- AND RP D-PHENYLALANINE, ACTIVITY REGULATION, FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=16686544; DOI=10.1021/jm0603320; RA Temperini C., Scozzafava A., Vullo D., Supuran C.T.; RT "Carbonic anhydrase activators. Activation of isoforms I, II, IV, VA, VII, RT and XIV with L- and D-phenylalanine and crystallographic analysis of their RT adducts with isozyme II: stereospecific recognition within the active site RT of an enzyme and its consequences for the drug design."; RL J. Med. Chem. 49:3019-3027(2006). RN [79] RP X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) IN COMPLEX WITH INHIBITOR. RX PubMed=16942027; DOI=10.1021/jm060531j; RA De Simone G., Vitale R.M., Di Fiore A., Pedone C., Scozzafava A., RA Montero J.-L., Winum J.-Y., Supuran C.T.; RT "Carbonic anhydrase inhibitors: Hypoxia-activatable sulfonamides RT incorporating disulfide bonds that target the tumor-associated isoform RT IX."; RL J. Med. Chem. 49:5544-5551(2006). RN [80] RP X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) IN COMPLEX WITH INHIBITOR. RX PubMed=17125255; DOI=10.1021/jm060807n; RA Winum J.Y., Temperini C., El Cheikh K., Innocenti A., Vullo D., RA Ciattini S., Montero J.-L., Scozzafava A., Supuran C.T.; RT "Carbonic anhydrase inhibitors: clash with Ala65 as a means for designing RT inhibitors with low affinity for the ubiquitous isozyme II, exemplified by RT the crystal structure of the topiramate sulfamide analogue."; RL J. Med. Chem. 49:7024-7031(2006). RN [81] RP X-RAY CRYSTALLOGRAPHY (1.46 ANGSTROMS) IN COMPLEX WITH INHIBITORS. RX PubMed=17181151; DOI=10.1021/jm060705x; RA Leese M.P., Leblond B., Smith A., Newman S.P., Di Fiore A., De Simone G., RA Supuran C.T., Purohit A., Reed M.J., Potter B.V.; RT "2-substituted estradiol bis-sulfamates, multitargeted antitumor agents: RT synthesis, in vitro SAR, protein crystallography, and in vivo activity."; RL J. Med. Chem. 49:7683-7696(2006). RN [82] RP X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) IN COMPLEX WITH SACCHARIN, ACTIVITY RP REGULATION, FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=17705204; DOI=10.1002/anie.200701189; RA Koehler K., Hillebrecht A., Schulze Wischeler J., Innocenti A., Heine A., RA Supuran C.T., Klebe G.; RT "Saccharin inhibits carbonic anhydrases: possible explanation for its RT unpleasant metallic aftertaste."; RL Angew. Chem. Int. Ed. Engl. 46:7697-7699(2007). RN [83] RP X-RAY CRYSTALLOGRAPHY (1.05 ANGSTROMS). RX PubMed=17319692; DOI=10.1021/bi062066y; RA Fisher S.Z., Maupin C.M., Budayova-Spano M., Govindasamy L., Tu C., RA Agbandje-McKenna M., Silverman D.N., Voth G.A., McKenna R.; RT "Atomic crystal and molecular dynamics simulation structures of human RT carbonic anhydrase II: insights into the proton transfer mechanism."; RL Biochemistry 46:2930-2937(2007). RN [84] RP X-RAY CRYSTALLOGRAPHY (1.15 ANGSTROMS), MUTAGENESIS OF TYR-7; ASN-62 AND RP ASN-67, FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES. RX PubMed=17330962; DOI=10.1021/bi602620k; RA Fisher S.Z., Tu C., Bhatt D., Govindasamy L., Agbandje-McKenna M., RA McKenna R., Silverman D.N.; RT "Speeding up proton transfer in a fast enzyme: kinetic and crystallographic RT studies on the effect of hydrophobic amino acid substitutions in the active RT site of human carbonic anhydrase II."; RL Biochemistry 46:3803-3813(2007). RN [85] RP X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) IN COMPLEX WITH ACTIVATOR RP L-ADRENALINE, ACTIVITY REGULATION, FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=17127057; DOI=10.1016/j.bmcl.2006.11.027; RA Temperini C., Innocenti A., Scozzafava A., Mastrolorenzo A., Supuran C.T.; RT "Carbonic anhydrase activators: L-Adrenaline plugs the active site entrance RT of isozyme II, activating better isoforms I, IV, VA, VII, and XIV."; RL Bioorg. Med. Chem. Lett. 17:628-635(2007). RN [86] RP X-RAY CRYSTALLOGRAPHY (1.55 ANGSTROMS) IN COMPLEX WITH INHIBITOR, FUNCTION, RP AND CATALYTIC ACTIVITY. RX PubMed=17251017; DOI=10.1016/j.bmcl.2006.12.099; RA Di Fiore A., Scozzafava A., Winum J.-Y., Montero J.-L., Pedone C., RA Supuran C.T., De Simone G.; RT "Carbonic anhydrase inhibitors: binding of an antiglaucoma glycosyl- RT sulfanilamide derivative to human isoform II and its consequences for the RT drug design of enzyme inhibitors incorporating sugar moieties."; RL Bioorg. Med. Chem. Lett. 17:1726-1731(2007). RN [87] RP X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) IN COMPLEX WITH INHIBITOR RP N-HYDROXYSULFAMIDE, FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=17346964; DOI=10.1016/j.bmcl.2007.02.068; RA Temperini C., Winum J.Y., Montero J.L., Scozzafava A., Supuran C.T.; RT "Carbonic anhydrase inhibitors: the X-ray crystal structure of the adduct RT of N-hydroxysulfamide with isozyme II explains why this new zinc binding RT function is effective in the design of potent inhibitors."; RL Bioorg. Med. Chem. Lett. 17:2795-2801(2007). RN [88] RP X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) IN COMPLEX WITH INHIBITORS, ACTIVITY RP REGULATION, FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=17540563; DOI=10.1016/j.bmcl.2007.05.045; RA Alterio V., De Simone G., Monti S.M., Scozzafava A., Supuran C.T.; RT "Carbonic anhydrase inhibitors: inhibition of human, bacterial, and RT archaeal isozymes with benzene-1,3-disulfonamides -- solution and RT crystallographic studies."; RL Bioorg. Med. Chem. Lett. 17:4201-4207(2007). RN [89] RP X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) IN COMPLEX WITH INHIBITORS, ACTIVITY RP REGULATION, FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=17588751; DOI=10.1016/j.bmcl.2007.06.044; RA Temperini C., Innocenti A., Mastrolorenzo A., Scozzafava A., Supuran C.T.; RT "Carbonic anhydrase inhibitors. Interaction of the antiepileptic drug RT sulthiame with twelve mammalian isoforms: kinetic and X-ray RT crystallographic studies."; RL Bioorg. Med. Chem. Lett. 17:4866-4872(2007). RN [90] RP X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) IN COMPLEX WITH 4-METHYLIMIDAZOLE, RP AND MUTAGENESIS OF TRP-5 AND HIS-64. RX PubMed=17071654; DOI=10.1529/biophysj.106.093203; RA Bhatt D., Fisher S.Z., Tu C., McKenna R., Silverman D.N.; RT "Location of binding sites in small molecule rescue of human carbonic RT anhydrase II."; RL Biophys. J. 92:562-570(2007). RN [91] RP X-RAY CRYSTALLOGRAPHY (1.01 ANGSTROMS) IN COMPLEX WITH INHIBITORS. RX PubMed=17407288; DOI=10.1021/ja068359w; RA Srivastava D.K., Jude K.M., Banerjee A.L., Haldar M., Manokaran S., RA Kooren J., Mallik S., Christianson D.W.; RT "Structural analysis of charge discrimination in the binding of inhibitors RT to human carbonic anhydrases I and II."; RL J. Am. Chem. Soc. 129:5528-5537(2007). RN [92] RP X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) IN COMPLEX WITH INHIBITOR RP THIOXOLONE, ACTIVITY REGULATION, FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=18266323; DOI=10.1021/bi702385k; RA Barrese A.A. III, Genis C., Fisher S.Z., Orwenyo J.N., Kumara M.T., RA Dutta S.K., Phillips E., Kiddle J.J., Tu C., Silverman D.N., RA Govindasamy L., Agbandje-McKenna M., McKenna R., Tripp B.C.; RT "Inhibition of carbonic anhydrase II by thioxolone: a mechanistic and RT structural study."; RL Biochemistry 47:3174-3184(2008). RN [93] RP X-RAY CRYSTALLOGRAPHY (1.60 ANGSTROMS) OF MUTANTS, MUTAGENESIS OF ASN-62, RP FUNCTION, CATALYTIC ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES. RX PubMed=18942852; DOI=10.1021/bi801473w; RA Zheng J., Avvaru B.S., Tu C., McKenna R., Silverman D.N.; RT "Role of hydrophilic residues in proton transfer during catalysis by human RT carbonic anhydrase II."; RL Biochemistry 47:12028-12036(2008). RN [94] RP X-RAY CRYSTALLOGRAPHY (1.89 ANGSTROMS) IN COMPLEX WITH INHIBITORS, ACTIVITY RP REGULATION, FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=18024029; DOI=10.1016/j.bmcl.2007.10.110; RA Guezel O., Temperini C., Innocenti A., Scozzafava A., Salman A., RA Supuran C.T.; RT "Carbonic anhydrase inhibitors. Interaction of 2-(hydrazinocarbonyl)-3- RT phenyl-1H-indole-5-sulfonamide with 12 mammalian isoforms: kinetic and X- RT ray crystallographic studies."; RL Bioorg. Med. Chem. Lett. 18:152-158(2008). RN [95] RP X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) IN COMPLEX WITH INHIBITORS, ACTIVITY RP REGULATION, FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=18162396; DOI=10.1016/j.bmcl.2007.12.022; RA Temperini C., Cecchi A., Boyle N.A., Scozzafava A., Cabeza J.E., RA Wentworth P. Jr., Blackburn G.M., Supuran C.T.; RT "Carbonic anhydrase inhibitors. Interaction of 2-N,N-dimethylamino-1,3,4- RT thiadiazole-5-methanesulfonamide with 12 mammalian isoforms: kinetic and X- RT ray crystallographic studies."; RL Bioorg. Med. Chem. Lett. 18:999-1005(2008). RN [96] RP X-RAY CRYSTALLOGRAPHY (2.10 ANGSTROMS) IN COMPLEX WITH INHIBITORS, ACTIVITY RP REGULATION, FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=18374572; DOI=10.1016/j.bmcl.2008.03.051; RA Temperini C., Cecchi A., Scozzafava A., Supuran C.T.; RT "Carbonic anhydrase inhibitors. Interaction of indapamide and related RT diuretics with 12 mammalian isozymes and X-ray crystallographic studies for RT the indapamide-isozyme II adduct."; RL Bioorg. Med. Chem. Lett. 18:2567-2573(2008). RN [97] RP X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) IN COMPLEX WITH INHIBITORS. RX PubMed=18359629; DOI=10.1016/j.bmcl.2008.03.023; RA Di Fiore A., Pedone C., Antel J., Waldeck H., Witte A., Wurl M., RA Scozzafava A., Supuran C.T., De Simone G.; RT "Carbonic anhydrase inhibitors: the X-ray crystal structure of RT ethoxzolamide complexed to human isoform II reveals the importance of RT thr200 and gln92 for obtaining tight-binding inhibitors."; RL Bioorg. Med. Chem. Lett. 18:2669-2674(2008). RN [98] RP X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) IN COMPLEX WITH INHIBITORS, ACTIVITY RP REGULATION, FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=18640037; DOI=10.1016/j.bmcl.2008.06.105; RA Temperini C., Innocenti A., Scozzafava A., Supuran C.T.; RT "Carbonic anhydrase inhibitors. Interaction of the antitumor sulfamate EMD RT 486019 with twelve mammalian carbonic anhydrase isoforms: Kinetic and X-ray RT crystallographic studies."; RL Bioorg. Med. Chem. Lett. 18:4282-4286(2008). RN [99] RP X-RAY CRYSTALLOGRAPHY (1.40 ANGSTROMS) IN COMPLEX WITH INHIBITORS RP INDANESULFONAMIDES. RX PubMed=18161740; DOI=10.1002/cmdc.200700274; RA D'Ambrosio K., Masereel B., Thiry A., Scozzafava A., Supuran C.T., RA De Simone G.; RT "Carbonic anhydrase inhibitors: binding of indanesulfonamides to the human RT isoform II."; RL ChemMedChem 3:473-477(2008). RN [100] RP X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) IN COMPLEX WITH (129)XE-CRYPTOPHANE RP BIOSENSOR. RX PubMed=18461940; DOI=10.1021/ja802214x; RA Aaron J.A., Chambers J.M., Jude K.M., Di Costanzo L., Dmochowski I.J., RA Christianson D.W.; RT "Structure of a (129)Xe-cryptophane biosensor complexed with human carbonic RT anhydrase II."; RL J. Am. Chem. Soc. 130:6942-6943(2008). RN [101] RP X-RAY CRYSTALLOGRAPHY (1.10 ANGSTROMS) IN COMPLEX WITH CO2. RX PubMed=18768466; DOI=10.1074/jbc.m805353200; RA Domsic J.F., Avvaru B.S., Kim C.U., Gruner S.M., Agbandje-McKenna M., RA Silverman D.N., McKenna R.; RT "Entrapment of carbon dioxide in the active site of carbonic anhydrase RT II."; RL J. Biol. Chem. 283:30766-30771(2008). RN [102] RP X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) IN COMPLEX WITH INHIBITORS. RX PubMed=18260615; DOI=10.1021/jm701319c; RA Leese M.P., Jourdan F.L., Gaukroger K., Mahon M.F., Newman S.P., RA Foster P.A., Stengel C., Regis-Lydi S., Ferrandis E., Di Fiore A., RA De Simone G., Supuran C.T., Purohit A., Reed M.J., Potter B.V.; RT "Structure-activity relationships of C-17 cyano-substituted estratrienes as RT anticancer agents."; RL J. Med. Chem. 51:1295-1308(2008). RN [103] RP X-RAY CRYSTALLOGRAPHY (1.45 ANGSTROMS) IN COMPLEX WITH INHIBITORS, ACTIVITY RP REGULATION, FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=18481843; DOI=10.1021/jm800121c; RA D'Ambrosio K., Vitale R.-M., Dogne J.-M., Masereel B., Innocenti A., RA Scozzafava A., De Simone G., Supuran C.T.; RT "Carbonic anhydrase inhibitors: bioreductive nitro-containing sulfonamides RT with selectivity for targeting the tumor associated isoforms IX and XII."; RL J. Med. Chem. 51:3230-3237(2008). RN [104] RP X-RAY CRYSTALLOGRAPHY (1.70 ANGSTROMS) IN COMPLEX WITH INHIBITORS. RX PubMed=18723489; DOI=10.1158/1535-7163.mct-08-0195; RA Woo L.W.L., Fischer D.S., Sharland C.M., Trusselle M., Foster P.A., RA Chander S.K., Di Fiore A., Supuran C.T., De Simone G., Purohit A., RA Reed M.J., Potter B.V.L.; RT "Anticancer steroid sulfatase inhibitors: synthesis of a potent fluorinated RT second-generation agent, in vitro and in vivo activities, molecular RT modeling, and protein crystallography."; RL Mol. Cancer Ther. 7:2435-2444(2008). RN [105] RP X-RAY CRYSTALLOGRAPHY (1.48 ANGSTROMS) IN COMPLEX WITH INHIBITORS, ACTIVITY RP REGULATION, MUTAGENESIS OF ALA-65 AND ASN-67, FUNCTION, AND CATALYTIC RP ACTIVITY. RX PubMed=19170619; DOI=10.1021/bi802035f; RA Genis C., Sippel K.H., Case N., Cao W., Avvaru B.S., Tartaglia L.J., RA Govindasamy L., Tu C., Agbandje-McKenna M., Silverman D.N., Rosser C.J., RA McKenna R.; RT "Design of a carbonic anhydrase IX active-site mimic to screen inhibitors RT for possible anticancer properties."; RL Biochemistry 48:1322-1331(2009). RN [106] RP X-RAY CRYSTALLOGRAPHY (1.26 ANGSTROMS) FREE AND IN COMPLEX WITH ZINC ION, RP AND COFACTOR. RX PubMed=19583303; DOI=10.1021/bi9007512; RA Avvaru B.S., Busby S.A., Chalmers M.J., Griffin P.R., Venkatakrishnan B., RA Agbandje-McKenna M., Silverman D.N., McKenna R.; RT "Apo-human carbonic anhydrase II revisited: implications of the loss of a RT metal in protein structure, stability, and solvent network."; RL Biochemistry 48:7365-7372(2009). RN [107] RP X-RAY CRYSTALLOGRAPHY (1.81 ANGSTROMS) OF 1-260 IN COMPLEX WITH INHIBITOR RP THIABENDAZOLE-5-SULFONAMIDE, ACTIVITY REGULATION, FUNCTION, AND CATALYTIC RP ACTIVITY. RX PubMed=19186056; DOI=10.1016/j.bmcl.2009.01.038; RA Crocetti L., Maresca A., Temperini C., Hall R.A., Scozzafava A., RA Muehlschlegel F.A., Supuran C.T.; RT "A thiabendazole sulfonamide shows potent inhibitory activity against RT mammalian and nematode alpha-carbonic anhydrases."; RL Bioorg. Med. Chem. Lett. 19:1371-1375(2009). RN [108] RP X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 1-260 IN COMPLEX WITH COUMARIN RP INHIBITORS, ACTIVITY REGULATION, FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=19206230; DOI=10.1021/ja809683v; RA Maresca A., Temperini C., Vu H., Pham N.B., Poulsen S.-A., Scozzafava A., RA Quinn R.J., Supuran C.T.; RT "Non-zinc mediated inhibition of carbonic anhydrases: coumarins are a new RT class of suicide inhibitors."; RL J. Am. Chem. Soc. 131:3057-3062(2009). RN [109] RP X-RAY CRYSTALLOGRAPHY (1.90 ANGSTROMS) IN COMPLEX WITH INHIBITORS. RX PubMed=19115843; DOI=10.1021/jm801386n; RA Temperini C., Cecchi A., Scozzafava A., Supuran C.T.; RT "Carbonic anhydrase inhibitors. Comparison of chlorthalidone and indapamide RT X-ray crystal structures in adducts with isozyme II: when three water RT molecules and the keto-enol tautomerism make the difference."; RL J. Med. Chem. 52:322-328(2009). RN [110] RP X-RAY CRYSTALLOGRAPHY (1.41 ANGSTROMS) IN COMPLEX WITH INHIBITORS. RX PubMed=19731956; DOI=10.1021/jm900641r; RA Vitale R.M., Alterio V., Innocenti A., Winum J.-Y., Monti S.M., RA De Simone G., Supuran C.T.; RT "Carbonic anhydrase inhibitors. Comparison of aliphatic sulfamate/bis- RT sulfamate adducts with isozymes II and IX as a platform for designing RT tight-binding, more isoform-selective inhibitors."; RL J. Med. Chem. 52:5990-5998(2009). RN [111] RP X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 1-260 IN COMPLEX WITH INHIBITORS. RX PubMed=19827837; DOI=10.1021/jm900914e; RA Lopez M., Paul B., Hofmann A., Morizzi J., Wu Q.K., Charman S.A., RA Innocenti A., Vullo D., Supuran C.T., Poulsen S.-A.; RT "S-glycosyl primary sulfonamides--a new structural class for selective RT inhibition of cancer-associated carbonic anhydrases."; RL J. Med. Chem. 52:6421-6432(2009). RN [112] RP X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 1-260 IN COMPLEX WITH INHIBITORS, RP ACTIVITY REGULATION, FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=19778001; DOI=10.1021/jp906593c; RA Ciani L., Cecchi A., Temperini C., Supuran C.T., Ristori S.; RT "Dissecting the inhibition mechanism of cytosolic versus transmembrane RT carbonic anhydrases by ESR."; RL J. Phys. Chem. B 113:13998-14005(2009). RN [113] RP X-RAY CRYSTALLOGRAPHY (1.56 ANGSTROMS) IN COMPLEX WITH SUBSTRATES, ACTIVITY RP REGULATION, FUNCTION, AND CATALYTIC ACTIVITY. RX PubMed=19520834; DOI=10.1073/pnas.0904184106; RA Sjoeblom B., Polentarutti M., Djinovic-Carugo K.; RT "Structural study of X-ray induced activation of carbonic anhydrase."; RL Proc. Natl. Acad. Sci. U.S.A. 106:10609-10613(2009). RN [114] RP VARIANT JOGJAKARTA GLU-18. RX PubMed=6817747; DOI=10.1007/bf00484072; RA Jones G.L., Sofro A.S.M., Shaw D.C.; RT "Chemical and enzymological characterization of an Indonesian variant of RT human erythrocyte carbonic anhydrase II, CAII Jogjakarta (17 Lys leads to RT Glu)."; RL Biochem. Genet. 20:979-1000(1982). RN [115] RP VARIANT MELBOURNE HIS-236. RX PubMed=6407977; DOI=10.1007/bf00274768; RA Jones G.L., Shaw D.C.; RT "A chemical and enzymological comparison of the common major human RT erythrocyte carbonic anhydrase II, its minor component, and a new genetic RT variant, CA II Melbourne (237 Pro leads to His)."; RL Hum. Genet. 63:392-399(1983). RN [116] RP VARIANT OPTB3 TYR-107. RX PubMed=1928091; RA Venta P.J., Welty R.J., Johnson T.M., Sly W.S., Tashian R.E.; RT "Carbonic anhydrase II deficiency syndrome in a Belgian family is caused by RT a point mutation at an invariant histidine residue (107 His-->Tyr): RT complete structure of the normal human CA II gene."; RL Am. J. Hum. Genet. 49:1082-1090(1991). RN [117] RP VARIANT OPTB3 TYR-107. RX PubMed=1542674; DOI=10.1073/pnas.89.5.1804; RA Roth D.E., Venta P.J., Tashian R.E., Sly W.S.; RT "Molecular basis of human carbonic anhydrase II deficiency."; RL Proc. Natl. Acad. Sci. U.S.A. 89:1804-1808(1992). RN [118] RP VARIANT OPTB3 TYR-107. RX PubMed=8834238; DOI=10.1007/bf02267062; RA Soda H., Yukizane S., Yoshida I., Koga Y., Aramaki S., Kato H.; RT "A point mutation in exon 3 (His 107-->Tyr) in two unrelated Japanese RT patients with carbonic anhydrase II deficiency with central nervous system RT involvement."; RL Hum. Genet. 97:435-437(1996). RN [119] RP VARIANT OPTB3 PRO-92. RX PubMed=9143915; RX DOI=10.1002/(sici)1098-1004(1997)9:5<383::aid-humu1>3.0.co;2-5; RA Hu P.Y., Lim E.J., Ciccolella J., Strisciuglio P., Sly W.S.; RT "Seven novel mutations in carbonic anhydrase II deficiency syndrome RT identified by SSCP and direct sequencing analysis."; RL Hum. Mutat. 9:383-387(1997). RN [120] RP VARIANTS OPTB3 PRO-92; TYR-94; TYR-107 AND ARG-144, FUNCTION, CATALYTIC RP ACTIVITY, AND CHARACTERIZATION OF VARIANTS TYR-94 AND ARG-144. RX PubMed=15300855; DOI=10.1002/humu.9266; RA Shah G.N., Bonapace G., Hu P.Y., Strisciuglio P., Sly W.S.; RT "Carbonic anhydrase II deficiency syndrome (osteopetrosis with renal RT tubular acidosis and brain calcification): novel mutations in CA2 RT identified by direct sequencing expand the opportunity for genotype- RT phenotype correlation."; RL Hum. Mutat. 24:272-272(2004). CC -!- FUNCTION: Catalyzes the reversible hydration of carbon dioxide CC (PubMed:11327835, PubMed:11802772, PubMed:11831900, PubMed:12056894, CC PubMed:12171926, PubMed:1336460, PubMed:14736236, PubMed:15300855, CC PubMed:15453828, PubMed:15667203, PubMed:15865431, PubMed:16106378, CC PubMed:16214338, PubMed:16290146, PubMed:16686544, PubMed:16759856, CC PubMed:16807956, PubMed:17127057, PubMed:17251017, PubMed:17314045, CC PubMed:17330962, PubMed:17346964, PubMed:17540563, PubMed:17588751, CC PubMed:17705204, PubMed:18024029, PubMed:18162396, PubMed:18266323, CC PubMed:18374572, PubMed:18481843, PubMed:18640037, PubMed:18942852, CC PubMed:1909891, PubMed:1910042, PubMed:19170619, PubMed:19186056, CC PubMed:19206230, PubMed:19520834, PubMed:19778001, PubMed:7761440, CC PubMed:7901850, PubMed:8218160, PubMed:8262987, PubMed:8399159, CC PubMed:8451242, PubMed:8485129, PubMed:8639494, PubMed:9265618, CC PubMed:9398308, PubMed:4994926). Can also hydrate cyanamide to urea CC (PubMed:10550681, PubMed:11015219). Stimulates the chloride-bicarbonate CC exchange activity of SLC26A6 (PubMed:15990874). Essential for bone CC resorption and osteoclast differentiation (PubMed:15300855). Involved CC in the regulation of fluid secretion into the anterior chamber of the CC eye. Contributes to intracellular pH regulation in the duodenal upper CC villous epithelium during proton-coupled peptide absorption. CC {ECO:0000269|PubMed:10550681, ECO:0000269|PubMed:11015219, CC ECO:0000269|PubMed:11327835, ECO:0000269|PubMed:11802772, CC ECO:0000269|PubMed:11831900, ECO:0000269|PubMed:12056894, CC ECO:0000269|PubMed:12171926, ECO:0000269|PubMed:1336460, CC ECO:0000269|PubMed:14736236, ECO:0000269|PubMed:15300855, CC ECO:0000269|PubMed:15453828, ECO:0000269|PubMed:15667203, CC ECO:0000269|PubMed:15865431, ECO:0000269|PubMed:15990874, CC ECO:0000269|PubMed:16106378, ECO:0000269|PubMed:16214338, CC ECO:0000269|PubMed:16290146, ECO:0000269|PubMed:16686544, CC ECO:0000269|PubMed:16759856, ECO:0000269|PubMed:16807956, CC ECO:0000269|PubMed:17127057, ECO:0000269|PubMed:17251017, CC ECO:0000269|PubMed:17314045, ECO:0000269|PubMed:17330962, CC ECO:0000269|PubMed:17346964, ECO:0000269|PubMed:17540563, CC ECO:0000269|PubMed:17588751, ECO:0000269|PubMed:17705204, CC ECO:0000269|PubMed:18024029, ECO:0000269|PubMed:18162396, CC ECO:0000269|PubMed:18266323, ECO:0000269|PubMed:18374572, CC ECO:0000269|PubMed:18481843, ECO:0000269|PubMed:18640037, CC ECO:0000269|PubMed:18942852, ECO:0000269|PubMed:1909891, CC ECO:0000269|PubMed:1910042, ECO:0000269|PubMed:19170619, CC ECO:0000269|PubMed:19186056, ECO:0000269|PubMed:19206230, CC ECO:0000269|PubMed:19520834, ECO:0000269|PubMed:19778001, CC ECO:0000269|PubMed:4994926, ECO:0000269|PubMed:7761440, CC ECO:0000269|PubMed:7901850, ECO:0000269|PubMed:8218160, CC ECO:0000269|PubMed:8262987, ECO:0000269|PubMed:8399159, CC ECO:0000269|PubMed:8451242, ECO:0000269|PubMed:8485129, CC ECO:0000269|PubMed:8639494, ECO:0000269|PubMed:9265618, CC ECO:0000269|PubMed:9398308}. CC -!- CATALYTIC ACTIVITY: CC Reaction=hydrogencarbonate + H(+) = CO2 + H2O; Xref=Rhea:RHEA:10748, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:16526, CC ChEBI:CHEBI:17544; EC=4.2.1.1; Evidence={ECO:0000269|PubMed:11327835, CC ECO:0000269|PubMed:11802772, ECO:0000269|PubMed:11831900, CC ECO:0000269|PubMed:12056894, ECO:0000269|PubMed:12171926, CC ECO:0000269|PubMed:1336460, ECO:0000269|PubMed:14736236, CC ECO:0000269|PubMed:15300855, ECO:0000269|PubMed:15453828, CC ECO:0000269|PubMed:15667203, ECO:0000269|PubMed:15865431, CC ECO:0000269|PubMed:16106378, ECO:0000269|PubMed:16214338, CC ECO:0000269|PubMed:16290146, ECO:0000269|PubMed:16686544, CC ECO:0000269|PubMed:16759856, ECO:0000269|PubMed:16807956, CC ECO:0000269|PubMed:17127057, ECO:0000269|PubMed:17251017, CC ECO:0000269|PubMed:17314045, ECO:0000269|PubMed:17330962, CC ECO:0000269|PubMed:17346964, ECO:0000269|PubMed:17540563, CC ECO:0000269|PubMed:17588751, ECO:0000269|PubMed:17705204, CC ECO:0000269|PubMed:18024029, ECO:0000269|PubMed:18162396, CC ECO:0000269|PubMed:18266323, ECO:0000269|PubMed:18374572, CC ECO:0000269|PubMed:18481843, ECO:0000269|PubMed:18640037, CC ECO:0000269|PubMed:18942852, ECO:0000269|PubMed:1909891, CC ECO:0000269|PubMed:1910042, ECO:0000269|PubMed:19170619, CC ECO:0000269|PubMed:19186056, ECO:0000269|PubMed:19206230, CC ECO:0000269|PubMed:19520834, ECO:0000269|PubMed:19778001, CC ECO:0000269|PubMed:4994926, ECO:0000269|PubMed:7761440, CC ECO:0000269|PubMed:7901850, ECO:0000269|PubMed:8218160, CC ECO:0000269|PubMed:8262987, ECO:0000269|PubMed:8399159, CC ECO:0000269|PubMed:8451242, ECO:0000269|PubMed:8485129, CC ECO:0000269|PubMed:8639494, ECO:0000269|PubMed:9265618, CC ECO:0000269|PubMed:9398308}; CC -!- CATALYTIC ACTIVITY: CC Reaction=urea = cyanamide + H2O; Xref=Rhea:RHEA:23056, CC ChEBI:CHEBI:15377, ChEBI:CHEBI:16199, ChEBI:CHEBI:16698; EC=4.2.1.69; CC Evidence={ECO:0000269|PubMed:10550681, ECO:0000269|PubMed:11015219}; CC -!- COFACTOR: CC Name=Zn(2+); Xref=ChEBI:CHEBI:29105; CC Evidence={ECO:0000269|PubMed:11076507, ECO:0000269|PubMed:12499545, CC ECO:0000269|PubMed:1336460, ECO:0000269|PubMed:1433293, CC ECO:0000269|PubMed:1909891, ECO:0000269|PubMed:19583303, CC ECO:0000269|PubMed:3151019, ECO:0000269|PubMed:3151020, CC ECO:0000269|PubMed:7761440, ECO:0000269|PubMed:7803386, CC ECO:0000269|PubMed:7901850, ECO:0000269|PubMed:8218160, CC ECO:0000269|PubMed:8262987, ECO:0000269|PubMed:8331673, CC ECO:0000269|PubMed:8399159, ECO:0000269|PubMed:8431430, CC ECO:0000269|PubMed:8451242, ECO:0000269|PubMed:8482389, CC ECO:0000269|PubMed:8639494, ECO:0000269|PubMed:8987974, CC ECO:0000269|PubMed:9398308, ECO:0000269|PubMed:9865942}; CC Name=Co(2+); Xref=ChEBI:CHEBI:48828; CC Evidence={ECO:0000269|PubMed:19583303}; CC Note=Zinc. Can also use cobalt(II) with lower efficiency, but not CC copper(II), nickel(II) and manganese(II). CC {ECO:0000269|PubMed:19583303}; CC -!- ACTIVITY REGULATION: Activated by X-ray, histamine, L-adrenaline, CC L- and D-phenylalanine, L- and D-histidine, L-His-OMe and beta-Ala-His CC (carnosine). Competitively inhibited by saccharin, thioxolone, CC coumarins, 667-coumate, celecoxib (Celebrex), valdecoxib (Bextra), SC- CC 125, SC-560, diclofenac, acetate, azide, bromide, sulfonamide CC derivatives such as acetazolamide (AZA), methazolamide (MZA), CC ethoxzolamide (EZA), dichlorophenamide (DCP), brinzolamide, CC dansylamide, thiabendazole-5-sulfonamide, trifluoromethane sulfonamide CC and N-hydroxysulfamide, fructose-based sugar sulfamate RWJ-37497, and CC Foscarnet (phosphonoformate trisodium salt). Repressed strongly by CC hydrogen sulfide(HS) and weakly by nitrate (NO(3)). Esterase activity CC weakly reduced by cyanamide. N-hydroxyurea interferes with zinc binding CC and inhibit activity. {ECO:0000269|PubMed:11802772, CC ECO:0000269|PubMed:1336460, ECO:0000269|PubMed:14736236, CC ECO:0000269|PubMed:16214338, ECO:0000269|PubMed:16290146, CC ECO:0000269|PubMed:16686544, ECO:0000269|PubMed:16759856, CC ECO:0000269|PubMed:16807956, ECO:0000269|PubMed:17127057, CC ECO:0000269|PubMed:17314045, ECO:0000269|PubMed:17540563, CC ECO:0000269|PubMed:17588751, ECO:0000269|PubMed:17705204, CC ECO:0000269|PubMed:18024029, ECO:0000269|PubMed:18162396, CC ECO:0000269|PubMed:18266323, ECO:0000269|PubMed:18374572, CC ECO:0000269|PubMed:18481843, ECO:0000269|PubMed:18640037, CC ECO:0000269|PubMed:1910042, ECO:0000269|PubMed:19170619, CC ECO:0000269|PubMed:19186056, ECO:0000269|PubMed:19206230, CC ECO:0000269|PubMed:19520834, ECO:0000269|PubMed:19778001, CC ECO:0000269|PubMed:9265618}. CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=9.3 mM for CO(2) {ECO:0000269|PubMed:4994926, CC ECO:0000269|PubMed:7761440}; CC KM=11 mM for CO(2) {ECO:0000269|PubMed:1909891}; CC KM=8.2 mM for CO(2) {ECO:0000269|PubMed:9398308}; CC KM=82 mM for H(2)CO(3) {ECO:0000269|PubMed:8262987}; CC KM=2.9 mM for 4-nitrophenyl acetate {ECO:0000269|PubMed:10550681}; CC pH dependence: CC Optimum pH is 6-8. {ECO:0000269|PubMed:15667203, CC ECO:0000269|PubMed:17330962, ECO:0000269|PubMed:18942852, CC ECO:0000269|PubMed:8262987, ECO:0000269|PubMed:9398308}; CC -!- SUBUNIT: Interacts with SLC4A4 (PubMed:14567693, PubMed:15218065). CC Interaction with SLC4A7 regulates SLC4A7 transporter activity CC (PubMed:14736710). Interacts with SLC26A6 isoform 4 (via C-terminus CC cytoplasmic domain) (PubMed:15990874). {ECO:0000269|PubMed:14567693, CC ECO:0000269|PubMed:14736710, ECO:0000269|PubMed:15218065, CC ECO:0000269|PubMed:15990874}. CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15990874}. Cell CC membrane {ECO:0000269|PubMed:15990874}. Note=Colocalized with SLC26A6 CC at the surface of the cell membrane in order to form a bicarbonate CC transport metabolon. Displaced from the cytosolic surface of the cell CC membrane by PKC in phorbol myristate acetate (PMA)-induced cells. CC {ECO:0000269|PubMed:15990874}. CC -!- DISEASE: Osteopetrosis, autosomal recessive 3 (OPTB3) [MIM:259730]: A CC rare genetic disease characterized by abnormally dense bone, due to CC defective resorption of immature bone. Osteopetrosis occurs in two CC forms: a severe autosomal recessive form occurring in utero, infancy, CC or childhood, and a benign autosomal dominant form occurring in CC adolescence or adulthood. Recessive osteopetrosis commonly manifests in CC early infancy with macrocephaly, feeding difficulties, evolving CC blindness and deafness, bone marrow failure, severe anemia, and CC hepatosplenomegaly. Deafness and blindness are generally thought to CC represent effects of pressure on nerves. OPTB3 is associated with renal CC tubular acidosis, cerebral calcification (marble brain disease) and in CC some cases with intellectual disability. {ECO:0000269|PubMed:15300855, CC ECO:0000269|PubMed:1542674, ECO:0000269|PubMed:1928091, CC ECO:0000269|PubMed:8834238, ECO:0000269|PubMed:9143915}. Note=The CC disease is caused by variants affecting the gene represented in this CC entry. CC -!- MISCELLANEOUS: Target of drugs used in treatments against glaucoma CC disorder and breast cancer. {ECO:0000269|PubMed:17251017}. CC -!- SIMILARITY: Belongs to the alpha-carbonic anhydrase family. CC {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; M77181; AAA51909.1; -; Genomic_DNA. DR EMBL; M77176; AAA51909.1; JOINED; Genomic_DNA. DR EMBL; M77177; AAA51909.1; JOINED; Genomic_DNA. DR EMBL; M77178; AAA51909.1; JOINED; Genomic_DNA. DR EMBL; M77179; AAA51909.1; JOINED; Genomic_DNA. DR EMBL; M77180; AAA51909.1; JOINED; Genomic_DNA. DR EMBL; Y00339; CAA68426.1; -; mRNA. DR EMBL; X03251; CAA27012.1; -; Genomic_DNA. DR EMBL; J03037; AAA51908.1; -; mRNA. DR EMBL; CR536526; CAG38763.1; -; mRNA. DR EMBL; CR541875; CAG46673.1; -; mRNA. DR EMBL; AK312978; BAG35815.1; -; mRNA. DR EMBL; CH471068; EAW87136.1; -; Genomic_DNA. DR EMBL; BC011949; AAH11949.1; -; mRNA. DR EMBL; M36532; AAA51911.1; -; mRNA. DR CCDS; CCDS6239.1; -. DR PIR; A27175; CRHU2. DR RefSeq; NP_000058.1; NM_000067.3. DR PDB; 12CA; X-ray; 2.40 A; A=1-260. DR PDB; 1A42; X-ray; 2.25 A; A=2-260. DR PDB; 1AM6; X-ray; 2.00 A; A=2-260. DR PDB; 1AVN; X-ray; 2.00 A; A=2-260. DR PDB; 1BCD; X-ray; 1.90 A; A=2-260. DR PDB; 1BIC; X-ray; 1.90 A; A=2-260. DR PDB; 1BN1; X-ray; 2.10 A; A=2-260. DR PDB; 1BN3; X-ray; 2.20 A; A=2-260. DR PDB; 1BN4; X-ray; 2.10 A; A=2-260. DR PDB; 1BNM; X-ray; 2.60 A; A=2-260. DR PDB; 1BNN; X-ray; 2.30 A; A=2-260. DR PDB; 1BNQ; X-ray; 2.40 A; A=2-260. DR PDB; 1BNT; X-ray; 2.15 A; A=2-260. DR PDB; 1BNU; X-ray; 2.15 A; A=2-260. DR PDB; 1BNV; X-ray; 2.40 A; A=2-260. DR PDB; 1BNW; X-ray; 2.25 A; A=2-260. DR PDB; 1BV3; X-ray; 1.85 A; A=2-260. DR PDB; 1CA2; X-ray; 2.00 A; A=2-260. DR PDB; 1CA3; X-ray; 2.30 A; A=1-260. DR PDB; 1CAH; X-ray; 1.88 A; A=2-260. DR PDB; 1CAI; X-ray; 1.80 A; A=2-260. DR PDB; 1CAJ; X-ray; 1.90 A; A=2-260. DR PDB; 1CAK; X-ray; 1.90 A; A=2-260. DR PDB; 1CAL; X-ray; 2.20 A; A=2-260. DR PDB; 1CAM; X-ray; 1.70 A; A=2-260. DR PDB; 1CAN; X-ray; 1.90 A; A=2-260. DR PDB; 1CAO; X-ray; 1.90 A; A=2-260. DR PDB; 1CAY; X-ray; 2.10 A; A=2-260. DR PDB; 1CAZ; X-ray; 1.90 A; A=2-260. DR PDB; 1CCS; X-ray; 2.35 A; A=2-260. DR PDB; 1CCT; X-ray; 2.20 A; A=2-260. DR PDB; 1CCU; X-ray; 2.25 A; A=2-260. DR PDB; 1CIL; X-ray; 1.60 A; A=2-260. DR PDB; 1CIM; X-ray; 2.10 A; A=2-260. DR PDB; 1CIN; X-ray; 2.10 A; A=2-260. DR PDB; 1CNB; X-ray; 2.35 A; A=2-260. DR PDB; 1CNC; X-ray; 2.20 A; A=2-260. DR PDB; 1CNG; X-ray; 1.90 A; A=2-260. DR PDB; 1CNH; X-ray; 2.05 A; A=2-260. DR PDB; 1CNI; X-ray; 1.80 A; A=2-260. DR PDB; 1CNJ; X-ray; 1.80 A; A=2-260. DR PDB; 1CNK; X-ray; 2.15 A; A=2-260. DR PDB; 1CNW; X-ray; 2.00 A; A=1-260. DR PDB; 1CNX; X-ray; 1.90 A; A=1-260. DR PDB; 1CNY; X-ray; 2.30 A; A=1-260. DR PDB; 1CRA; X-ray; 1.90 A; A=2-260. DR PDB; 1CVA; X-ray; 2.25 A; A=2-260. DR PDB; 1CVB; X-ray; 2.40 A; A=2-260. DR PDB; 1CVC; X-ray; 2.30 A; A=2-260. DR PDB; 1CVD; X-ray; 2.20 A; A=5-259. DR PDB; 1CVE; X-ray; 2.25 A; A=2-260. DR PDB; 1CVF; X-ray; 2.25 A; A=2-260. DR PDB; 1CVH; X-ray; 2.30 A; A=5-259. DR PDB; 1DCA; X-ray; 2.20 A; A=1-260. DR PDB; 1DCB; X-ray; 2.10 A; A=1-260. DR PDB; 1EOU; X-ray; 2.10 A; A=1-260. DR PDB; 1F2W; X-ray; 1.90 A; A=2-260. DR PDB; 1FQL; X-ray; 2.00 A; A=1-260. DR PDB; 1FQM; X-ray; 2.00 A; A=1-260. DR PDB; 1FQN; X-ray; 2.00 A; A=1-260. DR PDB; 1FQR; X-ray; 2.00 A; A=1-260. DR PDB; 1FR4; X-ray; 1.60 A; A=1-260. DR PDB; 1FR7; X-ray; 1.50 A; A/B=1-260. DR PDB; 1FSN; X-ray; 2.00 A; A/B=1-260. DR PDB; 1FSQ; X-ray; 2.00 A; A/B=1-260. DR PDB; 1FSR; X-ray; 2.00 A; A/B=1-260. DR PDB; 1G0E; X-ray; 1.60 A; A=1-260. DR PDB; 1G0F; X-ray; 1.60 A; A=1-260. DR PDB; 1G1D; X-ray; 2.04 A; A=2-260. DR PDB; 1G3Z; X-ray; 1.86 A; A=2-260. DR PDB; 1G45; X-ray; 1.83 A; A=2-260. DR PDB; 1G46; X-ray; 1.84 A; A=2-260. DR PDB; 1G48; X-ray; 1.86 A; A=2-260. DR PDB; 1G4J; X-ray; 1.84 A; A=2-260. DR PDB; 1G4O; X-ray; 1.96 A; A=2-260. DR PDB; 1G52; X-ray; 1.80 A; A=2-260. DR PDB; 1G53; X-ray; 1.94 A; A=2-260. DR PDB; 1G54; X-ray; 1.86 A; A=2-260. DR PDB; 1H4N; X-ray; 2.00 A; A=2-260. DR PDB; 1H9N; X-ray; 1.85 A; A=2-260. DR PDB; 1H9Q; X-ray; 2.20 A; A=2-260. DR PDB; 1HCA; X-ray; 2.30 A; A=1-260. DR PDB; 1HEA; X-ray; 2.00 A; A=1-260. DR PDB; 1HEB; X-ray; 2.00 A; A=1-260. DR PDB; 1HEC; X-ray; 2.00 A; A=1-260. DR PDB; 1HED; X-ray; 2.00 A; A=1-260. DR PDB; 1HVA; X-ray; 2.30 A; A=1-260. DR PDB; 1I8Z; X-ray; 1.93 A; A=2-260. DR PDB; 1I90; X-ray; 2.00 A; A=2-260. DR PDB; 1I91; X-ray; 2.00 A; A=2-260. DR PDB; 1I9L; X-ray; 1.93 A; A=2-260. DR PDB; 1I9M; X-ray; 1.84 A; A=2-260. DR PDB; 1I9N; X-ray; 1.86 A; A=2-260. DR PDB; 1I9O; X-ray; 1.86 A; A=2-260. DR PDB; 1I9P; X-ray; 1.92 A; A=2-260. DR PDB; 1I9Q; X-ray; 1.80 A; A=2-260. DR PDB; 1IF4; X-ray; 1.93 A; A=2-260. DR PDB; 1IF5; X-ray; 2.00 A; A=2-260. DR PDB; 1IF6; X-ray; 2.09 A; A=2-260. DR PDB; 1IF7; X-ray; 1.98 A; A=2-260. DR PDB; 1IF8; X-ray; 1.94 A; A=2-260. DR PDB; 1IF9; X-ray; 2.00 A; A=2-260. DR PDB; 1KWQ; X-ray; 2.60 A; A=1-260. DR PDB; 1KWR; X-ray; 2.25 A; A=1-260. DR PDB; 1LG5; X-ray; 1.75 A; A=1-260. DR PDB; 1LG6; X-ray; 2.20 A; A=1-260. DR PDB; 1LGD; X-ray; 1.90 A; A=1-260. DR PDB; 1LUG; X-ray; 0.95 A; A=2-260. DR PDB; 1LZV; X-ray; 2.30 A; A=1-260. DR PDB; 1MOO; X-ray; 1.05 A; A=1-260. DR PDB; 1MUA; X-ray; 1.70 A; A=4-259. DR PDB; 1OKL; X-ray; 2.10 A; A=2-260. DR PDB; 1OKM; X-ray; 2.20 A; A=2-260. DR PDB; 1OKN; X-ray; 2.40 A; A=2-260. DR PDB; 1OQ5; X-ray; 1.50 A; A=2-260. DR PDB; 1RAY; X-ray; 1.80 A; A=2-260. DR PDB; 1RAZ; X-ray; 1.90 A; A=2-260. DR PDB; 1RZA; X-ray; 1.90 A; A=2-260. DR PDB; 1RZB; X-ray; 1.80 A; A=2-260. DR PDB; 1RZC; X-ray; 1.90 A; A=2-260. DR PDB; 1RZD; X-ray; 1.90 A; A=2-260. DR PDB; 1RZE; X-ray; 1.90 A; A=2-260. DR PDB; 1T9N; X-ray; 2.00 A; A=1-260. DR PDB; 1TB0; X-ray; 2.00 A; X=1-260. DR PDB; 1TBT; X-ray; 2.00 A; X=1-260. DR PDB; 1TE3; X-ray; 2.00 A; X=1-260. DR PDB; 1TEQ; X-ray; 2.00 A; X=1-260. DR PDB; 1TEU; X-ray; 2.00 A; X=1-260. DR PDB; 1TG3; X-ray; 1.80 A; A=1-260. DR PDB; 1TG9; X-ray; 1.90 A; A=1-260. DR PDB; 1TH9; X-ray; 1.63 A; A=1-260. DR PDB; 1THK; X-ray; 1.80 A; A=1-260. DR PDB; 1TTM; X-ray; 1.95 A; A=2-260. DR PDB; 1UGA; X-ray; 2.00 A; A=3-260. DR PDB; 1UGB; X-ray; 2.00 A; A=3-260. DR PDB; 1UGC; X-ray; 2.00 A; A=3-260. DR PDB; 1UGD; X-ray; 2.00 A; A=3-260. DR PDB; 1UGE; X-ray; 1.90 A; A=3-260. DR PDB; 1UGF; X-ray; 2.00 A; A=3-260. DR PDB; 1UGG; X-ray; 2.20 A; A=3-260. DR PDB; 1XEG; X-ray; 1.81 A; A=1-260. DR PDB; 1XEV; X-ray; 2.20 A; A/B/C/D=1-260. DR PDB; 1XPZ; X-ray; 2.02 A; A=3-260. DR PDB; 1XQ0; X-ray; 1.76 A; A=2-260. DR PDB; 1YDA; X-ray; 2.10 A; A=2-260. DR PDB; 1YDB; X-ray; 1.90 A; A=2-260. DR PDB; 1YDC; X-ray; 1.95 A; A=2-260. DR PDB; 1YDD; X-ray; 2.10 A; A=2-260. DR PDB; 1YO0; X-ray; 1.80 A; A=1-260. DR PDB; 1YO1; X-ray; 1.70 A; A=1-260. DR PDB; 1YO2; X-ray; 1.80 A; A=1-260. DR PDB; 1Z9Y; X-ray; 1.66 A; A=2-260. DR PDB; 1ZE8; X-ray; 2.00 A; A=2-260. DR PDB; 1ZFK; X-ray; 1.56 A; A=2-260. DR PDB; 1ZFQ; X-ray; 1.55 A; A=2-260. DR PDB; 1ZGE; X-ray; 1.65 A; A=2-260. DR PDB; 1ZGF; X-ray; 1.75 A; A=2-260. DR PDB; 1ZH9; X-ray; 1.70 A; A=2-260. DR PDB; 1ZSA; X-ray; 2.50 A; A=2-260. DR PDB; 1ZSB; X-ray; 2.00 A; A=2-260. DR PDB; 1ZSC; X-ray; 1.80 A; A=2-260. DR PDB; 2ABE; X-ray; 2.00 A; A=2-260. DR PDB; 2AW1; X-ray; 1.46 A; A=2-260. DR PDB; 2AX2; X-ray; 1.50 A; A=1-260. DR PDB; 2CA2; X-ray; 1.90 A; A=2-260. DR PDB; 2CBA; X-ray; 1.54 A; A=2-260. DR PDB; 2CBB; X-ray; 1.67 A; A=2-260. DR PDB; 2CBC; X-ray; 1.88 A; A=2-260. DR PDB; 2CBD; X-ray; 1.67 A; A=2-260. DR PDB; 2CBE; X-ray; 1.82 A; A=2-260. DR PDB; 2EU2; X-ray; 1.15 A; A=1-260. DR PDB; 2EU3; X-ray; 1.60 A; A=1-260. DR PDB; 2EZ7; X-ray; 2.00 A; A=1-260. DR PDB; 2F14; X-ray; 1.71 A; A=2-260. DR PDB; 2FMG; X-ray; 1.60 A; A=1-260. DR PDB; 2FMZ; X-ray; 1.60 A; A=1-260. DR PDB; 2FNK; X-ray; 1.80 A; A=1-260. DR PDB; 2FNM; X-ray; 1.80 A; A=1-260. DR PDB; 2FNN; X-ray; 1.80 A; A=1-260. DR PDB; 2FOQ; X-ray; 1.25 A; A=1-260. DR PDB; 2FOS; X-ray; 1.10 A; A=1-260. DR PDB; 2FOU; X-ray; 0.99 A; A=1-260. DR PDB; 2FOV; X-ray; 1.15 A; A=1-260. DR PDB; 2GD8; X-ray; 1.46 A; A=2-260. DR PDB; 2GEH; X-ray; 2.00 A; A=1-260. DR PDB; 2H15; X-ray; 1.90 A; A=1-260. DR PDB; 2H4N; X-ray; 1.90 A; A=2-260. DR PDB; 2HD6; X-ray; 1.80 A; A=2-260. DR PDB; 2HKK; X-ray; 1.90 A; A=1-260. DR PDB; 2HL4; X-ray; 1.55 A; A=2-260. DR PDB; 2HNC; X-ray; 1.55 A; A=2-260. DR PDB; 2HOC; X-ray; 2.10 A; A=2-260. DR PDB; 2ILI; X-ray; 1.05 A; A=2-260. DR PDB; 2NNG; X-ray; 1.20 A; A=2-260. DR PDB; 2NNO; X-ray; 1.01 A; A=2-260. DR PDB; 2NNS; X-ray; 1.03 A; A=2-260. DR PDB; 2NNV; X-ray; 1.10 A; A=2-260. DR PDB; 2NWO; X-ray; 1.70 A; A=1-260. DR PDB; 2NWP; X-ray; 1.80 A; A=1-260. DR PDB; 2NWY; X-ray; 1.65 A; A=1-260. DR PDB; 2NWZ; X-ray; 1.80 A; A=1-260. DR PDB; 2NXR; X-ray; 1.70 A; A=1-260. DR PDB; 2NXS; X-ray; 1.80 A; A=1-260. DR PDB; 2NXT; X-ray; 1.15 A; A=1-260. DR PDB; 2O4Z; X-ray; 2.10 A; A=1-260. DR PDB; 2OSF; X-ray; 1.60 A; A=2-260. DR PDB; 2OSM; X-ray; 1.60 A; A=2-260. DR PDB; 2POU; X-ray; 1.60 A; A=1-260. DR PDB; 2POV; X-ray; 1.60 A; A=1-259. DR PDB; 2POW; X-ray; 1.75 A; A=1-260. DR PDB; 2Q1B; X-ray; 1.70 A; A=1-260. DR PDB; 2Q1Q; X-ray; 1.90 A; A=1-260. DR PDB; 2Q38; X-ray; 1.95 A; A=1-260. DR PDB; 2QO8; X-ray; 1.40 A; A=2-260. DR PDB; 2QOA; X-ray; 1.60 A; A=2-260. DR PDB; 2QP6; X-ray; 1.45 A; A=2-260. DR PDB; 2VVA; X-ray; 1.56 A; X=1-260. DR PDB; 2VVB; X-ray; 1.66 A; X=1-260. DR PDB; 2WD2; X-ray; 1.49 A; A=2-260. DR PDB; 2WD3; X-ray; 1.80 A; A=2-260. DR PDB; 2WEG; X-ray; 1.10 A; A=2-260. DR PDB; 2WEH; X-ray; 2.09 A; A=2-260. DR PDB; 2WEJ; X-ray; 1.45 A; A=2-260. DR PDB; 2WEO; X-ray; 1.40 A; A=2-260. DR PDB; 2X7S; X-ray; 1.64 A; A=2-260. DR PDB; 2X7T; X-ray; 1.89 A; A=2-260. DR PDB; 2X7U; X-ray; 2.12 A; A=2-260. DR PDB; 3B4F; X-ray; 1.89 A; A=1-260. DR PDB; 3BET; X-ray; 1.85 A; A=2-260. DR PDB; 3BL0; X-ray; 1.90 A; A=1-260. DR PDB; 3BL1; X-ray; 2.10 A; A=1-260. DR PDB; 3C7P; X-ray; 1.70 A; A=1-260. DR PDB; 3CA2; X-ray; 2.00 A; A=2-260. DR PDB; 3CAJ; X-ray; 1.80 A; A=1-260. DR PDB; 3CYU; X-ray; 1.70 A; A=1-260. DR PDB; 3D8W; X-ray; 1.70 A; A=1-260. DR PDB; 3D92; X-ray; 1.10 A; A=1-260. DR PDB; 3D93; X-ray; 1.10 A; A=1-260. DR PDB; 3D9Z; X-ray; 1.65 A; A=1-260. DR PDB; 3DAZ; X-ray; 1.60 A; A=1-260. DR PDB; 3DBU; X-ray; 1.70 A; A=1-260. DR PDB; 3DC3; X-ray; 1.70 A; A=1-260. DR PDB; 3DC9; X-ray; 1.60 A; A=1-260. DR PDB; 3DCC; X-ray; 1.60 A; A=1-260. DR PDB; 3DCS; X-ray; 1.80 A; A=1-260. DR PDB; 3DCW; X-ray; 1.50 A; A=1-260. DR PDB; 3DD0; X-ray; 1.48 A; A=1-260. DR PDB; 3DD8; X-ray; 1.90 A; A=1-260. DR PDB; 3DV7; X-ray; 1.70 A; A=2-260. DR PDB; 3DVB; X-ray; 1.70 A; A=2-260. DR PDB; 3DVC; X-ray; 1.60 A; A=2-260. DR PDB; 3DVD; X-ray; 1.60 A; A=2-260. DR PDB; 3EFI; X-ray; 1.75 A; A=1-260. DR PDB; 3EFT; X-ray; 1.85 A; A=1-260. DR PDB; 3F4X; X-ray; 1.90 A; A=1-260. DR PDB; 3F8E; X-ray; 2.00 A; A=1-260. DR PDB; 3FFP; X-ray; 1.81 A; X=1-260. DR PDB; 3GZ0; X-ray; 1.26 A; A=2-260. DR PDB; 3HFP; X-ray; 2.10 A; A=1-260. DR PDB; 3HKN; X-ray; 1.80 A; A=1-260. DR PDB; 3HKQ; X-ray; 1.70 A; A=1-260. DR PDB; 3HKT; X-ray; 2.36 A; A=1-260. DR PDB; 3HKU; X-ray; 1.80 A; A=1-260. DR PDB; 3HLJ; X-ray; 1.44 A; A=1-260. DR PDB; 3HS4; X-ray; 1.10 A; A=1-260. DR PDB; 3IBI; X-ray; 1.93 A; A=2-260. DR PDB; 3IBL; X-ray; 1.55 A; A=2-260. DR PDB; 3IBN; X-ray; 2.20 A; A=2-260. DR PDB; 3IBU; X-ray; 1.41 A; A=2-260. DR PDB; 3IEO; X-ray; 2.00 A; A=1-260. DR PDB; 3IGP; X-ray; 1.65 A; A=1-260. DR PDB; 3K2F; X-ray; 1.98 A; A=1-260. DR PDB; 3K34; X-ray; 0.90 A; A=1-260. DR PDB; 3K7K; X-ray; 1.90 A; A=1-260. DR PDB; 3KIG; X-ray; 1.39 A; A=1-260. DR PDB; 3KKX; Neutron; 2.00 A; A=1-260. DR PDB; 3KNE; X-ray; 1.35 A; A=1-260. DR PDB; 3KOI; X-ray; 1.64 A; A=1-260. DR PDB; 3KOK; X-ray; 1.50 A; A=1-260. DR PDB; 3KON; X-ray; 1.50 A; A=1-260. DR PDB; 3KS3; X-ray; 0.90 A; A=1-260. DR PDB; 3KWA; X-ray; 2.00 A; A=1-260. DR PDB; 3L14; X-ray; 1.22 A; A=1-260. DR PDB; 3M04; X-ray; 1.40 A; A=1-260. DR PDB; 3M14; X-ray; 1.38 A; A=1-260. DR PDB; 3M1J; X-ray; 1.80 A; A=1-260. DR PDB; 3M1K; X-ray; 1.35 A; A=1-260. DR PDB; 3M1Q; X-ray; 1.69 A; A=1-260. DR PDB; 3M1W; X-ray; 1.38 A; A=1-260. DR PDB; 3M2N; X-ray; 1.65 A; A=1-260. DR PDB; 3M2X; X-ray; 1.87 A; A=1-260. DR PDB; 3M2Y; X-ray; 1.17 A; A=1-260. DR PDB; 3M2Z; X-ray; 1.70 A; A=1-260. DR PDB; 3M3X; X-ray; 1.68 A; A=1-260. DR PDB; 3M40; X-ray; 1.60 A; A=1-260. DR PDB; 3M5E; X-ray; 1.70 A; A=1-260. DR PDB; 3M5S; X-ray; 1.40 A; A=1-260. DR PDB; 3M5T; X-ray; 1.95 A; A=1-260. DR PDB; 3M67; X-ray; 1.80 A; A=1-260. DR PDB; 3M96; X-ray; 1.40 A; A=1-260. DR PDB; 3M98; X-ray; 1.50 A; A=1-260. DR PDB; 3MHC; X-ray; 1.70 A; A=1-260. DR PDB; 3MHI; X-ray; 1.70 A; A=1-260. DR PDB; 3MHL; X-ray; 1.90 A; A=1-260. DR PDB; 3MHM; X-ray; 1.50 A; A=1-260. DR PDB; 3MHO; X-ray; 1.15 A; A=1-260. DR PDB; 3ML2; X-ray; 1.80 A; A=1-260. DR PDB; 3MMF; X-ray; 1.50 A; A=1-260. DR PDB; 3MNA; X-ray; 1.50 A; A=1-260. DR PDB; 3MNH; X-ray; 1.65 A; A=1-260. DR PDB; 3MNI; X-ray; 1.75 A; A=1-260. DR PDB; 3MNJ; X-ray; 1.75 A; A=1-260. DR PDB; 3MNK; X-ray; 1.75 A; A=1-260. DR PDB; 3MNU; X-ray; 1.80 A; A=2-260. DR PDB; 3MWO; X-ray; 1.40 A; A/B=1-260. DR PDB; 3MYQ; X-ray; 1.35 A; A=1-260. DR PDB; 3MZC; X-ray; 1.50 A; A=1-260. DR PDB; 3N0N; X-ray; 1.50 A; A=1-260. DR PDB; 3N2P; X-ray; 1.65 A; A=1-260. DR PDB; 3N3J; X-ray; 1.50 A; A=1-260. DR PDB; 3N4B; X-ray; 1.60 A; A=1-260. DR PDB; 3NB5; X-ray; 1.80 A; A=1-260. DR PDB; 3NI5; X-ray; 2.10 A; A=1-260. DR PDB; 3NJ9; X-ray; 2.00 A; A=1-260. DR PDB; 3OIK; X-ray; 1.50 A; A=1-260. DR PDB; 3OIL; X-ray; 1.50 A; A=1-260. DR PDB; 3OIM; X-ray; 1.45 A; A=1-260. DR PDB; 3OKU; X-ray; 1.45 A; A=1-260. DR PDB; 3OKV; X-ray; 1.45 A; A=1-260. DR PDB; 3OY0; X-ray; 1.60 A; A=1-260. DR PDB; 3OYQ; X-ray; 1.47 A; A=1-260. DR PDB; 3OYS; X-ray; 1.54 A; A=1-260. DR PDB; 3P3H; X-ray; 1.50 A; A=1-260. DR PDB; 3P3J; X-ray; 1.60 A; A=1-260. DR PDB; 3P44; X-ray; 2.20 A; A=1-260. DR PDB; 3P4V; X-ray; 2.00 A; A=1-260. DR PDB; 3P55; X-ray; 2.00 A; A=1-260. DR PDB; 3P58; X-ray; 1.49 A; A=1-260. DR PDB; 3P5A; X-ray; 1.49 A; A=1-260. DR PDB; 3P5L; X-ray; 1.50 A; A=1-260. DR PDB; 3PJJ; X-ray; 1.80 A; A=2-260. DR PDB; 3PO6; X-ray; 1.47 A; A=2-260. DR PDB; 3PYK; X-ray; 1.30 A; A=1-260. DR PDB; 3QYK; X-ray; 1.47 A; A=1-260. DR PDB; 3R16; X-ray; 1.60 A; A=4-260. DR PDB; 3R17; X-ray; 1.70 A; B=4-260. DR PDB; 3RG3; X-ray; 1.90 A; A=1-260. DR PDB; 3RG4; X-ray; 1.50 A; A=1-260. DR PDB; 3RGE; X-ray; 2.10 A; A=1-260. DR PDB; 3RJ7; X-ray; 1.20 A; A=3-260. DR PDB; 3RLD; X-ray; 1.50 A; A=1-260. DR PDB; 3RYJ; X-ray; 1.39 A; B=2-260. DR PDB; 3RYV; X-ray; 1.20 A; B=2-260. DR PDB; 3RYX; X-ray; 1.60 A; B=2-260. DR PDB; 3RYY; X-ray; 1.16 A; A=2-260. DR PDB; 3RYZ; X-ray; 1.37 A; A=2-260. DR PDB; 3RZ0; X-ray; 1.80 A; B=2-260. DR PDB; 3RZ1; X-ray; 1.51 A; B=2-260. DR PDB; 3RZ5; X-ray; 1.65 A; A=2-260. DR PDB; 3RZ7; X-ray; 1.80 A; A=2-260. DR PDB; 3RZ8; X-ray; 1.70 A; A=2-260. DR PDB; 3S71; X-ray; 1.25 A; B=3-260. DR PDB; 3S72; X-ray; 1.60 A; B=3-260. DR PDB; 3S73; X-ray; 1.75 A; B=3-260. DR PDB; 3S74; X-ray; 1.40 A; B=3-260. DR PDB; 3S75; X-ray; 1.50 A; B=3-260. DR PDB; 3S76; X-ray; 1.60 A; A=3-260. DR PDB; 3S77; X-ray; 1.86 A; B=3-260. DR PDB; 3S78; X-ray; 1.98 A; B=3-260. DR PDB; 3S8X; X-ray; 1.30 A; A=1-260. DR PDB; 3S9T; X-ray; 1.30 A; A=1-260. DR PDB; 3SAP; X-ray; 1.75 A; A=1-260. DR PDB; 3SAX; X-ray; 1.10 A; A=1-260. DR PDB; 3SBH; X-ray; 1.65 A; A=1-260. DR PDB; 3SBI; X-ray; 1.40 A; A=1-260. DR PDB; 3T5U; X-ray; 1.75 A; A=2-260. DR PDB; 3T5Z; X-ray; 1.65 A; A=2-260. DR PDB; 3T82; X-ray; 2.00 A; A=1-260. DR PDB; 3T83; X-ray; 1.80 A; A=1-260. DR PDB; 3T84; X-ray; 2.00 A; A=1-260. DR PDB; 3T85; X-ray; 2.40 A; A=1-260. DR PDB; 3TMJ; Other; 2.00 A; A=3-260. DR PDB; 3TVN; X-ray; 1.50 A; X=3-260. DR PDB; 3TVO; X-ray; 1.60 A; X=3-260. DR PDB; 3U3A; X-ray; 1.55 A; X=1-260. DR PDB; 3U45; X-ray; 1.70 A; X=1-260. DR PDB; 3U47; X-ray; 1.60 A; A=1-260. DR PDB; 3U7C; X-ray; 0.93 A; A=1-260. DR PDB; 3V2J; X-ray; 1.70 A; A=1-260. DR PDB; 3V2M; X-ray; 1.47 A; A=1-260. DR PDB; 3V3F; X-ray; 2.00 A; A=1-260. DR PDB; 3V3G; X-ray; 1.56 A; B=1-260. DR PDB; 3V3H; X-ray; 1.85 A; B=1-260. DR PDB; 3V3I; X-ray; 1.73 A; B=1-260. DR PDB; 3V3J; X-ray; 1.63 A; A=1-260. DR PDB; 3V5G; X-ray; 1.50 A; A=1-260. DR PDB; 3V7X; X-ray; 1.03 A; A=2-260. DR PDB; 3VBD; X-ray; 1.05 A; A=2-260. DR PDB; 3ZP9; X-ray; 1.31 A; A=1-260. DR PDB; 4BCW; X-ray; 1.50 A; A=4-260. DR PDB; 4BF1; X-ray; 1.35 A; A=2-260. DR PDB; 4BF6; X-ray; 1.82 A; A=2-260. DR PDB; 4CA2; X-ray; 2.10 A; A=1-260. DR PDB; 4CAC; X-ray; 2.20 A; A=2-260. DR PDB; 4CQ0; X-ray; 1.45 A; A=1-260. DR PDB; 4DZ7; X-ray; 1.49 A; A=1-260. DR PDB; 4DZ9; X-ray; 1.49 A; A=1-260. DR PDB; 4E3D; X-ray; 1.60 A; A=1-260. DR PDB; 4E3F; X-ray; 1.50 A; A=1-260. DR PDB; 4E3G; X-ray; 1.55 A; A=1-260. DR PDB; 4E3H; X-ray; 1.50 A; A=1-260. DR PDB; 4E49; X-ray; 1.45 A; A=1-260. DR PDB; 4E4A; X-ray; 1.45 A; A=1-260. DR PDB; 4E5Q; X-ray; 1.70 A; A=1-260. DR PDB; 4FIK; X-ray; 1.20 A; A=1-260. DR PDB; 4FL7; X-ray; 1.85 A; A=2-260. DR PDB; 4FPT; X-ray; 0.98 A; A=1-260. DR PDB; 4FRC; X-ray; 0.98 A; A=1-260. DR PDB; 4FU5; X-ray; 0.98 A; A=1-260. DR PDB; 4FVN; X-ray; 1.05 A; A=1-260. DR PDB; 4FVO; X-ray; 1.05 A; A=1-260. DR PDB; 4G0C; Neutron; 2.00 A; A=4-260. DR PDB; 4GL1; X-ray; 1.50 A; X=1-260. DR PDB; 4HBA; X-ray; 1.76 A; A=1-260. DR PDB; 4HEW; X-ray; 1.70 A; A=1-260. DR PDB; 4HEY; X-ray; 1.45 A; A=1-260. DR PDB; 4HEZ; X-ray; 1.34 A; A=1-260. DR PDB; 4HF3; X-ray; 1.15 A; A=1-260. DR PDB; 4HT0; X-ray; 1.60 A; A=1-260. DR PDB; 4IDR; X-ray; 1.60 A; X=3-260. DR PDB; 4ILX; X-ray; 1.60 A; A=4-260. DR PDB; 4ITO; X-ray; 1.16 A; A=1-260. DR PDB; 4ITP; X-ray; 1.70 A; A=4-260. DR PDB; 4IWZ; X-ray; 1.60 A; A=4-260. DR PDB; 4JS6; X-ray; 1.55 A; A=1-260. DR PDB; 4JSA; X-ray; 1.50 A; A=1-260. DR PDB; 4JSS; X-ray; 1.50 A; A=1-260. DR PDB; 4JSW; X-ray; 1.90 A; A=1-260. DR PDB; 4JSZ; X-ray; 1.90 A; A=1-260. DR PDB; 4K0S; X-ray; 1.80 A; A=4-260. DR PDB; 4K0T; X-ray; 1.78 A; A=4-260. DR PDB; 4K0Z; X-ray; 1.80 A; A=3-260. DR PDB; 4K13; X-ray; 1.60 A; A=4-260. DR PDB; 4K1Q; X-ray; 1.70 A; A=3-260. DR PDB; 4KAP; X-ray; 1.45 A; A=5-260. DR PDB; 4KNI; X-ray; 1.80 A; A=1-260. DR PDB; 4KNJ; X-ray; 2.00 A; A=1-260. DR PDB; 4KUV; X-ray; 1.35 A; A=5-260. DR PDB; 4KUW; X-ray; 1.55 A; A=4-260. DR PDB; 4KUY; X-ray; 1.65 A; A=4-260. DR PDB; 4KV0; X-ray; 1.55 A; A=4-260. DR PDB; 4L5U; X-ray; 2.05 A; A=1-260. DR PDB; 4L5V; X-ray; 1.63 A; A=1-260. DR PDB; 4L5W; X-ray; 1.70 A; A=1-260. DR PDB; 4LHI; X-ray; 1.60 A; A=1-260. DR PDB; 4LP6; X-ray; 2.15 A; A/B=1-260. DR PDB; 4M2R; X-ray; 1.99 A; A=4-260. DR PDB; 4M2U; X-ray; 2.00 A; A=4-260. DR PDB; 4M2V; X-ray; 1.72 A; A=4-260. DR PDB; 4M2W; X-ray; 1.66 A; A=4-260. DR PDB; 4MDG; X-ray; 1.35 A; A=3-260. DR PDB; 4MDL; X-ray; 1.52 A; A=3-260. DR PDB; 4MDM; X-ray; 1.55 A; A=3-260. DR PDB; 4MLT; X-ray; 2.00 A; A=1-260. DR PDB; 4MLX; X-ray; 1.65 A; A=1-260. DR PDB; 4MO8; X-ray; 1.85 A; A=1-260. DR PDB; 4MTY; X-ray; 1.00 A; A=1-260. DR PDB; 4N0X; X-ray; 1.63 A; B=1-260. DR PDB; 4N16; X-ray; 1.54 A; A=1-260. DR PDB; 4PQ7; X-ray; 1.85 A; A=1-260. DR PDB; 4PXX; X-ray; 1.85 A; A=1-260. DR PDB; 4PYX; X-ray; 1.80 A; A=1-260. DR PDB; 4PYY; X-ray; 1.75 A; A=1-260. DR PDB; 4PZH; X-ray; 1.06 A; A=1-260. DR PDB; 4Q06; X-ray; 1.15 A; A=1-260. DR PDB; 4Q07; X-ray; 1.15 A; A=1-260. DR PDB; 4Q08; X-ray; 1.07 A; A=1-260. DR PDB; 4Q09; X-ray; 1.20 A; A=1-260. DR PDB; 4Q49; Neutron; 1.80 A; A=1-260. DR PDB; 4Q6D; X-ray; 1.12 A; A=1-260. DR PDB; 4Q6E; X-ray; 1.12 A; A=1-260. DR PDB; 4Q78; X-ray; 1.00 A; A=3-260. DR PDB; 4Q7P; X-ray; 1.65 A; A=1-260. DR PDB; 4Q7S; X-ray; 1.80 A; A=1-260. DR PDB; 4Q7V; X-ray; 1.60 A; A=1-260. DR PDB; 4Q7W; X-ray; 1.45 A; A=1-260. DR PDB; 4Q81; X-ray; 1.55 A; A=1-260. DR PDB; 4Q83; X-ray; 1.55 A; A=1-260. DR PDB; 4Q87; X-ray; 1.55 A; A=1-260. DR PDB; 4Q8X; X-ray; 1.55 A; A=1-260. DR PDB; 4Q8Y; X-ray; 1.45 A; A=1-260. DR PDB; 4Q8Z; X-ray; 1.50 A; A=1-260. DR PDB; 4Q90; X-ray; 1.54 A; A=1-260. DR PDB; 4Q99; X-ray; 1.50 A; A=1-260. DR PDB; 4Q9Y; X-ray; 1.55 A; A=1-260. DR PDB; 4QEF; X-ray; 1.47 A; A=1-260. DR PDB; 4QIY; X-ray; 1.30 A; A/B/C/D=1-260. DR PDB; 4QJM; X-ray; 1.75 A; A=1-260. DR PDB; 4QK1; X-ray; 1.60 A; A=1-260. DR PDB; 4QK2; X-ray; 1.52 A; A=1-260. DR PDB; 4QK3; X-ray; 1.34 A; A=1-260. DR PDB; 4QSA; X-ray; 1.50 A; A=1-260. DR PDB; 4QSB; X-ray; 1.40 A; A=1-260. DR PDB; 4QSI; X-ray; 1.95 A; A=1-260. DR PDB; 4QTL; X-ray; 1.80 A; A=1-260. DR PDB; 4QY3; X-ray; 1.50 A; A=2-260. DR PDB; 4R59; X-ray; 1.65 A; A=1-260. DR PDB; 4R5A; X-ray; 1.64 A; A=1-260. DR PDB; 4R5B; X-ray; 1.50 A; A=1-260. DR PDB; 4RFC; X-ray; 1.65 A; A=1-260. DR PDB; 4RFD; X-ray; 1.63 A; A=1-260. DR PDB; 4RH2; X-ray; 1.30 A; A=1-260. DR PDB; 4RIU; X-ray; 1.65 A; A=1-260. DR PDB; 4RIV; X-ray; 1.63 A; A=1-260. DR PDB; 4RN4; X-ray; 1.53 A; A=1-260. DR PDB; 4RUX; X-ray; 1.14 A; A=1-260. DR PDB; 4RUY; X-ray; 1.14 A; A=1-260. DR PDB; 4RUZ; X-ray; 1.63 A; A=1-260. DR PDB; 4WL4; X-ray; 1.10 A; A=1-260. DR PDB; 4WW6; X-ray; 1.06 A; A=1-260. DR PDB; 4XE1; X-ray; 1.80 A; A=1-260. DR PDB; 4Y0J; Neutron; 2.00 A; A=3-260. DR PDB; 4YGJ; X-ray; 1.10 A; A=3-260. DR PDB; 4YGK; X-ray; 1.50 A; A=3-260. DR PDB; 4YGL; X-ray; 1.51 A; A=3-260. DR PDB; 4YGN; X-ray; 1.23 A; A=3-260. DR PDB; 4YVY; X-ray; 1.45 A; A=2-260. DR PDB; 4YWP; X-ray; 1.45 A; A=4-260. DR PDB; 4YX4; X-ray; 1.01 A; A=1-260. DR PDB; 4YXI; X-ray; 0.96 A; A=1-260. DR PDB; 4YXO; X-ray; 1.06 A; A=1-260. DR PDB; 4YXU; X-ray; 1.08 A; A=1-260. DR PDB; 4YYT; X-ray; 1.07 A; A=1-260. DR PDB; 4Z0Q; X-ray; 1.45 A; A=3-260. DR PDB; 4Z1E; X-ray; 2.01 A; A=2-260. DR PDB; 4Z1J; X-ray; 1.27 A; A=3-260. DR PDB; 4Z1K; X-ray; 1.35 A; A=4-260. DR PDB; 4Z1N; X-ray; 1.47 A; A=3-260. DR PDB; 4ZAO; X-ray; 1.80 A; A=1-257. DR PDB; 4ZWI; X-ray; 1.60 A; A=4-260. DR PDB; 4ZWX; X-ray; 1.70 A; A=4-260. DR PDB; 4ZWY; X-ray; 1.50 A; A=4-260. DR PDB; 4ZWZ; X-ray; 1.62 A; A=4-260. DR PDB; 4ZX0; X-ray; 1.60 A; A=4-260. DR PDB; 4ZX1; X-ray; 1.50 A; A=4-260. DR PDB; 5A6H; X-ray; 1.57 A; A=1-260. DR PDB; 5AMD; X-ray; 1.50 A; A=2-260. DR PDB; 5AMG; X-ray; 1.55 A; A=2-260. DR PDB; 5AML; X-ray; 1.36 A; A=2-260. DR PDB; 5BNL; X-ray; 2.00 A; A=4-260. DR PDB; 5BRU; X-ray; 1.60 A; A=3-260. DR PDB; 5BRV; X-ray; 1.60 A; A=3-260. DR PDB; 5BRW; X-ray; 1.40 A; A=1-260. DR PDB; 5BYI; X-ray; 1.15 A; A=1-260. DR PDB; 5C8I; Other; 1.56 A; A=1-260. DR PDB; 5CA2; X-ray; 2.10 A; A=1-260. DR PDB; 5CAC; X-ray; 2.20 A; A=2-260. DR PDB; 5CLU; X-ray; 1.55 A; A=4-260. DR PDB; 5DOG; X-ray; 1.70 A; A=1-260. DR PDB; 5DOH; X-ray; 1.05 A; A/B=1-260. DR PDB; 5DRS; X-ray; 1.10 A; A=1-260. DR PDB; 5DSK; X-ray; 1.30 A; A=1-260. DR PDB; 5DSL; X-ray; 1.45 A; A=1-260. DR PDB; 5DSM; X-ray; 1.30 A; A=1-260. DR PDB; 5DSO; X-ray; 1.40 A; A=1-260. DR PDB; 5DSP; X-ray; 1.40 A; A=1-260. DR PDB; 5DSQ; X-ray; 1.50 A; A=1-260. DR PDB; 5DSR; X-ray; 1.30 A; A=1-260. DR PDB; 5E28; X-ray; 1.30 A; A=4-260. DR PDB; 5E2K; X-ray; 1.40 A; A=4-260. DR PDB; 5E2R; X-ray; 1.60 A; A=1-260. DR PDB; 5E2S; X-ray; 1.50 A; A=3-260. DR PDB; 5EH5; X-ray; 1.21 A; A=1-260. DR PDB; 5EH7; X-ray; 1.43 A; A=1-260. DR PDB; 5EH8; X-ray; 1.38 A; A=1-260. DR PDB; 5EHE; X-ray; 1.50 A; A=1-260. DR PDB; 5EHV; X-ray; 1.21 A; A=1-260. DR PDB; 5EHW; X-ray; 1.39 A; A=1-260. DR PDB; 5EIJ; X-ray; 1.99 A; A=4-260. DR PDB; 5EKH; X-ray; 1.34 A; A=1-260. DR PDB; 5EKJ; X-ray; 1.13 A; A=1-260. DR PDB; 5EKM; X-ray; 1.33 A; A=1-260. DR PDB; 5EOI; X-ray; 1.80 A; A=3-260. DR PDB; 5FDC; X-ray; 1.75 A; A=1-260. DR PDB; 5FDI; X-ray; 1.85 A; A=1-260. DR PDB; 5FLO; X-ray; 1.66 A; A=1-260. DR PDB; 5FLP; X-ray; 1.71 A; A=1-260. DR PDB; 5FLQ; X-ray; 1.70 A; A=1-260. DR PDB; 5FLR; X-ray; 1.68 A; A=1-260. DR PDB; 5FLS; X-ray; 1.67 A; A=1-260. DR PDB; 5FLT; X-ray; 1.67 A; A=1-260. DR PDB; 5FNG; X-ray; 2.05 A; A=1-260. DR PDB; 5FNH; X-ray; 1.66 A; A=1-260. DR PDB; 5FNI; X-ray; 1.60 A; A=1-260. DR PDB; 5FNJ; X-ray; 1.67 A; A=1-260. DR PDB; 5FNK; X-ray; 1.59 A; A=1-260. DR PDB; 5FNL; X-ray; 1.59 A; A=1-260. DR PDB; 5FNM; X-ray; 1.59 A; A=1-260. DR PDB; 5G01; X-ray; 1.40 A; A=1-260. DR PDB; 5G03; X-ray; 1.35 A; A=1-260. DR PDB; 5G0B; X-ray; 1.55 A; A=1-260. DR PDB; 5G0C; X-ray; 1.28 A; A=1-260. DR PDB; 5GMN; X-ray; 1.80 A; A=1-260. DR PDB; 5J8Z; X-ray; 1.70 A; A=1-260. DR PDB; 5JDV; X-ray; 1.34 A; B=3-260. DR PDB; 5JE7; X-ray; 1.15 A; B=4-260. DR PDB; 5JEG; X-ray; 1.19 A; B=3-260. DR PDB; 5JEH; X-ray; 1.13 A; B=3-260. DR PDB; 5JEP; X-ray; 1.19 A; B=3-260. DR PDB; 5JES; X-ray; 1.21 A; B=3-260. DR PDB; 5JG3; X-ray; 1.21 A; B=3-260. DR PDB; 5JG5; X-ray; 1.19 A; B=3-260. DR PDB; 5JGS; X-ray; 1.11 A; B=4-260. DR PDB; 5JGT; X-ray; 1.10 A; B=3-260. DR PDB; 5JMZ; X-ray; 1.90 A; A=4-260. DR PDB; 5JN3; X-ray; 1.60 A; A=4-260. DR PDB; 5JN7; X-ray; 1.52 A; A=4-260. DR PDB; 5JQ0; X-ray; 1.40 A; A=1-260. DR PDB; 5JQT; X-ray; 1.36 A; A=1-260. DR PDB; 5L3O; X-ray; 1.98 A; A/B=1-260. DR PDB; 5L6K; X-ray; 1.70 A; A/B=1-260. DR PDB; 5L6T; X-ray; 2.65 A; A/B=1-260. DR PDB; 5L70; X-ray; 2.20 A; A/B=1-260. DR PDB; 5L9E; X-ray; 2.90 A; A/B/C/D=1-260. DR PDB; 5LJQ; X-ray; 1.05 A; A=3-260. DR PDB; 5LJT; X-ray; 1.00 A; A=3-260. DR PDB; 5LL4; X-ray; 1.12 A; A/B=1-260. DR PDB; 5LL8; X-ray; 1.03 A; A=1-260. DR PDB; 5LLC; X-ray; 1.10 A; A=1-260. DR PDB; 5LLE; X-ray; 1.90 A; A=1-260. DR PDB; 5LLG; X-ray; 1.12 A; A=1-260. DR PDB; 5LLH; X-ray; 1.90 A; A=1-260. DR PDB; 5LMD; X-ray; 1.70 A; A=1-260. DR PDB; 5LVS; X-ray; 1.42 A; A/B=2-260. DR PDB; 5M78; X-ray; 1.08 A; A=1-260. DR PDB; 5MJN; X-ray; 1.17 A; A=2-260. DR PDB; 5N0D; X-ray; 1.70 A; A=1-260. DR PDB; 5N0E; X-ray; 1.75 A; A=1-260. DR PDB; 5N1R; X-ray; 1.30 A; A=1-260. DR PDB; 5N1S; X-ray; 1.30 A; A=1-260. DR PDB; 5N24; X-ray; 1.50 A; A=1-260. DR PDB; 5N25; X-ray; 1.40 A; A=1-260. DR PDB; 5NEA; X-ray; 1.30 A; A=1-260. DR PDB; 5NEE; X-ray; 1.70 A; A=1-260. DR PDB; 5NXG; X-ray; 1.20 A; A=4-260. DR PDB; 5NXI; X-ray; 1.16 A; A=2-260. DR PDB; 5NXM; X-ray; 1.25 A; A=3-260. DR PDB; 5NXO; X-ray; 1.20 A; A=3-260. DR PDB; 5NXP; X-ray; 1.25 A; A=3-260. DR PDB; 5NXV; X-ray; 1.10 A; A=3-260. DR PDB; 5NXW; X-ray; 1.10 A; A=4-260. DR PDB; 5NY1; X-ray; 1.10 A; A=4-260. DR PDB; 5NY3; X-ray; 1.40 A; A=3-260. DR PDB; 5NY6; X-ray; 1.10 A; A=3-260. DR PDB; 5NYA; X-ray; 1.20 A; A=4-260. DR PDB; 5O07; X-ray; 1.80 A; A=1-260. DR PDB; 5OGN; X-ray; 1.10 A; A/B=3-260. DR PDB; 5OGO; X-ray; 0.99 A; A=1-260. DR PDB; 5OGP; X-ray; 1.10 A; A=2-260. DR PDB; 5SZ0; X-ray; 1.63 A; A=4-260. DR PDB; 5SZ1; X-ray; 1.55 A; A=4-260. DR PDB; 5SZ2; X-ray; 1.63 A; A=4-260. DR PDB; 5SZ3; X-ray; 1.69 A; A=4-260. DR PDB; 5SZ4; X-ray; 1.60 A; A=4-260. DR PDB; 5SZ5; X-ray; 1.27 A; A=4-260. DR PDB; 5SZ6; X-ray; 1.15 A; A=4-260. DR PDB; 5SZ7; X-ray; 1.78 A; A=4-260. DR PDB; 5T71; X-ray; 1.30 A; A=1-260. DR PDB; 5T72; X-ray; 1.30 A; A=1-260. DR PDB; 5T74; X-ray; 1.20 A; A=1-260. DR PDB; 5T75; X-ray; 1.50 A; A=1-260. DR PDB; 5TFX; X-ray; 1.50 A; A=1-260. DR PDB; 5TH4; X-ray; 1.47 A; A=1-260. DR PDB; 5THI; X-ray; 1.50 A; A=1-260. DR PDB; 5THJ; X-ray; 1.50 A; A=1-260. DR PDB; 5THN; X-ray; 1.33 A; A=1-260. DR PDB; 5TI0; X-ray; 1.42 A; A=1-260. DR PDB; 5TXY; X-ray; 1.21 A; A=1-260. DR PDB; 5TY1; X-ray; 1.60 A; A=1-260. DR PDB; 5TY8; X-ray; 1.45 A; A=1-260. DR PDB; 5TY9; X-ray; 1.53 A; A=1-260. DR PDB; 5TYA; X-ray; 1.50 A; A=1-260. DR PDB; 5U0D; X-ray; 1.59 A; A=1-260. DR PDB; 5U0E; X-ray; 1.27 A; A=1-260. DR PDB; 5U0F; X-ray; 1.21 A; A=1-260. DR PDB; 5U0G; X-ray; 1.54 A; A=1-260. DR PDB; 5ULN; X-ray; 1.35 A; A=1-260. DR PDB; 5UMC; X-ray; 2.15 A; A=1-260. DR PDB; 5VGY; X-ray; 1.39 A; A=1-260. DR PDB; 5W8B; X-ray; 1.60 A; A=4-260. DR PDB; 5WEX; X-ray; 1.26 A; A=1-260. DR PDB; 5WG7; X-ray; 1.45 A; A=4-260. DR PDB; 5WGP; X-ray; 1.53 A; A=4-260. DR PDB; 5WLR; X-ray; 1.49 A; A=4-260. DR PDB; 5WLT; X-ray; 1.57 A; A=4-260. DR PDB; 5WLU; X-ray; 1.39 A; A=4-260. DR PDB; 5WLV; X-ray; 1.40 A; A=4-260. DR PDB; 5Y2R; X-ray; 1.00 A; A=1-260. DR PDB; 5Y2S; X-ray; 0.90 A; A=1-260. DR PDB; 5YUI; X-ray; 1.20 A; A=1-260. DR PDB; 5YUJ; X-ray; 1.25 A; A=1-260. DR PDB; 5YUK; X-ray; 1.45 A; A=1-260. DR PDB; 5ZXW; X-ray; 1.32 A; A=5-260. DR PDB; 6B00; X-ray; 0.90 A; A=3-260. DR PDB; 6B4D; X-ray; 1.20 A; A=4-260. DR PDB; 6B59; X-ray; 1.64 A; A=4-260. DR PDB; 6B5A; X-ray; 1.62 A; A=4-260. DR PDB; 6BBS; Other; 2.00 A; A=1-260. DR PDB; 6BC9; Other; 1.80 A; A=1-260. DR PDB; 6BCC; Other; 1.80 A; A=1-260. DR PDB; 6C7W; X-ray; 1.28 A; A=1-260. DR PDB; 6C7X; X-ray; 1.50 A; A=1-260. DR PDB; 6CA2; X-ray; 2.50 A; A=1-260. DR PDB; 6CEH; X-ray; 1.43 A; A=2-260. DR PDB; 6CJV; X-ray; 1.55 A; A=4-260. DR PDB; 6D1L; X-ray; 1.40 A; A=1-260. DR PDB; 6D1M; X-ray; 1.21 A; A=1-260. DR PDB; 6E8P; X-ray; 1.90 A; A=4-260. DR PDB; 6E8X; X-ray; 1.60 A; A=4-260. DR PDB; 6E91; X-ray; 1.80 A; A=4-260. DR PDB; 6E92; X-ray; 1.77 A; A=4-260. DR PDB; 6EBE; X-ray; 1.88 A; A=4-260. DR PDB; 6ECZ; X-ray; 2.21 A; A=4-260. DR PDB; 6EDA; X-ray; 1.88 A; A=4-260. DR PDB; 6EEA; X-ray; 1.63 A; A=4-260. DR PDB; 6EEH; X-ray; 1.63 A; A=4-260. DR PDB; 6EEO; X-ray; 1.72 A; A=4-260. DR PDB; 6EQU; X-ray; 1.65 A; A=1-260. DR PDB; 6FJI; Other; 1.60 A; A=1-260. DR PDB; 6FJJ; Other; 1.50 A; A=1-260. DR PDB; 6G3Q; X-ray; 1.01 A; A=1-260. DR PDB; 6G6T; X-ray; 1.12 A; A=1-260. DR PDB; 6GCY; Other; 1.30 A; A=1-260. DR PDB; 6GDC; X-ray; 1.08 A; A=1-260. DR PDB; 6GM9; X-ray; 1.09 A; A=1-260. DR PDB; 6GOT; X-ray; 1.56 A; A=1-260. DR PDB; 6GXB; X-ray; 1.35 A; A=4-260. DR PDB; 6GXE; X-ray; 1.30 A; A=4-260. DR PDB; 6H29; X-ray; 1.46 A; A=1-260. DR PDB; 6H2Z; X-ray; 1.94 A; A=1-260. DR PDB; 6H33; X-ray; 1.58 A; A=1-260. DR PDB; 6H34; X-ray; 1.55 A; A=1-260. DR PDB; 6H3Q; X-ray; 1.31 A; A=1-260. DR PDB; 6H6S; X-ray; 1.45 A; A/B=2-260. DR PDB; 6HD2; NMR; -; A=1-260. DR PDB; 6HQX; X-ray; 1.10 A; A=1-260. DR PDB; 6HR3; X-ray; 1.02 A; A=1-260. DR PDB; 6HX5; X-ray; 1.44 A; A=1-260. DR PDB; 6HXD; X-ray; 1.12 A; A=1-260. DR PDB; 6HZX; X-ray; 2.91 A; A/B=4-260. DR PDB; 6I0W; X-ray; 1.04 A; A=1-260. DR PDB; 6I1U; X-ray; 1.08 A; A=1-260. DR PDB; 6I2F; X-ray; 1.20 A; A=1-260. DR PDB; 6I3E; X-ray; 1.07 A; A=1-260. DR PDB; 6IC2; X-ray; 1.15 A; A=1-260. DR PDB; 6KLZ; X-ray; 0.90 A; A=1-260. DR PDB; 6KM0; X-ray; 0.93 A; A=1-260. DR PDB; 6KM1; X-ray; 1.05 A; A=1-260. DR PDB; 6KM2; X-ray; 0.90 A; A=1-260. DR PDB; 6KM3; X-ray; 1.15 A; A=1-260. DR PDB; 6KM4; X-ray; 1.15 A; A=1-260. DR PDB; 6KM5; X-ray; 1.15 A; A=1-260. DR PDB; 6KM6; X-ray; 1.15 A; A=1-260. DR PDB; 6LUU; X-ray; 1.20 A; A=1-260. DR PDB; 6LUV; X-ray; 1.20 A; A=1-260. DR PDB; 6LUW; X-ray; 1.20 A; A=1-260. DR PDB; 6LUX; X-ray; 1.20 A; A=1-260. DR PDB; 6LUY; X-ray; 1.20 A; A=1-260. DR PDB; 6LUZ; X-ray; 1.20 A; A=1-260. DR PDB; 6LV1; X-ray; 1.20 A; A=1-260. DR PDB; 6LV2; X-ray; 1.20 A; A=1-260. DR PDB; 6LV3; X-ray; 1.20 A; A=1-260. DR PDB; 6LV4; X-ray; 1.20 A; A=1-260. DR PDB; 6LV5; X-ray; 1.20 A; A=1-260. DR PDB; 6LV6; X-ray; 1.20 A; A=1-260. DR PDB; 6LV7; X-ray; 1.20 A; A=1-260. DR PDB; 6LV8; X-ray; 1.20 A; A=1-260. DR PDB; 6LV9; X-ray; 1.20 A; A=1-260. DR PDB; 6LVA; X-ray; 1.20 A; A=1-260. DR PDB; 6MBV; X-ray; 1.70 A; A=4-260. DR PDB; 6MBY; X-ray; 1.50 A; A=4-260. DR PDB; 6NJ2; X-ray; 1.50 A; A/B=3-260. DR PDB; 6NJ3; X-ray; 1.01 A; A=3-260. DR PDB; 6NJ4; X-ray; 1.30 A; A=3-260. DR PDB; 6NJ5; X-ray; 1.25 A; A=3-260. DR PDB; 6NJ6; X-ray; 1.60 A; A/B=3-260. DR PDB; 6NLV; X-ray; 1.79 A; A=4-260. DR PDB; 6NM0; X-ray; 1.44 A; A=4-260. DR PDB; 6ODZ; X-ray; 1.30 A; A=1-260. DR PDB; 6OE0; X-ray; 1.30 A; A=1-260. DR PDB; 6OE1; X-ray; 1.45 A; A=1-260. DR PDB; 6OTI; X-ray; 2.00 A; A=4-260. DR PDB; 6OTK; X-ray; 1.12 A; A=4-260. DR PDB; 6OTM; X-ray; 1.31 A; A=4-260. DR PDB; 6OTO; X-ray; 1.50 A; A=1-260. DR PDB; 6OTP; X-ray; 1.47 A; A=4-260. DR PDB; 6OTQ; X-ray; 1.47 A; A=4-260. DR PDB; 6OUB; X-ray; 1.42 A; A=4-260. DR PDB; 6OUD; X-ray; 1.26 A; A=4-260. DR PDB; 6OUE; X-ray; 1.42 A; A=4-260. DR PDB; 6OUF; X-ray; 1.36 A; A=4-260. DR PDB; 6OUH; X-ray; 1.45 A; A=4-260. DR PDB; 6OUI; X-ray; 1.53 A; A=4-260. DR PDB; 6OUJ; X-ray; 1.47 A; A=4-260. DR PDB; 6OUK; X-ray; 1.50 A; A=4-260. DR PDB; 6OUM; X-ray; 1.56 A; A=4-260. DR PDB; 6PDV; X-ray; 1.23 A; A=1-260. DR PDB; 6PEA; X-ray; 1.36 A; A=1-260. DR PDB; 6PGX; X-ray; 1.36 A; A=1-260. DR PDB; 6Q3O; X-ray; 2.23 A; A/B/C/D=2-260. DR PDB; 6Q9T; X-ray; 2.68 A; A=2-260. DR PDB; 6QEB; NMR; -; A=1-260. DR PDB; 6QFU; X-ray; 1.80 A; A=3-260. DR PDB; 6QFV; X-ray; 1.45 A; A=3-260. DR PDB; 6QFW; X-ray; 1.20 A; A=3-260. DR PDB; 6QFX; X-ray; 1.32 A; A=3-260. DR PDB; 6QL1; X-ray; 1.42 A; A=1-260. DR PDB; 6QL2; X-ray; 1.30 A; A=1-260. DR PDB; 6QL3; X-ray; 1.35 A; A=1-260. DR PDB; 6R6F; X-ray; 1.20 A; A=1-260. DR PDB; 6R6J; X-ray; 1.55 A; A=1-260. DR PDB; 6RFH; X-ray; 0.97 A; A=1-260. DR PDB; 6RG3; X-ray; 1.32 A; A=1-260. DR PDB; 6RG4; X-ray; 1.25 A; A=1-260. DR PDB; 6RG5; X-ray; 1.09 A; A=1-260. DR PDB; 6RH4; X-ray; 0.95 A; A=1-260. DR PDB; 6RHJ; X-ray; 1.44 A; A=1-260. DR PDB; 6RHK; X-ray; 1.44 A; A=1-260. DR PDB; 6RIG; X-ray; 1.00 A; A=1-260. DR PDB; 6RIT; X-ray; 1.01 A; A=1-260. DR PDB; 6RJJ; X-ray; 1.06 A; A=1-260. DR PDB; 6RKN; X-ray; 0.96 A; A=1-260. DR PDB; 6RL9; X-ray; 1.00 A; A=1-260. DR PDB; 6RM1; X-ray; 1.68 A; A=1-260. DR PDB; 6RMP; X-ray; 1.22 A; A=1-260. DR PDB; 6RMX; X-ray; 1.60 A; A=4-260. DR PDB; 6RMY; X-ray; 1.50 A; A=1-260. DR PDB; 6RNP; X-ray; 1.07 A; A=1-260. DR PDB; 6ROB; X-ray; 0.93 A; A=1-260. DR PDB; 6ROE; X-ray; 0.94 A; A=1-260. DR PDB; 6ROF; X-ray; 1.50 A; A=1-260. DR PDB; 6RQI; X-ray; 0.95 A; A=1-260. DR PDB; 6RRG; X-ray; 1.13 A; A=1-260. DR PDB; 6RRI; X-ray; 1.10 A; A=1-260. DR PDB; 6RS5; X-ray; 1.07 A; A=1-260. DR PDB; 6RSZ; X-ray; 1.09 A; A=1-260. DR PDB; 6RVF; X-ray; 2.07 A; A=1-260. DR PDB; 6RVK; X-ray; 1.58 A; A=1-260. DR PDB; 6RVL; X-ray; 1.72 A; A=1-260. DR PDB; 6RW1; X-ray; 1.70 A; A=1-260. DR PDB; 6RZX; X-ray; 1.00 A; A=1-260. DR PDB; 6S03; X-ray; 1.38 A; A=1-260. DR PDB; 6S9G; X-ray; 1.14 A; A=1-260. DR PDB; 6S9Z; X-ray; 0.95 A; A=1-260. DR PDB; 6SAC; X-ray; 1.02 A; A=1-260. DR PDB; 6SAS; X-ray; 1.10 A; A=1-260. DR PDB; 6SAY; X-ray; 0.95 A; A=1-260. DR PDB; 6SB7; X-ray; 1.09 A; A=1-260. DR PDB; 6SBH; X-ray; 0.95 A; A=1-260. DR PDB; 6SBL; X-ray; 0.94 A; A=1-260. DR PDB; 6SBM; X-ray; 0.95 A; A=1-260. DR PDB; 6SD7; X-ray; 1.05 A; A=1-260. DR PDB; 6SDH; X-ray; 1.04 A; A=1-260. DR PDB; 6SDI; X-ray; 1.03 A; A=1-260. DR PDB; 6SDJ; X-ray; 1.02 A; A=1-260. DR PDB; 6SDL; X-ray; 1.08 A; A=1-260. DR PDB; 6SDS; X-ray; 1.26 A; A=1-260. DR PDB; 6SEY; X-ray; 1.23 A; A=1-260. DR PDB; 6SFQ; X-ray; 1.00 A; A=1-260. DR PDB; 6SFU; X-ray; 1.04 A; A=1-260. DR PDB; 6SG0; X-ray; 1.13 A; A=1-260. DR PDB; 6SG6; X-ray; 0.98 A; A=1-260. DR PDB; 6SX9; X-ray; 1.43 A; A=1-260. DR PDB; 6SYB; X-ray; 1.60 A; A=1-260. DR PDB; 6SYS; X-ray; 1.30 A; A=1-260. DR PDB; 6T4N; X-ray; 1.40 A; A=1-260. DR PDB; 6T4O; X-ray; 1.13 A; A=1-260. DR PDB; 6T4P; X-ray; 1.75 A; A=1-260. DR PDB; 6T5C; X-ray; 1.22 A; A=1-260. DR PDB; 6T7U; X-ray; 1.20 A; A=1-260. DR PDB; 6T81; X-ray; 0.98 A; A=1-260. DR PDB; 6T9Z; X-ray; 1.12 A; A=1-260. DR PDB; 6U4Q; X-ray; 1.31 A; A=4-260. DR PDB; 6U4T; X-ray; 1.36 A; A=4-260. DR PDB; 6UFB; X-ray; 1.67 A; A=1-260. DR PDB; 6UFC; X-ray; 1.32 A; A=1-260. DR PDB; 6UFD; X-ray; 1.48 A; A=1-260. DR PDB; 6UGN; X-ray; 1.41 A; A=4-260. DR PDB; 6UGO; X-ray; 1.46 A; A=4-260. DR PDB; 6UGP; X-ray; 1.31 A; A=4-260. DR PDB; 6UGQ; X-ray; 1.30 A; A=4-260. DR PDB; 6UGR; X-ray; 1.31 A; A=4-260. DR PDB; 6UGZ; X-ray; 1.31 A; A=4-260. DR PDB; 6UH0; X-ray; 1.31 A; A=4-260. DR PDB; 6UX1; X-ray; 1.36 A; A=1-260. DR PDB; 6UZU; X-ray; 1.50 A; A=4-260. DR PDB; 6VJ3; X-ray; 1.35 A; A=3-260. DR PDB; 6VKG; X-ray; 1.37 A; A=1-260. DR PDB; 6WKA; X-ray; 1.34 A; A=1-260. DR PDB; 6WQ4; X-ray; 1.35 A; A=1-260. DR PDB; 6WQ5; X-ray; 1.30 A; A=1-260. DR PDB; 6WQ7; X-ray; 1.30 A; A=1-260. DR PDB; 6WQ8; X-ray; 1.41 A; A=1-260. DR PDB; 6WQ9; X-ray; 1.30 A; A=1-260. DR PDB; 6XVH; X-ray; 1.80 A; A=4-260. DR PDB; 6XWZ; X-ray; 1.38 A; AAA=1-260. DR PDB; 6XXT; X-ray; 1.05 A; X=1-260. DR PDB; 6YH4; X-ray; 1.30 A; A=1-260. DR PDB; 6YH5; X-ray; 1.20 A; A=1-260. DR PDB; 6YH6; X-ray; 1.40 A; A=1-260. DR PDB; 6YH7; X-ray; 1.12 A; A=1-260. DR PDB; 6YH8; X-ray; 1.20 A; A=1-260. DR PDB; 6YH9; X-ray; 1.55 A; A=1-260. DR PDB; 6YHA; X-ray; 1.25 A; A=1-260. DR PDB; 6YHB; X-ray; 1.65 A; A=1-260. DR PDB; 6YHC; X-ray; 1.28 A; A=1-260. DR PDB; 6YJ3; X-ray; 1.55 A; A=1-260. DR PDB; 6YKC; X-ray; 1.20 A; A=1-260. DR PDB; 6YKH; X-ray; 1.10 A; A=1-260. DR PDB; 6YMA; EM; 2.50 A; A=1-260. DR PDB; 6YMB; EM; 2.50 A; A=1-260. DR PDB; 6YO2; X-ray; 1.20 A; A=1-260. DR PDB; 6YO4; X-ray; 1.70 A; A=1-260. DR PDB; 6YO7; X-ray; 1.17 A; A=1-260. DR PDB; 6YOI; X-ray; 1.20 A; A=1-260. DR PDB; 6YOK; X-ray; 1.25 A; A=1-260. DR PDB; 6YOL; X-ray; 1.15 A; A=1-260. DR PDB; 6YPW; X-ray; 1.10 A; A=1-260. DR PDB; 6YQT; X-ray; 1.50 A; A=1-260. DR PDB; 6YQU; X-ray; 1.48 A; A=1-260. DR PDB; 6YRI; X-ray; 1.60 A; A=1-260. DR PDB; 6YZJ; X-ray; 1.20 A; A=1-260. DR PDB; 6YZK; X-ray; 0.99 A; A=1-260. DR PDB; 6YZL; X-ray; 1.20 A; A=1-260. DR PDB; 6YZM; X-ray; 1.50 A; A=1-260. DR PDB; 6YZN; X-ray; 0.95 A; A=1-260. DR PDB; 6YZO; X-ray; 1.50 A; A=1-260. DR PDB; 6YZP; X-ray; 1.35 A; A=1-260. DR PDB; 6YZQ; X-ray; 1.04 A; A=1-260. DR PDB; 6YZR; X-ray; 1.20 A; A=1-260. DR PDB; 6YZS; X-ray; 1.05 A; A=1-260. DR PDB; 6YZT; X-ray; 1.05 A; A=1-260. DR PDB; 6YZU; X-ray; 1.00 A; A=1-260. DR PDB; 6YZV; X-ray; 1.65 A; A=1-260. DR PDB; 6YZW; X-ray; 1.03 A; A=1-260. DR PDB; 6YZX; X-ray; 1.10 A; A=1-260. DR PDB; 6Z04; X-ray; 1.05 A; A=1-260. DR PDB; 6ZR8; X-ray; 1.79 A; A=1-260. DR PDB; 7A6V; X-ray; 2.00 A; A=3-260. DR PDB; 7AEQ; X-ray; 1.50 A; A=1-260. DR PDB; 7AES; X-ray; 1.40 A; A=1-260. DR PDB; 7AGN; X-ray; 1.15 A; A/B/C/D=1-260. DR PDB; 7ASJ; X-ray; 1.43 A; A=1-260. DR PDB; 7BFA; X-ray; 1.60 A; AAA=1-260. DR PDB; 7BG5; X-ray; 1.43 A; AAA=1-260. DR PDB; 7BHH; X-ray; 1.40 A; A=1-260. DR PDB; 7BI5; X-ray; 1.74 A; A=1-260. DR PDB; 7CA2; X-ray; 2.40 A; A=1-260. DR PDB; 7JNR; X-ray; 1.44 A; A=1-260. DR PDB; 7JNV; X-ray; 1.49 A; A=1-260. DR PDB; 7JNW; X-ray; 1.29 A; A=1-260. DR PDB; 7JNX; X-ray; 1.29 A; A=1-260. DR PDB; 7JNZ; X-ray; 1.29 A; A=1-260. DR PDB; 7JO0; X-ray; 1.61 A; A=1-257. DR PDB; 7JO1; X-ray; 1.50 A; A=1-257. DR PDB; 7JO2; X-ray; 1.31 A; A=1-257. DR PDB; 7JO3; X-ray; 1.45 A; A=1-257. DR PDB; 7JOB; X-ray; 1.38 A; A=1-257. DR PDB; 7JOC; X-ray; 1.39 A; A=1-257. DR PDB; 7K6I; X-ray; 1.41 A; A=1-260. DR PDB; 7K6J; X-ray; 1.75 A; A=1-260. DR PDB; 7K6K; X-ray; 1.31 A; A=1-260. DR PDB; 7K6L; X-ray; 1.66 A; A=1-260. DR PDB; 7K6T; X-ray; 1.76 A; A=1-257. DR PDB; 7K6U; X-ray; 1.60 A; A=1-257. DR PDB; 7K6X; X-ray; 1.76 A; A=1-257. DR PDB; 7K6Z; X-ray; 1.66 A; A=1-257. DR PDB; 7M23; X-ray; 1.30 A; A=3-260. DR PDB; 7M24; X-ray; 1.30 A; A=3-260. DR PDB; 7M26; X-ray; 1.30 A; A=3-260. DR PDB; 7MU3; X-ray; 1.35 A; A=1-260. DR PDB; 7NH6; X-ray; 1.28 A; AAA=1-260. DR PDB; 7NH8; X-ray; 1.37 A; AAA=1-260. DR PDB; 7NTB; X-ray; 1.70 A; A=2-260. DR PDB; 7NZR; X-ray; 1.28 A; A=1-260. DR PDB; 7NZS; X-ray; 1.50 A; A=1-260. DR PDB; 7NZT; X-ray; 1.35 A; A=1-260. DR PDB; 7NZU; X-ray; 1.24 A; A=1-260. DR PDB; 7NZW; X-ray; 1.45 A; A=1-260. DR PDB; 7NZX; X-ray; 1.33 A; A=1-260. DR PDB; 7OK8; X-ray; 1.43 A; AAA=1-260. DR PDB; 7ONM; X-ray; 1.77 A; A=3-260. DR PDB; 7ONP; X-ray; 1.41 A; AAA=3-260. DR PDB; 7ONQ; X-ray; 1.65 A; A=3-260. DR PDB; 7ONV; X-ray; 1.04 A; A=3-260. DR PDB; 7ORP; X-ray; 1.43 A; AAA=1-260. DR PDB; 7ORQ; X-ray; 1.43 A; AAA=1-260. DR PDB; 7OYM; X-ray; 0.98 A; A=1-260. DR PDB; 7OYN; X-ray; 0.98 A; A=1-260. DR PDB; 7OYO; X-ray; 1.03 A; A=1-260. DR PDB; 7OYP; X-ray; 1.05 A; A=1-260. DR PDB; 7OYQ; X-ray; 1.15 A; A=1-260. DR PDB; 7OYR; X-ray; 1.15 A; A=1-260. DR PDB; 7Q0C; X-ray; 1.12 A; A/B=1-260. DR PDB; 7Q0E; X-ray; 1.30 A; A=3-260. DR PDB; 7QBH; X-ray; 1.22 A; AAA=1-260. DR PDB; 7QGX; X-ray; 1.19 A; A=1-260. DR PDB; 7QGY; X-ray; 1.50 A; A=1-260. DR PDB; 7QGZ; X-ray; 1.13 A; A=1-260. DR PDB; 7QNV; X-ray; 1.28 A; AAA=1-260. DR PDB; 7QRK; X-ray; 1.43 A; AAA=1-260. DR PDB; 7QSE; X-ray; 1.43 A; AAA=1-260. DR PDB; 7QSI; X-ray; 1.30 A; AAA=1-260. DR PDB; 7QZX; X-ray; 1.24 A; AAA=1-260. DR PDB; 7R1X; X-ray; 1.35 A; AAA=1-260. DR PDB; 7RNY; X-ray; 1.29 A; A=1-260. DR PDB; 7RNZ; X-ray; 1.30 A; A=1-260. DR PDB; 7RRE; X-ray; 1.44 A; A=1-260. DR PDB; 7RRF; X-ray; 1.45 A; A=4-260. DR PDB; 7SUW; X-ray; 1.46 A; A=4-260. DR PDB; 7SUY; X-ray; 1.41 A; A=4-260. DR PDB; 7SV1; X-ray; 1.56 A; A=4-260. DR PDB; 7SV8; X-ray; 1.39 A; A=4-260. DR PDB; 7U5W; X-ray; 1.13 A; A=3-260. DR PDB; 7U5X; X-ray; 1.04 A; A=3-260. DR PDB; 7Y2A; X-ray; 1.20 A; A=1-260. DR PDB; 7Y2C; X-ray; 1.20 A; A=1-260. DR PDB; 7Y2E; X-ray; 1.20 A; A=1-260. DR PDB; 7Y2F; X-ray; 1.20 A; A=1-260. DR PDB; 7Y2G; X-ray; 1.20 A; A=1-260. DR PDB; 7Y2H; X-ray; 1.20 A; A=1-260. DR PDB; 7Y2I; X-ray; 1.40 A; A=1-260. DR PDB; 7Y2J; X-ray; 1.25 A; A=1-260. DR PDB; 7Y2K; X-ray; 1.25 A; A=1-260. DR PDB; 7Y2L; X-ray; 1.25 A; A=1-260. DR PDB; 7Y2M; X-ray; 1.25 A; A=1-260. DR PDB; 7Y2N; X-ray; 1.25 A; A=1-260. DR PDB; 7Y2O; X-ray; 1.25 A; A=1-260. DR PDB; 7Y2Q; X-ray; 1.35 A; A=1-260. DR PDB; 7Y2R; X-ray; 1.20 A; A=1-260. DR PDB; 7Y2S; X-ray; 1.20 A; A=1-260. DR PDB; 7Y2T; X-ray; 1.20 A; A=1-260. DR PDB; 7Y2U; X-ray; 1.20 A; A=1-260. DR PDB; 7Y2V; X-ray; 1.20 A; A=1-260. DR PDB; 7Y2W; X-ray; 1.20 A; A=1-260. DR PDB; 7Y2X; X-ray; 1.50 A; A=1-260. DR PDB; 7YWT; X-ray; 1.11 A; AAA=1-260. DR PDB; 7ZL6; X-ray; 1.38 A; AAA=1-260. DR PDB; 7ZWB; X-ray; 1.48 A; AAA=1-260. DR PDB; 8AA6; X-ray; 1.15 A; A=1-260. DR PDB; 8AAE; X-ray; 1.15 A; A=1-260. DR PDB; 8B29; X-ray; 1.70 A; A=3-260. DR PDB; 8BJX; X-ray; 1.28 A; AAA=1-260. DR PDB; 8BOE; X-ray; 1.55 A; AAA=1-260. DR PDB; 8BZZ; X-ray; 1.07 A; AAA=1-260. DR PDB; 8C0Q; X-ray; 1.67 A; A=1-260. DR PDB; 8C0R; X-ray; 1.56 A; A=1-260. DR PDB; 8CA2; X-ray; 2.40 A; A=1-260. DR PDB; 8CR0; X-ray; 1.22 A; X=1-260. DR PDB; 8DJ9; X-ray; 1.54 A; A=1-260. DR PDB; 8EM3; X-ray; 1.62 A; A=1-260. DR PDB; 8EMU; X-ray; 1.13 A; A=1-260. DR PDB; 8EXC; X-ray; 1.90 A; A=1-260. DR PDB; 8EXG; X-ray; 1.99 A; A=1-260. DR PDB; 8EYL; X-ray; 1.18 A; A=1-260. DR PDB; 8FAL; X-ray; 1.37 A; A=1-260. DR PDB; 8FAU; X-ray; 1.44 A; A=1-260. DR PDB; 8FQX; X-ray; 1.50 A; A=1-260. DR PDB; 8FQY; X-ray; 1.47 A; A=1-260. DR PDB; 8FQZ; X-ray; 1.47 A; A=1-260. DR PDB; 8FR1; X-ray; 2.00 A; A=4-260. DR PDB; 8FR2; X-ray; 1.31 A; A=4-260. DR PDB; 8FR4; X-ray; 1.12 A; A=4-260. DR PDB; 8IGF; X-ray; 2.60 A; A=4-260. DR PDB; 8J2O; X-ray; 2.60 A; A=1-260. DR PDB; 8JEE; X-ray; 2.96 A; A=4-260. DR PDB; 8OGD; X-ray; 1.75 A; A=1-260. DR PDB; 8OGE; X-ray; 1.46 A; A=1-260. DR PDB; 8OGF; X-ray; 1.32 A; AAA=1-260. DR PDB; 8OKE; X-ray; 1.05 A; A=1-260. DR PDB; 8OKG; X-ray; 1.45 A; A=1-260. DR PDB; 8OKJ; X-ray; 1.40 A; A=1-260. DR PDB; 8OKO; X-ray; 1.25 A; A=1-260. DR PDB; 8OKP; X-ray; 1.25 A; A=1-260. DR PDB; 8OKQ; X-ray; 1.00 A; A=1-260. DR PDB; 8OKT; X-ray; 1.50 A; A=1-260. DR PDB; 8OLA; X-ray; 1.40 A; A=1-260. DR PDB; 8OLF; X-ray; 1.45 A; A=1-260. DR PDB; 8OLI; X-ray; 1.40 A; A=1-260. DR PDB; 8OLK; X-ray; 1.27 A; A=1-260. DR PDB; 8OLM; X-ray; 1.50 A; A=1-260. DR PDB; 8OMB; X-ray; 1.35 A; A=1-260. DR PDB; 8OMH; X-ray; 1.45 A; A=1-260. DR PDB; 8OMN; X-ray; 1.40 A; A=1-260. DR PDB; 8OMP; X-ray; 1.41 A; A=1-260. DR PDB; 8OO8; X-ray; 1.40 A; A=2-260. DR PDB; 8OTP; X-ray; 1.40 A; AAA=1-260. DR PDB; 8OUB; X-ray; 1.18 A; AAA=1-260. DR PDB; 8P6U; X-ray; 1.30 A; A=3-260. DR PDB; 8PHL; X-ray; 1.30 A; A=3-260. DR PDB; 8PHM; X-ray; 1.45 A; A=5-260. DR PDB; 8Q0C; X-ray; 1.30 A; A=3-260. DR PDB; 8QF7; X-ray; 1.23 A; AAA=1-260. DR PDB; 8QF9; X-ray; 1.28 A; AAA=1-260. DR PDB; 8QFK; X-ray; 1.11 A; AAA=1-260. DR PDB; 8QH8; X-ray; 1.04 A; A=1-260. DR PDB; 8QHG; X-ray; 1.91 A; A=1-260. DR PDB; 8QHJ; X-ray; 1.62 A; A=1-260. DR PDB; 8QHO; X-ray; 1.43 A; AAA=1-260. DR PDB; 8QKZ; X-ray; 1.34 A; AAA=1-260. DR PDB; 8QQA; X-ray; 1.35 A; AAA=1-260. DR PDB; 8QUF; X-ray; 1.14 A; AAA=1-260. DR PDB; 8R1I; X-ray; 1.46 A; A=1-260. DR PDB; 8R2F; X-ray; 1.25 A; AAA=1-260. DR PDB; 8R2K; X-ray; 1.60 A; AAA=1-260. DR PDB; 8RAR; X-ray; 1.15 A; A=1-260. DR PDB; 8RBP; X-ray; 1.15 A; A=1-260. DR PDB; 8RJ2; X-ray; 1.12 A; A=1-260. DR PDB; 8RLP; X-ray; 1.34 A; AAA=1-260. DR PDB; 8RLQ; X-ray; 1.50 A; AAA=1-260. DR PDB; 8RNS; X-ray; 1.14 A; A=1-260. DR PDB; 8ROU; X-ray; 1.08 A; A=1-260. DR PDB; 8ROW; X-ray; 1.05 A; A=1-260. DR PDB; 8SAF; X-ray; 1.23 A; A=1-260. DR PDB; 8SAG; X-ray; 1.52 A; A=1-260. DR PDB; 8SD1; X-ray; 1.30 A; A=1-260. DR PDB; 8SD6; X-ray; 1.40 A; A=1-260. DR PDB; 8SD7; X-ray; 1.70 A; A=1-260. DR PDB; 8SD8; X-ray; 1.79 A; A=1-260. DR PDB; 8SD9; X-ray; 1.90 A; A=1-260. DR PDB; 8SF1; X-ray; 1.70 A; A=1-260. DR PDB; 8TTR; X-ray; 1.45 A; A=1-260. DR PDB; 8UFW; X-ray; 1.22 A; A=1-260. DR PDB; 8UFX; X-ray; 1.21 A; A=1-260. DR PDB; 8VQ5; X-ray; 1.50 A; A=1-259. DR PDB; 8VQ6; X-ray; 1.45 A; A=1-260. DR PDB; 8VQ7; X-ray; 1.41 A; A=1-260. DR PDB; 8VZG; X-ray; 1.79 A; A=1-260. DR PDB; 8WEP; X-ray; 1.20 A; A=1-260. DR PDB; 8WER; X-ray; 1.42 A; A=1-260. DR PDB; 8WES; X-ray; 1.45 A; A=1-260. DR PDB; 8ZWV; X-ray; 1.50 A; A=1-260. DR PDB; 9CA2; X-ray; 2.80 A; A=1-260. DR PDB; 9EN8; X-ray; 1.10 A; A=1-260. DR PDB; 9EN9; X-ray; 2.02 A; A=1-260. DR PDB; 9F15; X-ray; 1.93 A; A=1-260. DR PDB; 9F2E; X-ray; 2.02 A; A=1-260. DR PDB; 9F2F; X-ray; 1.52 A; A/B/C/D=1-260. DR PDB; 9FAI; X-ray; 1.27 A; AAA=1-260. DR PDB; 9FAO; X-ray; 1.21 A; AAA=1-260. DR PDB; 9FJQ; X-ray; 1.10 A; A=1-260. DR PDB; 9FJV; X-ray; 1.20 A; A=1-260. DR PDB; 9FPQ; X-ray; 1.50 A; A=1-260. DR PDB; 9FPR; X-ray; 1.46 A; A=1-260. DR PDB; 9FPS; X-ray; 1.39 A; A=1-260. DR PDB; 9FPT; X-ray; 1.18 A; A=1-260. DR PDB; 9FPU; X-ray; 1.12 A; A=1-260. DR PDB; 9G38; X-ray; 1.20 A; A=1-260. DR PDB; 9GAJ; X-ray; 1.64 A; A=1-260. DR PDB; 9GAK; X-ray; 2.11 A; A=1-260. DR PDB; 9GAM; X-ray; 1.40 A; A=1-260. DR PDB; 9GFV; X-ray; 1.14 A; A=1-260. DR PDB; 9GFW; X-ray; 1.07 A; A=1-260. DR PDB; 9GFX; X-ray; 1.35 A; A=1-260. DR PDB; 9GOO; X-ray; 1.40 A; AAA=1-260. DR PDB; 9GU7; X-ray; 1.35 A; AAA=1-260. DR PDB; 9GUM; X-ray; 1.70 A; AAA=1-260. DR PDB; 9GUO; X-ray; 1.65 A; AAA=1-260. DR PDB; 9H0V; X-ray; 1.40 A; A=1-260. DR PDB; 9H0W; X-ray; 1.44 A; A=1-260. DR PDB; 9H3H; X-ray; 1.80 A; A=4-260. DR PDB; 9HD6; X-ray; 1.60 A; AAA=1-260. DR PDB; 9HGP; X-ray; 2.05 A; A=3-260. DR PDB; 9HNX; X-ray; 1.35 A; AAA=1-260. DR PDB; 9HQ3; X-ray; 1.50 A; AAA=1-260. DR PDB; 9HQG; X-ray; 1.32 A; AAA=1-260. DR PDB; 9HWM; X-ray; 1.15 A; A=1-260. DR PDB; 9HXZ; X-ray; 1.32 A; AAA=1-260. DR PDB; 9I29; X-ray; 1.62 A; AAA=1-260. DR PDB; 9JWE; X-ray; 1.29 A; A=1-260. DR PDB; 9JWU; X-ray; 1.23 A; A=1-260. DR PDB; 9JWW; X-ray; 1.25 A; A=1-260. DR PDB; 9KH8; X-ray; 1.20 A; A=1-260. DR PDB; 9L2X; X-ray; 1.14 A; A=1-260. DR PDB; 9L2Y; X-ray; 1.20 A; A=1-260. DR PDB; 9L2Z; X-ray; 1.20 A; A=1-260. DR PDB; 9L30; X-ray; 1.20 A; A=1-260. DR PDB; 9L31; X-ray; 1.20 A; A=1-260. DR PDB; 9L32; X-ray; 1.20 A; A=1-260. DR PDB; 9L33; X-ray; 1.35 A; A=1-260. DR PDB; 9LDO; X-ray; 1.14 A; A=1-260. DR PDB; 9LDP; X-ray; 1.14 A; A=1-260. DR PDB; 9LR6; X-ray; 1.25 A; A=1-260. DR PDB; 9O8X; X-ray; 1.40 A; A=1-260. DR PDB; 9OAF; X-ray; 1.40 A; A=1-260. DR PDB; 9OAM; X-ray; 1.40 A; A=1-260. DR PDB; 9OBJ; X-ray; 1.40 A; A=1-260. DR PDB; 9P0W; X-ray; 1.88 A; A=1-260. DR PDB; 9RAY; X-ray; 1.31 A; AAA=1-260. DR PDB; 9U5B; X-ray; 1.25 A; A=1-260. DR AlphaFoldDB; P00918; -. DR MDposit; P00918; -. DR MDRepo; P00918; -. DR SMR; P00918; -. DR BioGRID; 107215; 77. DR FunCoup; P00918; 607. DR IntAct; P00918; 28. DR MINT; P00918; -. DR NDEx; IQUERY-CP-CA2; 3 NDEx IQuery Curated Pathways. DR STRING; 9606.ENSP00000285379; -. DR BindingDB; P00918; -. DR ChEMBL; CHEMBL205; -. DR DrugBank; DB07596; (17beta)-17-(cyanomethyl)-2-methoxyestra-1(10),2,4-trien-3-yl sulfamate. DR DrugBank; DB03333; (4-sulfamoyl-phenyl)-thiocarbamic acid O-(2-thiophen-3-yl-ethyl) ester. DR DrugBank; DB08418; (4aS,4bR,10bS,12aS)-12a-methyl-1,3-dioxo-2-(pyridin-3-ylmethyl)-1,2,3,4,4a,4b,5,6,10b,11,12,12a-dodecahydronaphtho[2,1-f]isoquinolin-8-yl sulfamate. DR DrugBank; DB04081; (4s-Trans)-4-(Methylamino)-5,6-Dihydro-6-Methyl-4h-Thieno(2,3-B)Thiopyran-2-Sulfonamide-7,7-Dioxide. DR DrugBank; DB08416; (9BETA,13ALPHA,14BETA,17ALPHA)-2-METHOXYESTRA-1,3,5(10)-TRIENE-3,17-DIYL DISULFAMATE. DR DrugBank; DB02479; (R)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide. DR DrugBank; DB07467; (S)-Indapamide. DR DrugBank; DB03950; (S)-N-(3-Indol-1-Yl-2-Methyl-Propyl)-4-Sulfamoyl-Benzamide. DR DrugBank; DB03594; 1,2,4-Triazole. DR DrugBank; DB02232; 1,2-Dihydroxybenzene. DR DrugBank; DB03294; 1-Methyl-3-Oxo-1,3-Dihydro-Benzo[C]Isothiazole-5-Sulfonic Acid Amide. DR DrugBank; DB04763; 1-N-(4-SULFAMOYLPHENYL-ETHYL)-2,4,6-TRIMETHYLPYRIDINIUM. DR DrugBank; DB03270; 2,6-Difluorobenzenesulfonamide. DR DrugBank; DB08083; 2-(1,3-thiazol-4-yl)-1H-benzimidazole-5-sulfonamide. DR DrugBank; DB06954; 2-(cycloheptylmethyl)-1,1-dioxido-1-benzothiophen-6-yl sulfamate. DR DrugBank; DB08659; 2-(hydrazinocarbonyl)-3-phenyl-1H-indole-5-sulfonamide. DR DrugBank; DB08046; 2-chloro-5-[(1S)-1-hydroxy-3-oxo-2H-isoindol-1-yl]benzenesulfonamide. DR DrugBank; DB02087; 3,5-Difluorobenzenesulfonamide. DR DrugBank; DB08156; 3-[4-(AMINOSULFONYL)PHENYL]PROPANOIC ACID. DR DrugBank; DB04203; 3-Mercuri-4-Aminobenzenesulfonamide. DR DrugBank; DB04394; 3-Nitro-4-(2-Oxo-Pyrrolidin-1-Yl)-Benzenesulfonamide. DR DrugBank; DB08782; 4-(2-AMINOETHYL)BENZENESULFONAMIDE. DR DrugBank; DB04549; 4-(Aminosulfonyl)-N-[(2,3,4-Trifluorophenyl)Methyl]-Benzamide. DR DrugBank; DB02221; 4-(Aminosulfonyl)-N-[(2,4,6-Trifluorophenyl)Methyl]-Benzamide. DR DrugBank; DB04180; 4-(Aminosulfonyl)-N-[(2,4-Difluorophenyl)Methyl]-Benzamide. DR DrugBank; DB03039; 4-(Aminosulfonyl)-N-[(2,5-Difluorophenyl)Methyl]-Benzamide. DR DrugBank; DB02861; 4-(Aminosulfonyl)-N-[(3,4,5-Trifluorophenyl)Methyl]-Benzamide. DR DrugBank; DB02429; 4-(Aminosulfonyl)-N-[(4-Fluorophenyl)Methyl]-Benzamide. DR DrugBank; DB08202; 4-({[(4-METHYLPIPERAZIN-1-YL)AMINO]CARBONOTHIOYL}AMINO)BENZENESULFONAMIDE. DR DrugBank; DB04600; 4-[(3-BROMO-4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE. DR DrugBank; DB04601; 4-[(4-O-SULFAMOYLBENZYL)(4-CYANOPHENYL)AMINO]-4H-[1,2,4]-TRIAZOLE. DR DrugBank; DB01784; 4-Flourobenzenesulfonamide. DR DrugBank; DB03385; 4-Methylimidazole. DR DrugBank; DB04214; 4-Nitrophenyl Phosphate. DR DrugBank; DB03697; 4-Sulfonamide-[1-(4-Aminobutane)]Benzamide. DR DrugBank; DB04002; 4-Sulfonamide-[4-(Thiomethylaminobutane)]Benzamide. DR DrugBank; DB07632; 5-(2-chlorophenyl)-1,3,4-thiadiazole-2-sulfonamide. DR DrugBank; DB12348; 5-amino-1,3,4-thiadiazole-2-thiol. DR DrugBank; DB06891; 5-{[(4-AMINO-3-CHLORO-5-FLUOROPHENYL)SULFONYL]AMINO}-1,3,4-THIADIAZOLE-2-SULFONAMIDE. DR DrugBank; DB08645; 6-CHLORO-3-(DICHLOROMETHYL)-3,4-DIHYDRO-2H-1,2,4-BENZOTHIADIAZINE-7-SULFONAMIDE 1,1-DIOXIDE. DR DrugBank; DB08765; 6-HYDROXY-1,3-BENZOTHIAZOLE-2-SULFONAMIDE. DR DrugBank; DB14511; Acetate. DR DrugBank; DB00819; Acetazolamide. DR DrugBank; DB03877; AL-4623. DR DrugBank; DB03262; Al-6619, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Hydroxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]. DR DrugBank; DB03598; Al-6629, [2h-Thieno[3,2-E]-1,2-Thiazine-6-Sulfonamide,2-(3-Methoxyphenyl)-3-(4-Morpholinyl)-, 1,1-Dioxide]. DR DrugBank; DB04089; AL5300. DR DrugBank; DB01964; AL5424. DR DrugBank; DB03526; AL5927. DR DrugBank; DB04371; AL6528. DR DrugBank; DB02220; AL7089A. DR DrugBank; DB03221; AL7099A. DR DrugBank; DB02602; AL7182. DR DrugBank; DB02535; Aminodi(Ethyloxy)Ethylaminocarbonylbenzenesulfonamide. DR DrugBank; DB00436; Bendroflumethiazide. DR DrugBank; DB07050; Benzolamide. DR DrugBank; DB00562; Benzthiazide. DR DrugBank; DB01194; Brinzolamide. DR DrugBank; DB16863; Butylated hydroxytoluene. DR DrugBank; DB03854; Cadaverine. DR DrugBank; DB19764; Carzenide. DR DrugBank; DB00482; Celecoxib. DR DrugBank; DB07556; CGS-27023. DR DrugBank; DB00880; Chlorothiazide. DR DrugBank; DB14086; Cianidanol. DR DrugBank; DB04665; Coumarin. DR DrugBank; DB11672; Curcumin. DR DrugBank; DB02679; Cyanamide. DR DrugBank; DB00606; Cyclothiazide. DR DrugBank; DB02866; Dansylamide. DR DrugBank; DB01144; Diclofenamide. DR DrugBank; DB00869; Dorzolamide. DR DrugBank; DB08846; Ellagic acid. DR DrugBank; DB01031; Ethinamate. DR DrugBank; DB00311; Ethoxzolamide. DR DrugBank; DB08157; ETHYL 3-[4-(AMINOSULFONYL)PHENYL]PROPANOATE. DR DrugBank; DB07767; Ferulic acid. DR DrugBank; DB01942; Formic acid. DR DrugBank; DB00695; Furosemide. DR DrugBank; DB11359; Guaiacol. DR DrugBank; DB00774; Hydroflumethiazide. DR DrugBank; DB08165; indane-5-sulfonamide. DR DrugBank; DB12754; Iodide. DR DrugBank; DB02292; Irosustat. DR DrugBank; DB06795; Mafenide. DR DrugBank; DB03345; Mercaptoethanol. DR DrugBank; DB03975; Mercuribenzoic Acid. DR DrugBank; DB00703; Methazolamide. DR DrugBank; DB00232; Methyclothiazide. DR DrugBank; DB02610; N-(2,3,4,5,6-Pentaflouro-Benzyl)-4-Sulfamoyl-Benzamide. DR DrugBank; DB07742; N-(2,3-DIFLUORO-BENZYL)-4-SULFAMOYL-BENZAMIDE. DR DrugBank; DB03844; N-(2,6-Diflouro-Benzyl)-4-Sulfamoyl-Benzamide. DR DrugBank; DB02069; N-(2-Flouro-Benzyl)-4-Sulfamoyl-Benzamide. DR DrugBank; DB02986; N-(2-Thienylmethyl)-2,5-Thiophenedisulfonamide. DR DrugBank; DB08301; N-({[4-(AMINOSULFONYL)PHENYL]AMINO}CARBONYL)-4-METHYLBENZENESULFONAMIDE. DR DrugBank; DB07048; N-[(2R)-5-(aminosulfonyl)-2,3-dihydro-1H-inden-2-yl]-2-propylpentanamide. DR DrugBank; DB03596; N-[2-(1h-Indol-5-Yl)-Butyl]-4-Sulfamoyl-Benzamide. DR DrugBank; DB07476; N-[4-(AMINOSULFONYL)PHENYL]-2-MERCAPTOBENZAMIDE. DR DrugBank; DB01748; N-Benzyl-4-Sulfamoyl-Benzamide. DR DrugBank; DB08155; N-{2-[4-(AMINOSULFONYL)PHENYL]ETHYL}ACETAMIDE. DR DrugBank; DB14049; Nitrate. DR DrugBank; DB04066; p-Coumaric acid. DR DrugBank; DB01671; p-Hydroxymercuribenzoic acid. DR DrugBank; DB17299; p-Toluenesulfonamide. DR DrugBank; DB13495; Paraoxon. DR DrugBank; DB03255; Phenol. DR DrugBank; DB07710; PHENYLALANYLAMINODI(ETHYLOXY)ETHYL BENZENESULFONAMIDEAMINOCARBONYLBENZENESULFONAMIDE. DR DrugBank; DB01795; Phenylboronic acid. DR DrugBank; DB01963; Phenylethane Boronic Acid. DR DrugBank; DB12399; Polmacoxib. DR DrugBank; DB01325; Quinethazone. DR DrugBank; DB11085; Resorcinol. DR DrugBank; DB12418; Saccharin. DR DrugBank; DB00936; Salicylic acid. DR DrugBank; DB09460; Sodium carbonate. DR DrugBank; DB09472; Sodium sulfate. DR DrugBank; DB02894; Sulfamic Acid 2,3-O-(1-Methylethylidene)-4,5-O-Sulfonyl-Beta-Fructopyranose Ester. DR DrugBank; DB00391; Sulpiride. DR DrugBank; DB08329; Sulthiame. DR DrugBank; DB07363; THIOPHENE-2,5-DISULFONIC ACID 2-AMIDE-5-(4-METHYL-BENZYLAMIDE). DR DrugBank; DB13343; Tioxolone. DR DrugBank; DB00273; Topiramate. DR DrugBank; DB01650; trans-2-hydroxycinnamic acid. DR DrugBank; DB19785; Trecadrine. DR DrugBank; DB01021; Trichlormethiazide. DR DrugBank; DB03904; Urea. DR DrugBank; DB00580; Valdecoxib. DR DrugBank; DB14533; Zinc chloride. DR DrugBank; DB14548; Zinc sulfate, unspecified form. DR DrugBank; DB00909; Zonisamide. DR DrugCentral; P00918; -. DR GuidetoPHARMACOLOGY; 3092; -. DR GlyGen; P00918; 1 site, 1 O-linked glycan (1 site). DR iPTMnet; P00918; -. DR PhosphoSitePlus; P00918; -. DR BioMuta; CA2; -. DR OGP; P00918; -. DR REPRODUCTION-2DPAGE; IPI00218414; -. DR REPRODUCTION-2DPAGE; P00918; -. DR CPTAC; CPTAC-177; -. DR CPTAC; CPTAC-178; -. DR jPOST; P00918; -. DR MassIVE; P00918; -. DR PaxDb; 9606-ENSP00000285379; -. DR PeptideAtlas; P00918; -. DR ProteomicsDB; 51292; -. DR Pumba; P00918; -. DR Antibodypedia; 677; 719 antibodies from 46 providers. DR DNASU; 760; -. DR Ensembl; ENST00000285379.10; ENSP00000285379.4; ENSG00000104267.11. DR GeneID; 760; -. DR KEGG; hsa:760; -. DR MANE-Select; ENST00000285379.10; ENSP00000285379.4; NM_000067.3; NP_000058.1. DR AGR; HGNC:1373; -. DR ClinPGx; PA25989; -. DR CTD; 760; -. DR DisGeNET; 760; -. DR GeneCards; CA2; -. DR HGNC; HGNC:1373; CA2. DR HPA; ENSG00000104267; Tissue enhanced (choroid plexus, intestine, stomach). DR MalaCards; CA2; -. DR MIM; 259730; phenotype. DR MIM; 611492; gene. DR OpenTargets; ENSG00000104267; -. DR Orphanet; 2785; Osteopetrosis with renal tubular acidosis. DR VEuPathDB; HostDB:ENSG00000104267; -. DR eggNOG; KOG0382; Eukaryota. DR GeneTree; ENSGT00940000160385; -. DR HOGENOM; CLU_039326_2_1_1; -. DR InParanoid; P00918; -. DR OMA; INPHWKV; -. DR OrthoDB; 429145at2759; -. DR PAN-GO; P00918; 6 GO annotations based on evolutionary models. DR PhylomeDB; P00918; -. DR BRENDA; 4.2.1.1; 2681. DR PathwayCommons; P00918; -. DR Reactome; R-HSA-1237044; Erythrocytes take up carbon dioxide and release oxygen. DR Reactome; R-HSA-1247673; Erythrocytes take up oxygen and release carbon dioxide. DR Reactome; R-HSA-1475029; Reversible hydration of carbon dioxide. DR Reactome; R-HSA-9925563; Developmental Lineage of Pancreatic Ductal Cells. DR SABIO-RK; P00918; -. DR SignaLink; P00918; -. DR Agora; ENSG00000104267; -. DR BioGRID-ORCS; 760; 14 hits in 1166 CRISPR screens. DR CD-CODE; FB4E32DD; Presynaptic clusters and postsynaptic densities. DR ChiTaRS; CA2; human. DR EvolutionaryTrace; P00918; -. DR GeneWiki; Carbonic_anhydrase_II; -. DR GenomeRNAi; 760; -. DR Pharos; P00918; Tclin. DR PRO; PR:P00918; -. DR Proteomes; UP000005640; Chromosome 8. DR RNAct; P00918; protein. DR Bgee; ENSG00000104267; Expressed in colonic mucosa and 191 other cell types or tissues. DR ExpressionAtlas; P00918; baseline and differential. DR GO; GO:0045177; C:apical part of cell; IDA:UniProtKB. DR GO; GO:0005737; C:cytoplasm; IDA:UniProtKB. DR GO; GO:0005829; C:cytosol; TAS:Reactome. DR GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB. DR GO; GO:0043209; C:myelin sheath; IEA:Ensembl. DR GO; GO:0005886; C:plasma membrane; IDA:UniProtKB. DR GO; GO:0004064; F:arylesterase activity; IMP:CACAO. DR GO; GO:0004089; F:carbonate dehydratase activity; IDA:UniProtKB. DR GO; GO:0018820; F:cyanamide hydratase activity; EXP:UniProtKB. DR GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB. DR GO; GO:0038166; P:angiotensin-activated signaling pathway; IDA:UniProtKB. DR GO; GO:2001150; P:positive regulation of dipeptide transmembrane transport; ISS:UniProtKB. DR GO; GO:0051453; P:regulation of intracellular pH; ISS:UniProtKB. DR GO; GO:0044070; P:regulation of monoatomic anion transport; IDA:UniProtKB. DR CDD; cd03119; alpha_CA_I_II_III_XIII; 1. DR FunFam; 3.10.200.10:FF:000001; Carbonic anhydrase 2; 1. DR Gene3D; 3.10.200.10; Alpha carbonic anhydrase; 1. DR InterPro; IPR001148; CA_dom. DR InterPro; IPR036398; CA_dom_sf. DR InterPro; IPR023561; Carbonic_anhydrase_a-class. DR InterPro; IPR018338; Carbonic_anhydrase_a-class_CS. DR PANTHER; PTHR18952; CARBONIC ANHYDRASE; 1. DR PANTHER; PTHR18952:SF120; CARBONIC ANHYDRASE 2; 1. DR Pfam; PF00194; Carb_anhydrase; 1. DR SMART; SM01057; Carb_anhydrase; 1. DR SUPFAM; SSF51069; Carbonic anhydrase; 1. DR PROSITE; PS00162; ALPHA_CA_1; 1. DR PROSITE; PS51144; ALPHA_CA_2; 1. DR PDBsum; 12CA; -. DR PDBsum; 1A42; -. DR PDBsum; 1AM6; -. DR PDBsum; 1AVN; -. DR PDBsum; 1BCD; -. DR PDBsum; 1BIC; -. DR PDBsum; 1BN1; -. DR PDBsum; 1BN3; -. DR PDBsum; 1BN4; -. DR PDBsum; 1BNM; -. DR PDBsum; 1BNN; -. DR PDBsum; 1BNQ; -. DR PDBsum; 1BNT; -. DR PDBsum; 1BNU; -. DR PDBsum; 1BNV; -. DR PDBsum; 1BNW; -. DR PDBsum; 1BV3; -. DR PDBsum; 1CA2; -. DR PDBsum; 1CA3; -. DR PDBsum; 1CAH; -. DR PDBsum; 1CAI; -. DR PDBsum; 1CAJ; -. DR PDBsum; 1CAK; -. DR PDBsum; 1CAL; -. DR PDBsum; 1CAM; -. DR PDBsum; 1CAN; -. DR PDBsum; 1CAO; -. DR PDBsum; 1CAY; -. DR PDBsum; 1CAZ; -. DR PDBsum; 1CCS; -. DR PDBsum; 1CCT; -. DR PDBsum; 1CCU; -. DR PDBsum; 1CIL; -. DR PDBsum; 1CIM; -. DR PDBsum; 1CIN; -. DR PDBsum; 1CNB; -. DR PDBsum; 1CNC; -. DR PDBsum; 1CNG; -. DR PDBsum; 1CNH; -. DR PDBsum; 1CNI; -. DR PDBsum; 1CNJ; -. DR PDBsum; 1CNK; -. DR PDBsum; 1CNW; -. DR PDBsum; 1CNX; -. DR PDBsum; 1CNY; -. DR PDBsum; 1CRA; -. DR PDBsum; 1CVA; -. DR PDBsum; 1CVB; -. DR PDBsum; 1CVC; -. DR PDBsum; 1CVD; -. DR PDBsum; 1CVE; -. DR PDBsum; 1CVF; -. DR PDBsum; 1CVH; -. DR PDBsum; 1DCA; -. DR PDBsum; 1DCB; -. DR PDBsum; 1EOU; -. DR PDBsum; 1F2W; -. DR PDBsum; 1FQL; -. DR PDBsum; 1FQM; -. DR PDBsum; 1FQN; -. DR PDBsum; 1FQR; -. DR PDBsum; 1FR4; -. DR PDBsum; 1FR7; -. DR PDBsum; 1FSN; -. DR PDBsum; 1FSQ; -. DR PDBsum; 1FSR; -. DR PDBsum; 1G0E; -. DR PDBsum; 1G0F; -. DR PDBsum; 1G1D; -. DR PDBsum; 1G3Z; -. DR PDBsum; 1G45; -. DR PDBsum; 1G46; -. DR PDBsum; 1G48; -. DR PDBsum; 1G4J; -. DR PDBsum; 1G4O; -. DR PDBsum; 1G52; -. DR PDBsum; 1G53; -. DR PDBsum; 1G54; -. DR PDBsum; 1H4N; -. DR PDBsum; 1H9N; -. DR PDBsum; 1H9Q; -. DR PDBsum; 1HCA; -. DR PDBsum; 1HEA; -. DR PDBsum; 1HEB; -. DR PDBsum; 1HEC; -. DR PDBsum; 1HED; -. DR PDBsum; 1HVA; -. DR PDBsum; 1I8Z; -. DR PDBsum; 1I90; -. DR PDBsum; 1I91; -. DR PDBsum; 1I9L; -. DR PDBsum; 1I9M; -. DR PDBsum; 1I9N; -. DR PDBsum; 1I9O; -. DR PDBsum; 1I9P; -. DR PDBsum; 1I9Q; -. DR PDBsum; 1IF4; -. DR PDBsum; 1IF5; -. DR PDBsum; 1IF6; -. DR PDBsum; 1IF7; -. DR PDBsum; 1IF8; -. DR PDBsum; 1IF9; -. DR PDBsum; 1KWQ; -. DR PDBsum; 1KWR; -. DR PDBsum; 1LG5; -. DR PDBsum; 1LG6; -. DR PDBsum; 1LGD; -. DR PDBsum; 1LUG; -. DR PDBsum; 1LZV; -. DR PDBsum; 1MOO; -. DR PDBsum; 1MUA; -. DR PDBsum; 1OKL; -. DR PDBsum; 1OKM; -. DR PDBsum; 1OKN; -. DR PDBsum; 1OQ5; -. DR PDBsum; 1RAY; -. DR PDBsum; 1RAZ; -. DR PDBsum; 1RZA; -. DR PDBsum; 1RZB; -. DR PDBsum; 1RZC; -. DR PDBsum; 1RZD; -. DR PDBsum; 1RZE; -. DR PDBsum; 1T9N; -. DR PDBsum; 1TB0; -. DR PDBsum; 1TBT; -. DR PDBsum; 1TE3; -. DR PDBsum; 1TEQ; -. DR PDBsum; 1TEU; -. DR PDBsum; 1TG3; -. DR PDBsum; 1TG9; -. DR PDBsum; 1TH9; -. DR PDBsum; 1THK; -. DR PDBsum; 1TTM; -. DR PDBsum; 1UGA; -. DR PDBsum; 1UGB; -. DR PDBsum; 1UGC; -. DR PDBsum; 1UGD; -. DR PDBsum; 1UGE; -. DR PDBsum; 1UGF; -. DR PDBsum; 1UGG; -. DR PDBsum; 1XEG; -. DR PDBsum; 1XEV; -. DR PDBsum; 1XPZ; -. DR PDBsum; 1XQ0; -. DR PDBsum; 1YDA; -. DR PDBsum; 1YDB; -. DR PDBsum; 1YDC; -. DR PDBsum; 1YDD; -. DR PDBsum; 1YO0; -. DR PDBsum; 1YO1; -. DR PDBsum; 1YO2; -. DR PDBsum; 1Z9Y; -. DR PDBsum; 1ZE8; -. DR PDBsum; 1ZFK; -. DR PDBsum; 1ZFQ; -. DR PDBsum; 1ZGE; -. DR PDBsum; 1ZGF; -. DR PDBsum; 1ZH9; -. DR PDBsum; 1ZSA; -. DR PDBsum; 1ZSB; -. DR PDBsum; 1ZSC; -. DR PDBsum; 2ABE; -. DR PDBsum; 2AW1; -. DR PDBsum; 2AX2; -. DR PDBsum; 2CA2; -. DR PDBsum; 2CBA; -. DR PDBsum; 2CBB; -. DR PDBsum; 2CBC; -. DR PDBsum; 2CBD; -. DR PDBsum; 2CBE; -. DR PDBsum; 2EU2; -. DR PDBsum; 2EU3; -. DR PDBsum; 2EZ7; -. DR PDBsum; 2F14; -. DR PDBsum; 2FMG; -. DR PDBsum; 2FMZ; -. DR PDBsum; 2FNK; -. DR PDBsum; 2FNM; -. DR PDBsum; 2FNN; -. DR PDBsum; 2FOQ; -. DR PDBsum; 2FOS; -. DR PDBsum; 2FOU; -. DR PDBsum; 2FOV; -. DR PDBsum; 2GD8; -. DR PDBsum; 2GEH; -. DR PDBsum; 2H15; -. DR PDBsum; 2H4N; -. DR PDBsum; 2HD6; -. DR PDBsum; 2HKK; -. DR PDBsum; 2HL4; -. DR PDBsum; 2HNC; -. DR PDBsum; 2HOC; -. DR PDBsum; 2ILI; -. DR PDBsum; 2NNG; -. DR PDBsum; 2NNO; -. DR PDBsum; 2NNS; -. DR PDBsum; 2NNV; -. DR PDBsum; 2NWO; -. DR PDBsum; 2NWP; -. DR PDBsum; 2NWY; -. DR PDBsum; 2NWZ; -. DR PDBsum; 2NXR; -. DR PDBsum; 2NXS; -. DR PDBsum; 2NXT; -. DR PDBsum; 2O4Z; -. DR PDBsum; 2OSF; -. DR PDBsum; 2OSM; -. DR PDBsum; 2POU; -. DR PDBsum; 2POV; -. DR PDBsum; 2POW; -. DR PDBsum; 2Q1B; -. DR PDBsum; 2Q1Q; -. DR PDBsum; 2Q38; -. DR PDBsum; 2QO8; -. DR PDBsum; 2QOA; -. DR PDBsum; 2QP6; -. DR PDBsum; 2VVA; -. DR PDBsum; 2VVB; -. DR PDBsum; 2WD2; -. DR PDBsum; 2WD3; -. DR PDBsum; 2WEG; -. DR PDBsum; 2WEH; -. DR PDBsum; 2WEJ; -. DR PDBsum; 2WEO; -. DR PDBsum; 2X7S; -. DR PDBsum; 2X7T; -. DR PDBsum; 2X7U; -. DR PDBsum; 3B4F; -. DR PDBsum; 3BET; -. DR PDBsum; 3BL0; -. DR PDBsum; 3BL1; -. DR PDBsum; 3C7P; -. DR PDBsum; 3CA2; -. DR PDBsum; 3CAJ; -. DR PDBsum; 3CYU; -. DR PDBsum; 3D8W; -. DR PDBsum; 3D92; -. DR PDBsum; 3D93; -. DR PDBsum; 3D9Z; -. DR PDBsum; 3DAZ; -. DR PDBsum; 3DBU; -. DR PDBsum; 3DC3; -. DR PDBsum; 3DC9; -. DR PDBsum; 3DCC; -. DR PDBsum; 3DCS; -. DR PDBsum; 3DCW; -. DR PDBsum; 3DD0; -. DR PDBsum; 3DD8; -. DR PDBsum; 3DV7; -. DR PDBsum; 3DVB; -. DR PDBsum; 3DVC; -. DR PDBsum; 3DVD; -. DR PDBsum; 3EFI; -. DR PDBsum; 3EFT; -. DR PDBsum; 3F4X; -. DR PDBsum; 3F8E; -. DR PDBsum; 3FFP; -. DR PDBsum; 3GZ0; -. DR PDBsum; 3HFP; -. DR PDBsum; 3HKN; -. DR PDBsum; 3HKQ; -. DR PDBsum; 3HKT; -. DR PDBsum; 3HKU; -. DR PDBsum; 3HLJ; -. DR PDBsum; 3HS4; -. DR PDBsum; 3IBI; -. DR PDBsum; 3IBL; -. DR PDBsum; 3IBN; -. DR PDBsum; 3IBU; -. DR PDBsum; 3IEO; -. DR PDBsum; 3IGP; -. DR PDBsum; 3K2F; -. DR PDBsum; 3K34; -. DR PDBsum; 3K7K; -. DR PDBsum; 3KIG; -. DR PDBsum; 3KKX; -. DR PDBsum; 3KNE; -. DR PDBsum; 3KOI; -. DR PDBsum; 3KOK; -. DR PDBsum; 3KON; -. DR PDBsum; 3KS3; -. DR PDBsum; 3KWA; -. DR PDBsum; 3L14; -. DR PDBsum; 3M04; -. DR PDBsum; 3M14; -. DR PDBsum; 3M1J; -. DR PDBsum; 3M1K; -. DR PDBsum; 3M1Q; -. DR PDBsum; 3M1W; -. DR PDBsum; 3M2N; -. DR PDBsum; 3M2X; -. DR PDBsum; 3M2Y; -. DR PDBsum; 3M2Z; -. DR PDBsum; 3M3X; -. DR PDBsum; 3M40; -. DR PDBsum; 3M5E; -. DR PDBsum; 3M5S; -. DR PDBsum; 3M5T; -. DR PDBsum; 3M67; -. DR PDBsum; 3M96; -. DR PDBsum; 3M98; -. DR PDBsum; 3MHC; -. DR PDBsum; 3MHI; -. DR PDBsum; 3MHL; -. DR PDBsum; 3MHM; -. DR PDBsum; 3MHO; -. DR PDBsum; 3ML2; -. DR PDBsum; 3MMF; -. DR PDBsum; 3MNA; -. DR PDBsum; 3MNH; -. DR PDBsum; 3MNI; -. DR PDBsum; 3MNJ; -. DR PDBsum; 3MNK; -. DR PDBsum; 3MNU; -. DR PDBsum; 3MWO; -. DR PDBsum; 3MYQ; -. DR PDBsum; 3MZC; -. DR PDBsum; 3N0N; -. DR PDBsum; 3N2P; -. DR PDBsum; 3N3J; -. DR PDBsum; 3N4B; -. DR PDBsum; 3NB5; -. DR PDBsum; 3NI5; -. DR PDBsum; 3NJ9; -. DR PDBsum; 3OIK; -. DR PDBsum; 3OIL; -. DR PDBsum; 3OIM; -. DR PDBsum; 3OKU; -. DR PDBsum; 3OKV; -. DR PDBsum; 3OY0; -. DR PDBsum; 3OYQ; -. DR PDBsum; 3OYS; -. DR PDBsum; 3P3H; -. DR PDBsum; 3P3J; -. DR PDBsum; 3P44; -. DR PDBsum; 3P4V; -. DR PDBsum; 3P55; -. DR PDBsum; 3P58; -. DR PDBsum; 3P5A; -. DR PDBsum; 3P5L; -. DR PDBsum; 3PJJ; -. DR PDBsum; 3PO6; -. DR PDBsum; 3PYK; -. DR PDBsum; 3QYK; -. DR PDBsum; 3R16; -. DR PDBsum; 3R17; -. DR PDBsum; 3RG3; -. DR PDBsum; 3RG4; -. DR PDBsum; 3RGE; -. DR PDBsum; 3RJ7; -. DR PDBsum; 3RLD; -. DR PDBsum; 3RYJ; -. DR PDBsum; 3RYV; -. DR PDBsum; 3RYX; -. DR PDBsum; 3RYY; -. DR PDBsum; 3RYZ; -. DR PDBsum; 3RZ0; -. DR PDBsum; 3RZ1; -. DR PDBsum; 3RZ5; -. DR PDBsum; 3RZ7; -. DR PDBsum; 3RZ8; -. DR PDBsum; 3S71; -. DR PDBsum; 3S72; -. DR PDBsum; 3S73; -. DR PDBsum; 3S74; -. DR PDBsum; 3S75; -. DR PDBsum; 3S76; -. DR PDBsum; 3S77; -. DR PDBsum; 3S78; -. DR PDBsum; 3S8X; -. DR PDBsum; 3S9T; -. DR PDBsum; 3SAP; -. DR PDBsum; 3SAX; -. DR PDBsum; 3SBH; -. DR PDBsum; 3SBI; -. DR PDBsum; 3T5U; -. DR PDBsum; 3T5Z; -. DR PDBsum; 3T82; -. DR PDBsum; 3T83; -. DR PDBsum; 3T84; -. DR PDBsum; 3T85; -. DR PDBsum; 3TMJ; -. DR PDBsum; 3TVN; -. DR PDBsum; 3TVO; -. DR PDBsum; 3U3A; -. DR PDBsum; 3U45; -. DR PDBsum; 3U47; -. DR PDBsum; 3U7C; -. DR PDBsum; 3V2J; -. DR PDBsum; 3V2M; -. DR PDBsum; 3V3F; -. DR PDBsum; 3V3G; -. DR PDBsum; 3V3H; -. DR PDBsum; 3V3I; -. DR PDBsum; 3V3J; -. DR PDBsum; 3V5G; -. DR PDBsum; 3V7X; -. DR PDBsum; 3VBD; -. DR PDBsum; 3ZP9; -. DR PDBsum; 4BCW; -. DR PDBsum; 4BF1; -. DR PDBsum; 4BF6; -. DR PDBsum; 4CA2; -. DR PDBsum; 4CAC; -. DR PDBsum; 4CQ0; -. DR PDBsum; 4DZ7; -. DR PDBsum; 4DZ9; -. DR PDBsum; 4E3D; -. DR PDBsum; 4E3F; -. DR PDBsum; 4E3G; -. DR PDBsum; 4E3H; -. DR PDBsum; 4E49; -. DR PDBsum; 4E4A; -. DR PDBsum; 4E5Q; -. DR PDBsum; 4FIK; -. DR PDBsum; 4FL7; -. DR PDBsum; 4FPT; -. DR PDBsum; 4FRC; -. DR PDBsum; 4FU5; -. DR PDBsum; 4FVN; -. DR PDBsum; 4FVO; -. DR PDBsum; 4G0C; -. DR PDBsum; 4GL1; -. DR PDBsum; 4HBA; -. DR PDBsum; 4HEW; -. DR PDBsum; 4HEY; -. DR PDBsum; 4HEZ; -. DR PDBsum; 4HF3; -. DR PDBsum; 4HT0; -. DR PDBsum; 4IDR; -. DR PDBsum; 4ILX; -. DR PDBsum; 4ITO; -. DR PDBsum; 4ITP; -. DR PDBsum; 4IWZ; -. DR PDBsum; 4JS6; -. DR PDBsum; 4JSA; -. DR PDBsum; 4JSS; -. DR PDBsum; 4JSW; -. DR PDBsum; 4JSZ; -. DR PDBsum; 4K0S; -. DR PDBsum; 4K0T; -. DR PDBsum; 4K0Z; -. DR PDBsum; 4K13; -. DR PDBsum; 4K1Q; -. DR PDBsum; 4KAP; -. DR PDBsum; 4KNI; -. DR PDBsum; 4KNJ; -. DR PDBsum; 4KUV; -. DR PDBsum; 4KUW; -. DR PDBsum; 4KUY; -. DR PDBsum; 4KV0; -. DR PDBsum; 4L5U; -. DR PDBsum; 4L5V; -. DR PDBsum; 4L5W; -. DR PDBsum; 4LHI; -. DR PDBsum; 4LP6; -. DR PDBsum; 4M2R; -. DR PDBsum; 4M2U; -. DR PDBsum; 4M2V; -. DR PDBsum; 4M2W; -. DR PDBsum; 4MDG; -. DR PDBsum; 4MDL; -. DR PDBsum; 4MDM; -. DR PDBsum; 4MLT; -. DR PDBsum; 4MLX; -. DR PDBsum; 4MO8; -. DR PDBsum; 4MTY; -. DR PDBsum; 4N0X; -. DR PDBsum; 4N16; -. DR PDBsum; 4PQ7; -. DR PDBsum; 4PXX; -. DR PDBsum; 4PYX; -. DR PDBsum; 4PYY; -. DR PDBsum; 4PZH; -. DR PDBsum; 4Q06; -. DR PDBsum; 4Q07; -. DR PDBsum; 4Q08; -. DR PDBsum; 4Q09; -. DR PDBsum; 4Q49; -. DR PDBsum; 4Q6D; -. DR PDBsum; 4Q6E; -. DR PDBsum; 4Q78; -. DR PDBsum; 4Q7P; -. DR PDBsum; 4Q7S; -. DR PDBsum; 4Q7V; -. DR PDBsum; 4Q7W; -. DR PDBsum; 4Q81; -. DR PDBsum; 4Q83; -. DR PDBsum; 4Q87; -. DR PDBsum; 4Q8X; -. DR PDBsum; 4Q8Y; -. DR PDBsum; 4Q8Z; -. DR PDBsum; 4Q90; -. DR PDBsum; 4Q99; -. DR PDBsum; 4Q9Y; -. DR PDBsum; 4QEF; -. DR PDBsum; 4QIY; -. DR PDBsum; 4QJM; -. DR PDBsum; 4QK1; -. DR PDBsum; 4QK2; -. DR PDBsum; 4QK3; -. DR PDBsum; 4QSA; -. DR PDBsum; 4QSB; -. DR PDBsum; 4QSI; -. DR PDBsum; 4QTL; -. DR PDBsum; 4QY3; -. DR PDBsum; 4R59; -. DR PDBsum; 4R5A; -. DR PDBsum; 4R5B; -. DR PDBsum; 4RFC; -. DR PDBsum; 4RFD; -. DR PDBsum; 4RH2; -. DR PDBsum; 4RIU; -. DR PDBsum; 4RIV; -. DR PDBsum; 4RN4; -. DR PDBsum; 4RUX; -. DR PDBsum; 4RUY; -. DR PDBsum; 4RUZ; -. DR PDBsum; 4WL4; -. DR PDBsum; 4WW6; -. DR PDBsum; 4XE1; -. DR PDBsum; 4Y0J; -. DR PDBsum; 4YGJ; -. DR PDBsum; 4YGK; -. DR PDBsum; 4YGL; -. DR PDBsum; 4YGN; -. DR PDBsum; 4YVY; -. DR PDBsum; 4YWP; -. DR PDBsum; 4YX4; -. DR PDBsum; 4YXI; -. DR PDBsum; 4YXO; -. DR PDBsum; 4YXU; -. DR PDBsum; 4YYT; -. DR PDBsum; 4Z0Q; -. DR PDBsum; 4Z1E; -. DR PDBsum; 4Z1J; -. DR PDBsum; 4Z1K; -. DR PDBsum; 4Z1N; -. DR PDBsum; 4ZAO; -. DR PDBsum; 4ZWI; -. DR PDBsum; 4ZWX; -. DR PDBsum; 4ZWY; -. DR PDBsum; 4ZWZ; -. DR PDBsum; 4ZX0; -. DR PDBsum; 4ZX1; -. DR PDBsum; 5A6H; -. DR PDBsum; 5AMD; -. DR PDBsum; 5AMG; -. DR PDBsum; 5AML; -. DR PDBsum; 5BNL; -. DR PDBsum; 5BRU; -. DR PDBsum; 5BRV; -. DR PDBsum; 5BRW; -. DR PDBsum; 5BYI; -. DR PDBsum; 5C8I; -. DR PDBsum; 5CA2; -. DR PDBsum; 5CAC; -. DR PDBsum; 5CLU; -. DR PDBsum; 5DOG; -. DR PDBsum; 5DOH; -. DR PDBsum; 5DRS; -. DR PDBsum; 5DSK; -. DR PDBsum; 5DSL; -. DR PDBsum; 5DSM; -. DR PDBsum; 5DSO; -. DR PDBsum; 5DSP; -. DR PDBsum; 5DSQ; -. DR PDBsum; 5DSR; -. DR PDBsum; 5E28; -. DR PDBsum; 5E2K; -. DR PDBsum; 5E2R; -. DR PDBsum; 5E2S; -. DR PDBsum; 5EH5; -. DR PDBsum; 5EH7; -. DR PDBsum; 5EH8; -. DR PDBsum; 5EHE; -. DR PDBsum; 5EHV; -. DR PDBsum; 5EHW; -. DR PDBsum; 5EIJ; -. DR PDBsum; 5EKH; -. DR PDBsum; 5EKJ; -. DR PDBsum; 5EKM; -. DR PDBsum; 5EOI; -. DR PDBsum; 5FDC; -. DR PDBsum; 5FDI; -. DR PDBsum; 5FLO; -. DR PDBsum; 5FLP; -. DR PDBsum; 5FLQ; -. DR PDBsum; 5FLR; -. DR PDBsum; 5FLS; -. DR PDBsum; 5FLT; -. DR PDBsum; 5FNG; -. DR PDBsum; 5FNH; -. DR PDBsum; 5FNI; -. DR PDBsum; 5FNJ; -. DR PDBsum; 5FNK; -. DR PDBsum; 5FNL; -. DR PDBsum; 5FNM; -. DR PDBsum; 5G01; -. DR PDBsum; 5G03; -. DR PDBsum; 5G0B; -. DR PDBsum; 5G0C; -. DR PDBsum; 5GMN; -. DR PDBsum; 5J8Z; -. DR PDBsum; 5JDV; -. DR PDBsum; 5JE7; -. DR PDBsum; 5JEG; -. DR PDBsum; 5JEH; -. DR PDBsum; 5JEP; -. DR PDBsum; 5JES; -. DR PDBsum; 5JG3; -. DR PDBsum; 5JG5; -. DR PDBsum; 5JGS; -. DR PDBsum; 5JGT; -. DR PDBsum; 5JMZ; -. DR PDBsum; 5JN3; -. DR PDBsum; 5JN7; -. DR PDBsum; 5JQ0; -. DR PDBsum; 5JQT; -. DR PDBsum; 5L3O; -. DR PDBsum; 5L6K; -. DR PDBsum; 5L6T; -. DR PDBsum; 5L70; -. DR PDBsum; 5L9E; -. DR PDBsum; 5LJQ; -. DR PDBsum; 5LJT; -. DR PDBsum; 5LL4; -. DR PDBsum; 5LL8; -. DR PDBsum; 5LLC; -. DR PDBsum; 5LLE; -. DR PDBsum; 5LLG; -. DR PDBsum; 5LLH; -. DR PDBsum; 5LMD; -. DR PDBsum; 5LVS; -. DR PDBsum; 5M78; -. DR PDBsum; 5MJN; -. DR PDBsum; 5N0D; -. DR PDBsum; 5N0E; -. DR PDBsum; 5N1R; -. DR PDBsum; 5N1S; -. DR PDBsum; 5N24; -. DR PDBsum; 5N25; -. DR PDBsum; 5NEA; -. DR PDBsum; 5NEE; -. DR PDBsum; 5NXG; -. DR PDBsum; 5NXI; -. DR PDBsum; 5NXM; -. DR PDBsum; 5NXO; -. DR PDBsum; 5NXP; -. DR PDBsum; 5NXV; -. DR PDBsum; 5NXW; -. DR PDBsum; 5NY1; -. DR PDBsum; 5NY3; -. DR PDBsum; 5NY6; -. DR PDBsum; 5NYA; -. DR PDBsum; 5O07; -. DR PDBsum; 5OGN; -. DR PDBsum; 5OGO; -. DR PDBsum; 5OGP; -. DR PDBsum; 5SZ0; -. DR PDBsum; 5SZ1; -. DR PDBsum; 5SZ2; -. DR PDBsum; 5SZ3; -. DR PDBsum; 5SZ4; -. DR PDBsum; 5SZ5; -. DR PDBsum; 5SZ6; -. DR PDBsum; 5SZ7; -. DR PDBsum; 5T71; -. DR PDBsum; 5T72; -. DR PDBsum; 5T74; -. DR PDBsum; 5T75; -. DR PDBsum; 5TFX; -. DR PDBsum; 5TH4; -. DR PDBsum; 5THI; -. DR PDBsum; 5THJ; -. DR PDBsum; 5THN; -. DR PDBsum; 5TI0; -. DR PDBsum; 5TXY; -. DR PDBsum; 5TY1; -. DR PDBsum; 5TY8; -. DR PDBsum; 5TY9; -. DR PDBsum; 5TYA; -. DR PDBsum; 5U0D; -. DR PDBsum; 5U0E; -. DR PDBsum; 5U0F; -. DR PDBsum; 5U0G; -. DR PDBsum; 5ULN; -. DR PDBsum; 5UMC; -. DR PDBsum; 5VGY; -. DR PDBsum; 5W8B; -. DR PDBsum; 5WEX; -. DR PDBsum; 5WG7; -. DR PDBsum; 5WGP; -. DR PDBsum; 5WLR; -. DR PDBsum; 5WLT; -. DR PDBsum; 5WLU; -. DR PDBsum; 5WLV; -. DR PDBsum; 5Y2R; -. DR PDBsum; 5Y2S; -. DR PDBsum; 5YUI; -. DR PDBsum; 5YUJ; -. DR PDBsum; 5YUK; -. DR PDBsum; 5ZXW; -. DR PDBsum; 6B00; -. DR PDBsum; 6B4D; -. DR PDBsum; 6B59; -. DR PDBsum; 6B5A; -. DR PDBsum; 6BBS; -. DR PDBsum; 6BC9; -. DR PDBsum; 6BCC; -. DR PDBsum; 6C7W; -. DR PDBsum; 6C7X; -. DR PDBsum; 6CA2; -. DR PDBsum; 6CEH; -. DR PDBsum; 6CJV; -. DR PDBsum; 6D1L; -. DR PDBsum; 6D1M; -. DR PDBsum; 6E8P; -. DR PDBsum; 6E8X; -. DR PDBsum; 6E91; -. DR PDBsum; 6E92; -. DR PDBsum; 6EBE; -. DR PDBsum; 6ECZ; -. DR PDBsum; 6EDA; -. DR PDBsum; 6EEA; -. DR PDBsum; 6EEH; -. DR PDBsum; 6EEO; -. DR PDBsum; 6EQU; -. DR PDBsum; 6FJI; -. DR PDBsum; 6FJJ; -. DR PDBsum; 6G3Q; -. DR PDBsum; 6G6T; -. DR PDBsum; 6GCY; -. DR PDBsum; 6GDC; -. DR PDBsum; 6GM9; -. DR PDBsum; 6GOT; -. DR PDBsum; 6GXB; -. DR PDBsum; 6GXE; -. DR PDBsum; 6H29; -. DR PDBsum; 6H2Z; -. DR PDBsum; 6H33; -. DR PDBsum; 6H34; -. DR PDBsum; 6H3Q; -. DR PDBsum; 6H6S; -. DR PDBsum; 6HD2; -. DR PDBsum; 6HQX; -. DR PDBsum; 6HR3; -. DR PDBsum; 6HX5; -. DR PDBsum; 6HXD; -. DR PDBsum; 6HZX; -. DR PDBsum; 6I0W; -. DR PDBsum; 6I1U; -. DR PDBsum; 6I2F; -. DR PDBsum; 6I3E; -. DR PDBsum; 6IC2; -. DR PDBsum; 6KLZ; -. DR PDBsum; 6KM0; -. DR PDBsum; 6KM1; -. DR PDBsum; 6KM2; -. DR PDBsum; 6KM3; -. DR PDBsum; 6KM4; -. DR PDBsum; 6KM5; -. DR PDBsum; 6KM6; -. DR PDBsum; 6LUU; -. DR PDBsum; 6LUV; -. DR PDBsum; 6LUW; -. DR PDBsum; 6LUX; -. DR PDBsum; 6LUY; -. DR PDBsum; 6LUZ; -. DR PDBsum; 6LV1; -. DR PDBsum; 6LV2; -. DR PDBsum; 6LV3; -. DR PDBsum; 6LV4; -. DR PDBsum; 6LV5; -. DR PDBsum; 6LV6; -. DR PDBsum; 6LV7; -. DR PDBsum; 6LV8; -. DR PDBsum; 6LV9; -. DR PDBsum; 6LVA; -. DR PDBsum; 6MBV; -. DR PDBsum; 6MBY; -. DR PDBsum; 6NJ2; -. DR PDBsum; 6NJ3; -. DR PDBsum; 6NJ4; -. DR PDBsum; 6NJ5; -. DR PDBsum; 6NJ6; -. DR PDBsum; 6NLV; -. DR PDBsum; 6NM0; -. DR PDBsum; 6ODZ; -. DR PDBsum; 6OE0; -. DR PDBsum; 6OE1; -. DR PDBsum; 6OTI; -. DR PDBsum; 6OTK; -. DR PDBsum; 6OTM; -. DR PDBsum; 6OTO; -. DR PDBsum; 6OTP; -. DR PDBsum; 6OTQ; -. DR PDBsum; 6OUB; -. DR PDBsum; 6OUD; -. DR PDBsum; 6OUE; -. DR PDBsum; 6OUF; -. DR PDBsum; 6OUH; -. DR PDBsum; 6OUI; -. DR PDBsum; 6OUJ; -. DR PDBsum; 6OUK; -. DR PDBsum; 6OUM; -. DR PDBsum; 6PDV; -. DR PDBsum; 6PEA; -. DR PDBsum; 6PGX; -. DR PDBsum; 6Q3O; -. DR PDBsum; 6Q9T; -. DR PDBsum; 6QEB; -. DR PDBsum; 6QFU; -. DR PDBsum; 6QFV; -. DR PDBsum; 6QFW; -. DR PDBsum; 6QFX; -. DR PDBsum; 6QL1; -. DR PDBsum; 6QL2; -. DR PDBsum; 6QL3; -. DR PDBsum; 6R6F; -. DR PDBsum; 6R6J; -. DR PDBsum; 6RFH; -. DR PDBsum; 6RG3; -. DR PDBsum; 6RG4; -. DR PDBsum; 6RG5; -. DR PDBsum; 6RH4; -. DR PDBsum; 6RHJ; -. DR PDBsum; 6RHK; -. DR PDBsum; 6RIG; -. DR PDBsum; 6RIT; -. DR PDBsum; 6RJJ; -. DR PDBsum; 6RKN; -. DR PDBsum; 6RL9; -. DR PDBsum; 6RM1; -. DR PDBsum; 6RMP; -. DR PDBsum; 6RMX; -. DR PDBsum; 6RMY; -. DR PDBsum; 6RNP; -. DR PDBsum; 6ROB; -. DR PDBsum; 6ROE; -. DR PDBsum; 6ROF; -. DR PDBsum; 6RQI; -. DR PDBsum; 6RRG; -. DR PDBsum; 6RRI; -. DR PDBsum; 6RS5; -. DR PDBsum; 6RSZ; -. DR PDBsum; 6RVF; -. DR PDBsum; 6RVK; -. DR PDBsum; 6RVL; -. DR PDBsum; 6RW1; -. DR PDBsum; 6RZX; -. DR PDBsum; 6S03; -. DR PDBsum; 6S9G; -. DR PDBsum; 6S9Z; -. DR PDBsum; 6SAC; -. DR PDBsum; 6SAS; -. DR PDBsum; 6SAY; -. DR PDBsum; 6SB7; -. DR PDBsum; 6SBH; -. DR PDBsum; 6SBL; -. DR PDBsum; 6SBM; -. DR PDBsum; 6SD7; -. DR PDBsum; 6SDH; -. DR PDBsum; 6SDI; -. DR PDBsum; 6SDJ; -. DR PDBsum; 6SDL; -. DR PDBsum; 6SDS; -. DR PDBsum; 6SEY; -. DR PDBsum; 6SFQ; -. DR PDBsum; 6SFU; -. DR PDBsum; 6SG0; -. DR PDBsum; 6SG6; -. DR PDBsum; 6SX9; -. DR PDBsum; 6SYB; -. DR PDBsum; 6SYS; -. DR PDBsum; 6T4N; -. DR PDBsum; 6T4O; -. DR PDBsum; 6T4P; -. DR PDBsum; 6T5C; -. DR PDBsum; 6T7U; -. DR PDBsum; 6T81; -. DR PDBsum; 6T9Z; -. DR PDBsum; 6U4Q; -. DR PDBsum; 6U4T; -. DR PDBsum; 6UFB; -. DR PDBsum; 6UFC; -. DR PDBsum; 6UFD; -. DR PDBsum; 6UGN; -. DR PDBsum; 6UGO; -. DR PDBsum; 6UGP; -. DR PDBsum; 6UGQ; -. DR PDBsum; 6UGR; -. DR PDBsum; 6UGZ; -. DR PDBsum; 6UH0; -. DR PDBsum; 6UX1; -. DR PDBsum; 6UZU; -. DR PDBsum; 6VJ3; -. DR PDBsum; 6VKG; -. DR PDBsum; 6WKA; -. DR PDBsum; 6WQ4; -. DR PDBsum; 6WQ5; -. DR PDBsum; 6WQ7; -. DR PDBsum; 6WQ8; -. DR PDBsum; 6WQ9; -. DR PDBsum; 6XVH; -. DR PDBsum; 6XWZ; -. DR PDBsum; 6XXT; -. DR PDBsum; 6YH4; -. DR PDBsum; 6YH5; -. DR PDBsum; 6YH6; -. DR PDBsum; 6YH7; -. DR PDBsum; 6YH8; -. DR PDBsum; 6YH9; -. DR PDBsum; 6YHA; -. DR PDBsum; 6YHB; -. DR PDBsum; 6YHC; -. DR PDBsum; 6YJ3; -. DR PDBsum; 6YKC; -. DR PDBsum; 6YKH; -. DR PDBsum; 6YMA; -. DR PDBsum; 6YMB; -. DR PDBsum; 6YO2; -. DR PDBsum; 6YO4; -. DR PDBsum; 6YO7; -. DR PDBsum; 6YOI; -. DR PDBsum; 6YOK; -. DR PDBsum; 6YOL; -. DR PDBsum; 6YPW; -. DR PDBsum; 6YQT; -. DR PDBsum; 6YQU; -. DR PDBsum; 6YRI; -. DR PDBsum; 6YZJ; -. DR PDBsum; 6YZK; -. DR PDBsum; 6YZL; -. DR PDBsum; 6YZM; -. DR PDBsum; 6YZN; -. DR PDBsum; 6YZO; -. DR PDBsum; 6YZP; -. DR PDBsum; 6YZQ; -. DR PDBsum; 6YZR; -. DR PDBsum; 6YZS; -. DR PDBsum; 6YZT; -. DR PDBsum; 6YZU; -. DR PDBsum; 6YZV; -. DR PDBsum; 6YZW; -. DR PDBsum; 6YZX; -. DR PDBsum; 6Z04; -. DR PDBsum; 6ZR8; -. DR PDBsum; 7A6V; -. DR PDBsum; 7AEQ; -. DR PDBsum; 7AES; -. DR PDBsum; 7AGN; -. DR PDBsum; 7ASJ; -. DR PDBsum; 7BFA; -. DR PDBsum; 7BG5; -. DR PDBsum; 7BHH; -. DR PDBsum; 7BI5; -. DR PDBsum; 7CA2; -. DR PDBsum; 7JNR; -. DR PDBsum; 7JNV; -. DR PDBsum; 7JNW; -. DR PDBsum; 7JNX; -. DR PDBsum; 7JNZ; -. DR PDBsum; 7JO0; -. DR PDBsum; 7JO1; -. DR PDBsum; 7JO2; -. DR PDBsum; 7JO3; -. DR PDBsum; 7JOB; -. DR PDBsum; 7JOC; -. DR PDBsum; 7K6I; -. DR PDBsum; 7K6J; -. DR PDBsum; 7K6K; -. DR PDBsum; 7K6L; -. DR PDBsum; 7K6T; -. DR PDBsum; 7K6U; -. DR PDBsum; 7K6X; -. DR PDBsum; 7K6Z; -. DR PDBsum; 7M23; -. DR PDBsum; 7M24; -. DR PDBsum; 7M26; -. DR PDBsum; 7MU3; -. DR PDBsum; 7NH6; -. DR PDBsum; 7NH8; -. DR PDBsum; 7NTB; -. DR PDBsum; 7NZR; -. DR PDBsum; 7NZS; -. DR PDBsum; 7NZT; -. DR PDBsum; 7NZU; -. DR PDBsum; 7NZW; -. DR PDBsum; 7NZX; -. DR PDBsum; 7OK8; -. DR PDBsum; 7ONM; -. DR PDBsum; 7ONP; -. DR PDBsum; 7ONQ; -. DR PDBsum; 7ONV; -. DR PDBsum; 7ORP; -. DR PDBsum; 7ORQ; -. DR PDBsum; 7OYM; -. DR PDBsum; 7OYN; -. DR PDBsum; 7OYO; -. DR PDBsum; 7OYP; -. DR PDBsum; 7OYQ; -. DR PDBsum; 7OYR; -. DR PDBsum; 7Q0C; -. DR PDBsum; 7Q0E; -. DR PDBsum; 7QBH; -. DR PDBsum; 7QGX; -. DR PDBsum; 7QGY; -. DR PDBsum; 7QGZ; -. DR PDBsum; 7QNV; -. DR PDBsum; 7QRK; -. DR PDBsum; 7QSE; -. DR PDBsum; 7QSI; -. DR PDBsum; 7QZX; -. DR PDBsum; 7R1X; -. DR PDBsum; 7RNY; -. DR PDBsum; 7RNZ; -. DR PDBsum; 7RRE; -. DR PDBsum; 7RRF; -. DR PDBsum; 7SUW; -. DR PDBsum; 7SUY; -. DR PDBsum; 7SV1; -. DR PDBsum; 7SV8; -. DR PDBsum; 7U5W; -. DR PDBsum; 7U5X; -. DR PDBsum; 7Y2A; -. DR PDBsum; 7Y2C; -. DR PDBsum; 7Y2E; -. DR PDBsum; 7Y2F; -. DR PDBsum; 7Y2G; -. DR PDBsum; 7Y2H; -. DR PDBsum; 7Y2I; -. DR PDBsum; 7Y2J; -. DR PDBsum; 7Y2K; -. DR PDBsum; 7Y2L; -. DR PDBsum; 7Y2M; -. DR PDBsum; 7Y2N; -. DR PDBsum; 7Y2O; -. DR PDBsum; 7Y2Q; -. DR PDBsum; 7Y2R; -. DR PDBsum; 7Y2S; -. DR PDBsum; 7Y2T; -. DR PDBsum; 7Y2U; -. DR PDBsum; 7Y2V; -. DR PDBsum; 7Y2W; -. DR PDBsum; 7Y2X; -. DR PDBsum; 7YWT; -. DR PDBsum; 7ZL6; -. DR PDBsum; 7ZWB; -. DR PDBsum; 8AA6; -. DR PDBsum; 8AAE; -. DR PDBsum; 8B29; -. DR PDBsum; 8BJX; -. DR PDBsum; 8BOE; -. DR PDBsum; 8BZZ; -. DR PDBsum; 8C0Q; -. DR PDBsum; 8C0R; -. DR PDBsum; 8CA2; -. DR PDBsum; 8CR0; -. DR PDBsum; 8DJ9; -. DR PDBsum; 8EM3; -. DR PDBsum; 8EMU; -. DR PDBsum; 8EXC; -. DR PDBsum; 8EXG; -. DR PDBsum; 8EYL; -. DR PDBsum; 8FAL; -. DR PDBsum; 8FAU; -. DR PDBsum; 8FQX; -. DR PDBsum; 8FQY; -. DR PDBsum; 8FQZ; -. DR PDBsum; 8FR1; -. DR PDBsum; 8FR2; -. DR PDBsum; 8FR4; -. DR PDBsum; 8IGF; -. DR PDBsum; 8J2O; -. DR PDBsum; 8JEE; -. DR PDBsum; 8OGD; -. DR PDBsum; 8OGE; -. DR PDBsum; 8OGF; -. DR PDBsum; 8OKE; -. DR PDBsum; 8OKG; -. DR PDBsum; 8OKJ; -. DR PDBsum; 8OKO; -. DR PDBsum; 8OKP; -. DR PDBsum; 8OKQ; -. DR PDBsum; 8OKT; -. DR PDBsum; 8OLA; -. DR PDBsum; 8OLF; -. DR PDBsum; 8OLI; -. DR PDBsum; 8OLK; -. DR PDBsum; 8OLM; -. DR PDBsum; 8OMB; -. DR PDBsum; 8OMH; -. DR PDBsum; 8OMN; -. DR PDBsum; 8OMP; -. DR PDBsum; 8OO8; -. DR PDBsum; 8OTP; -. DR PDBsum; 8OUB; -. DR PDBsum; 8P6U; -. DR PDBsum; 8PHL; -. DR PDBsum; 8PHM; -. DR PDBsum; 8Q0C; -. DR PDBsum; 8QF7; -. DR PDBsum; 8QF9; -. DR PDBsum; 8QFK; -. DR PDBsum; 8QH8; -. DR PDBsum; 8QHG; -. DR PDBsum; 8QHJ; -. DR PDBsum; 8QHO; -. DR PDBsum; 8QKZ; -. DR PDBsum; 8QQA; -. DR PDBsum; 8QUF; -. DR PDBsum; 8R1I; -. DR PDBsum; 8R2F; -. DR PDBsum; 8R2K; -. DR PDBsum; 8RAR; -. DR PDBsum; 8RBP; -. DR PDBsum; 8RJ2; -. DR PDBsum; 8RLP; -. DR PDBsum; 8RLQ; -. DR PDBsum; 8RNS; -. DR PDBsum; 8ROU; -. DR PDBsum; 8ROW; -. DR PDBsum; 8SAF; -. DR PDBsum; 8SAG; -. DR PDBsum; 8SD1; -. DR PDBsum; 8SD6; -. DR PDBsum; 8SD7; -. DR PDBsum; 8SD8; -. DR PDBsum; 8SD9; -. DR PDBsum; 8SF1; -. DR PDBsum; 8TTR; -. DR PDBsum; 8UFW; -. DR PDBsum; 8UFX; -. DR PDBsum; 8VQ5; -. DR PDBsum; 8VQ6; -. DR PDBsum; 8VQ7; -. DR PDBsum; 8VZG; -. DR PDBsum; 8WEP; -. DR PDBsum; 8WER; -. DR PDBsum; 8WES; -. DR PDBsum; 8ZWV; -. DR PDBsum; 9CA2; -. DR PDBsum; 9EN8; -. DR PDBsum; 9EN9; -. DR PDBsum; 9F15; -. DR PDBsum; 9F2E; -. DR PDBsum; 9F2F; -. DR PDBsum; 9FAI; -. DR PDBsum; 9FAO; -. DR PDBsum; 9FJQ; -. DR PDBsum; 9FJV; -. DR PDBsum; 9FPQ; -. DR PDBsum; 9FPR; -. DR PDBsum; 9FPS; -. DR PDBsum; 9FPT; -. DR PDBsum; 9FPU; -. DR PDBsum; 9G38; -. DR PDBsum; 9GAJ; -. DR PDBsum; 9GAK; -. DR PDBsum; 9GAM; -. DR PDBsum; 9GFV; -. DR PDBsum; 9GFW; -. DR PDBsum; 9GFX; -. DR PDBsum; 9GOO; -. DR PDBsum; 9GU7; -. DR PDBsum; 9GUM; -. DR PDBsum; 9GUO; -. DR PDBsum; 9H0V; -. DR PDBsum; 9H0W; -. DR PDBsum; 9H3H; -. DR PDBsum; 9HD6; -. DR PDBsum; 9HGP; -. DR PDBsum; 9HNX; -. DR PDBsum; 9HQ3; -. DR PDBsum; 9HQG; -. DR PDBsum; 9HWM; -. DR PDBsum; 9HXZ; -. DR PDBsum; 9I29; -. DR PDBsum; 9JWE; -. DR PDBsum; 9JWU; -. DR PDBsum; 9JWW; -. DR PDBsum; 9KH8; -. DR PDBsum; 9L2X; -. DR PDBsum; 9L2Y; -. DR PDBsum; 9L2Z; -. DR PDBsum; 9L30; -. DR PDBsum; 9L31; -. DR PDBsum; 9L32; -. DR PDBsum; 9L33; -. DR PDBsum; 9LDO; -. DR PDBsum; 9LDP; -. DR PDBsum; 9LR6; -. DR PDBsum; 9O8X; -. DR PDBsum; 9OAF; -. DR PDBsum; 9OAM; -. DR PDBsum; 9OBJ; -. DR PDBsum; 9P0W; -. DR PDBsum; 9RAY; -. DR PDBsum; 9U5B; -. PE 1: Evidence at protein level; KW 3D-structure; Acetylation; Cell membrane; Cytoplasm; KW Direct protein sequencing; Disease variant; Lyase; Membrane; Metal-binding; KW Osteopetrosis; Phosphoprotein; Proteomics identification; KW Reference proteome; Zinc. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000269|PubMed:4207120, FT ECO:0000269|PubMed:823150" FT CHAIN 2..260 FT /note="Carbonic anhydrase 2" FT /id="PRO_0000077418" FT DOMAIN 3..259 FT /note="Alpha-carbonic anhydrase" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU01134" FT ACT_SITE 64 FT /note="Proton donor/acceptor" FT /evidence="ECO:0000305|PubMed:15667203, FT ECO:0000305|PubMed:17330962" FT BINDING 94 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_note="catalytic" FT /evidence="ECO:0000269|PubMed:11076507, FT ECO:0000269|PubMed:12499545, ECO:0000269|PubMed:1336460, FT ECO:0000269|PubMed:1433293, ECO:0000269|PubMed:1909891, FT ECO:0000269|PubMed:19583303, ECO:0000269|PubMed:3151019, FT ECO:0000269|PubMed:3151020, ECO:0000269|PubMed:4621826, FT ECO:0000269|PubMed:7761440, ECO:0000269|PubMed:7803386, FT ECO:0000269|PubMed:7901850, ECO:0000269|PubMed:8218160, FT ECO:0000269|PubMed:8262987, ECO:0000269|PubMed:8331673, FT ECO:0000269|PubMed:8399159, ECO:0000269|PubMed:8431430, FT ECO:0000269|PubMed:8451242, ECO:0000269|PubMed:8482389, FT ECO:0000269|PubMed:8639494, ECO:0000269|PubMed:8987974, FT ECO:0000269|PubMed:9398308, ECO:0000269|PubMed:9865942" FT BINDING 96 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_note="catalytic" FT /evidence="ECO:0000269|PubMed:11076507, FT ECO:0000269|PubMed:12499545, ECO:0000269|PubMed:1336460, FT ECO:0000269|PubMed:1433293, ECO:0000269|PubMed:1909891, FT ECO:0000269|PubMed:19583303, ECO:0000269|PubMed:3151019, FT ECO:0000269|PubMed:3151020, ECO:0000269|PubMed:7761440, FT ECO:0000269|PubMed:7803386, ECO:0000269|PubMed:7901850, FT ECO:0000269|PubMed:8218160, ECO:0000269|PubMed:8262987, FT ECO:0000269|PubMed:8331673, ECO:0000269|PubMed:8399159, FT ECO:0000269|PubMed:8431430, ECO:0000269|PubMed:8451242, FT ECO:0000269|PubMed:8482389, ECO:0000269|PubMed:8639494, FT ECO:0000269|PubMed:8987974, ECO:0000269|PubMed:9398308, FT ECO:0000269|PubMed:9865942" FT BINDING 119 FT /ligand="Zn(2+)" FT /ligand_id="ChEBI:CHEBI:29105" FT /ligand_note="catalytic" FT /evidence="ECO:0000269|PubMed:11076507, FT ECO:0000269|PubMed:12499545, ECO:0000269|PubMed:1336460, FT ECO:0000269|PubMed:1433293, ECO:0000269|PubMed:1909891, FT ECO:0000269|PubMed:19583303, ECO:0000269|PubMed:3151019, FT ECO:0000269|PubMed:3151020, ECO:0000269|PubMed:7761440, FT ECO:0000269|PubMed:7803386, ECO:0000269|PubMed:7901850, FT ECO:0000269|PubMed:8218160, ECO:0000269|PubMed:8262987, FT ECO:0000269|PubMed:8331673, ECO:0000269|PubMed:8399159, FT ECO:0000269|PubMed:8431430, ECO:0000269|PubMed:8451242, FT ECO:0000269|PubMed:8482389, ECO:0000269|PubMed:8639494, FT ECO:0000269|PubMed:8987974, ECO:0000269|PubMed:9398308, FT ECO:0000269|PubMed:9865942" FT BINDING 198..199 FT /ligand="substrate" FT /evidence="ECO:0000269|PubMed:10550681, FT ECO:0000269|PubMed:19520834" FT SITE 7 FT /note="Fine-tunes the proton-transfer properties of H-64" FT /evidence="ECO:0000305|PubMed:17330962" FT SITE 62 FT /note="Fine-tunes the proton-transfer properties of H-64; FT involved in the binding of some activators, including FT histamine and L-histidine" FT /evidence="ECO:0000269|PubMed:16214338, FT ECO:0000269|PubMed:9265618, ECO:0000305|PubMed:17330962" FT SITE 67 FT /note="Fine-tunes the proton-transfer properties of H-64; FT involved in the binding of some activators, including FT histamine and L-histidine" FT /evidence="ECO:0000269|PubMed:16214338, FT ECO:0000269|PubMed:9265618, ECO:0000305|PubMed:17330962" FT SITE 92 FT /note="Involved in the binding of some activators, FT including histamine and L-histidine" FT /evidence="ECO:0000269|PubMed:16214338, FT ECO:0000269|PubMed:9265618, ECO:0000305|PubMed:17330962" FT MOD_RES 2 FT /note="N-acetylserine" FT /evidence="ECO:0000269|PubMed:4207120, FT ECO:0000269|PubMed:823150" FT MOD_RES 2 FT /note="Phosphoserine" FT /evidence="ECO:0000250|UniProtKB:P27139" FT MOD_RES 165 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:24275569" FT MOD_RES 172 FT /note="Phosphoserine" FT /evidence="ECO:0007744|PubMed:24275569" FT VARIANT 18 FT /note="K -> E (in Jogjakarta; dbSNP:rs118203931)" FT /evidence="ECO:0000269|PubMed:6817747" FT /id="VAR_001380" FT VARIANT 92 FT /note="Q -> P (in OPTB3; in Czechoslovakia; FT dbSNP:rs1304160279)" FT /evidence="ECO:0000269|PubMed:15300855, FT ECO:0000269|PubMed:9143915" FT /id="VAR_001381" FT VARIANT 94 FT /note="H -> Y (in OPTB3; partial loss of activity)" FT /evidence="ECO:0000269|PubMed:15300855" FT /id="VAR_021009" FT VARIANT 107 FT /note="H -> Y (in OPTB3; dbSNP:rs118203933)" FT /evidence="ECO:0000269|PubMed:15300855, FT ECO:0000269|PubMed:1542674, ECO:0000269|PubMed:1928091, FT ECO:0000269|PubMed:8834238" FT /id="VAR_001382" FT VARIANT 144 FT /note="G -> R (in OPTB3; complete loss of activity)" FT /evidence="ECO:0000269|PubMed:15300855" FT /id="VAR_021010" FT VARIANT 236 FT /note="P -> H (in Melbourne; dbSNP:rs118203932)" FT /evidence="ECO:0000269|PubMed:6407977" FT /id="VAR_001383" FT VARIANT 252 FT /note="N -> D (in dbSNP:rs2228063)" FT /id="VAR_001384" FT MUTAGEN 5 FT /note="W->A: Impaired activity, not rescued by FT 4-methylimidazole (4-MI); when associated with W-64." FT /evidence="ECO:0000269|PubMed:17071654" FT MUTAGEN 7 FT /note="Y->F: Enhanced activity." FT /evidence="ECO:0000269|PubMed:12171926, FT ECO:0000269|PubMed:17330962" FT MUTAGEN 7 FT /note="Y->H: Reduced proton transfer rate." FT /evidence="ECO:0000269|PubMed:12171926, FT ECO:0000269|PubMed:17330962" FT MUTAGEN 62 FT /note="N->A: Reduced activity." FT /evidence="ECO:0000269|PubMed:18942852" FT MUTAGEN 62 FT /note="N->D: Strongly reduced activity." FT /evidence="ECO:0000269|PubMed:18942852" FT MUTAGEN 62 FT /note="N->H: Reduced proton transfer; when associated with FT A-64." FT /evidence="ECO:0000269|PubMed:15667203, FT ECO:0000269|PubMed:17330962, ECO:0000269|PubMed:18942852" FT MUTAGEN 62 FT /note="N->L: Reduced activity." FT /evidence="ECO:0000269|PubMed:17330962, FT ECO:0000269|PubMed:18942852" FT MUTAGEN 62 FT /note="N->T: Reduced activity." FT /evidence="ECO:0000269|PubMed:18942852" FT MUTAGEN 62 FT /note="N->V: Reduced activity." FT /evidence="ECO:0000269|PubMed:18942852" FT MUTAGEN 64 FT /note="H->A: Reduced CO(2) hydrase activity, rescued by FT 4-methylimidazole (4-MI). Reduced proton transfer; when FT associated with H-62. Enhanced proton transfer; when FT associated with H-67. Enhanced proton transfer capacity; FT when associated with H-99." FT /evidence="ECO:0000269|PubMed:11327835, FT ECO:0000269|PubMed:15667203, ECO:0000269|PubMed:16106378, FT ECO:0000269|PubMed:17071654" FT MUTAGEN 64 FT /note="H->G: Impaired activity, not rescued by FT 4-methylimidazole (4-MI)." FT /evidence="ECO:0000269|PubMed:11327835, FT ECO:0000269|PubMed:16106378, ECO:0000269|PubMed:17071654" FT MUTAGEN 64 FT /note="H->W: Impaired activity, rescued by FT 4-methylimidazole (4-MI). Impaired activity, not rescued by FT 4-methylimidazole (4-MI); when associated with A-5." FT /evidence="ECO:0000269|PubMed:11327835, FT ECO:0000269|PubMed:16106378, ECO:0000269|PubMed:17071654" FT MUTAGEN 65 FT /note="A->F: Reduced activity." FT MUTAGEN 65 FT /note="A->S: 2-fold decrease in enzyme efficiency, as FT determined by kcat/KM ratio, and efficiently inhibited by FT chlorzolamide; when associated with Q-67." FT /evidence="ECO:0000269|PubMed:19170619" FT MUTAGEN 67 FT /note="N->H: Enhanced proton transfer; when associated with FT A-64." FT /evidence="ECO:0000269|PubMed:15667203" FT MUTAGEN 67 FT /note="N->L: Reduced activity." FT /evidence="ECO:0000269|PubMed:17330962" FT MUTAGEN 67 FT /note="N->Q: 2-fold decrease in enzyme efficiency, as FT determined by kcat/KM ratio, and efficiently inhibited by FT chlorzolamide; when associated with S-65." FT /evidence="ECO:0000269|PubMed:19170619" FT MUTAGEN 94 FT /note="H->C,D,E,N,Q: Strongly reduced CO(2) hydrase and FT p-nitrophenyl acetate esterase activities, impaired FT stability of zinc binding." FT /evidence="ECO:0000269|PubMed:8431430, FT ECO:0000269|PubMed:9398308" FT MUTAGEN 106 FT /note="E->A,Q: Strongly reduced CO(2) hydrase activity." FT /evidence="ECO:0000269|PubMed:15299482, FT ECO:0000269|PubMed:7901850" FT MUTAGEN 106 FT /note="E->D: Normal CO(2) hydrase activity." FT /evidence="ECO:0000269|PubMed:15299482, FT ECO:0000269|PubMed:7901850" FT MUTAGEN 117 FT /note="E->Q: Strongly reduced activity and sulfonamide FT affinity." FT /evidence="ECO:0000269|PubMed:8639494" FT MUTAGEN 119 FT /note="H->D,N,Q: Reduced activity." FT /evidence="ECO:0000269|PubMed:9398308" FT MUTAGEN 119 FT /note="H->E: Strongly reduced activity." FT /evidence="ECO:0000269|PubMed:9398308" FT MUTAGEN 121 FT /note="V->A,G,I,L,S: Reduced CO(2) hydrase and FT p-nitrophenyl acetate esterase activities." FT /evidence="ECO:0000269|PubMed:1910042" FT MUTAGEN 121 FT /note="V->K,R: Strongly reduced CO(2) hydrase and FT p-nitrophenyl acetate esterase activities." FT /evidence="ECO:0000269|PubMed:1910042" FT MUTAGEN 142 FT /note="V->F,Y: Strongly impaired activity." FT /evidence="ECO:0000269|PubMed:1932029" FT MUTAGEN 142 FT /note="V->G: Weakly impaired activity." FT /evidence="ECO:0000269|PubMed:1932029" FT MUTAGEN 142 FT /note="V->H: Impaired activity." FT /evidence="ECO:0000269|PubMed:1932029" FT MUTAGEN 197 FT /note="L->A: Reduced CO(2) hydrase activity." FT /evidence="ECO:0000269|PubMed:8485129" FT MUTAGEN 197 FT /note="L->E,H,R: Strongly reduced CO(2) hydrase activity." FT /evidence="ECO:0000269|PubMed:8485129" FT MUTAGEN 197 FT /note="L->F: Normal activity." FT /evidence="ECO:0000269|PubMed:8485129" FT MUTAGEN 198 FT /note="T->A,C,H,P: Strongly reduced activity." FT /evidence="ECO:0000269|PubMed:12056894, FT ECO:0000269|PubMed:7761440, ECO:0000269|PubMed:7901850, FT ECO:0000269|PubMed:8262987, ECO:0000269|PubMed:8399159" FT MUTAGEN 198 FT /note="T->D,E: Strongly reduced activity, but enhanced zinc FT affinity." FT /evidence="ECO:0000269|PubMed:12056894, FT ECO:0000269|PubMed:7761440, ECO:0000269|PubMed:7901850, FT ECO:0000269|PubMed:8262987, ECO:0000269|PubMed:8399159" FT MUTAGEN 198 FT /note="T->S,V: Reduced activity." FT /evidence="ECO:0000269|PubMed:12056894, FT ECO:0000269|PubMed:7761440, ECO:0000269|PubMed:7901850, FT ECO:0000269|PubMed:8262987, ECO:0000269|PubMed:8399159" FT MUTAGEN 199 FT /note="T->H: Higher affinity for bicarbonate. Enhanced FT proton transfer capacity; when associated with A-64." FT /evidence="ECO:0000269|PubMed:16106378, FT ECO:0000269|PubMed:1909891, ECO:0000269|PubMed:8451242" FT MUTAGEN 199 FT /note="T->S: Enhanced p-nitrophenyl acetate esterase FT activity, but normal CO(2) hydrase activity." FT /evidence="ECO:0000269|PubMed:16106378, FT ECO:0000269|PubMed:1909891, ECO:0000269|PubMed:8451242" FT MUTAGEN 201 FT /note="P->A: Normal CO(2) hydrase activity, but impaired FT stability." FT /evidence="ECO:0000269|PubMed:8218160" FT CONFLICT 179..180 FT /note="DP -> AA (in Ref. 6; AAH11949)" FT /evidence="ECO:0000305" FT HELIX 3..5 FT /evidence="ECO:0007829|PDB:9F2F" FT STRAND 6..8 FT /evidence="ECO:0007829|PDB:5Y2R" FT TURN 9..11 FT /evidence="ECO:0007829|PDB:3K34" FT TURN 13..15 FT /evidence="ECO:0007829|PDB:3K34" FT HELIX 16..18 FT /evidence="ECO:0007829|PDB:3K34" FT HELIX 21..24 FT /evidence="ECO:0007829|PDB:3K34" FT STRAND 25..27 FT /evidence="ECO:0007829|PDB:3K34" FT STRAND 31..33 FT /evidence="ECO:0007829|PDB:2X7S" FT TURN 35..37 FT /evidence="ECO:0007829|PDB:3K34" FT STRAND 38..40 FT /evidence="ECO:0007829|PDB:3KS3" FT STRAND 42..44 FT /evidence="ECO:0007829|PDB:3KOI" FT STRAND 45..50 FT /evidence="ECO:0007829|PDB:3K34" FT STRAND 56..61 FT /evidence="ECO:0007829|PDB:3K34" FT STRAND 63..70 FT /evidence="ECO:0007829|PDB:3K34" FT STRAND 73..75 FT /evidence="ECO:0007829|PDB:3K34" FT STRAND 77..82 FT /evidence="ECO:0007829|PDB:3K34" FT TURN 83..85 FT /evidence="ECO:0007829|PDB:5GMN" FT STRAND 88..97 FT /evidence="ECO:0007829|PDB:3K34" FT STRAND 99..103 FT /evidence="ECO:0007829|PDB:6Q9T" FT STRAND 106..109 FT /evidence="ECO:0007829|PDB:3K34" FT STRAND 115..124 FT /evidence="ECO:0007829|PDB:3K34" FT HELIX 125..127 FT /evidence="ECO:0007829|PDB:3K34" FT HELIX 130..133 FT /evidence="ECO:0007829|PDB:3K34" FT STRAND 139..151 FT /evidence="ECO:0007829|PDB:3K34" FT HELIX 154..156 FT /evidence="ECO:0007829|PDB:3K34" FT HELIX 157..162 FT /evidence="ECO:0007829|PDB:3K34" FT HELIX 163..165 FT /evidence="ECO:0007829|PDB:3K34" FT STRAND 172..174 FT /evidence="ECO:0007829|PDB:3K34" FT HELIX 180..183 FT /evidence="ECO:0007829|PDB:3K34" FT STRAND 190..195 FT /evidence="ECO:0007829|PDB:3K34" FT STRAND 198..202 FT /evidence="ECO:0007829|PDB:6QEB" FT STRAND 206..213 FT /evidence="ECO:0007829|PDB:3K34" FT STRAND 215..217 FT /evidence="ECO:0007829|PDB:3K34" FT HELIX 219..225 FT /evidence="ECO:0007829|PDB:3K34" FT TURN 226..228 FT /evidence="ECO:0007829|PDB:4QK3" FT STRAND 229..231 FT /evidence="ECO:0007829|PDB:3K34" FT STRAND 233..236 FT /evidence="ECO:0007829|PDB:7Q0C" FT HELIX 245..247 FT /evidence="ECO:0007829|PDB:3K34" FT HELIX 253..255 FT /evidence="ECO:0007829|PDB:6SAY" FT STRAND 256..258 FT /evidence="ECO:0007829|PDB:3K34" SQ SEQUENCE 260 AA; 29246 MW; 2EC2BB7548F10558 CRC64; MSHHWGYGKH NGPEHWHKDF PIAKGERQSP VDIDTHTAKY DPSLKPLSVS YDQATSLRIL NNGHAFNVEF DDSQDKAVLK GGPLDGTYRL IQFHFHWGSL DGQGSEHTVD KKKYAAELHL VHWNTKYGDF GKAVQQPDGL AVLGIFLKVG SAKPGLQKVV DVLDSIKTKG KSADFTNFDP RGLLPESLDY WTYPGSLTTP PLLECVTWIV LKEPISVSSE QVLKFRKLNF NGEGEPEELM VDNWRPAQPL KNRQIKASFK //